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Abstract 
 
Human African trypanosomiasis (HAT), also known as sleeping sickness, has been a 
major health problem for populations in Africa caused by the Trypanosoma brucei 
spp parasite. Although, the current number of the reported cases is on the decrease, 
more efforts are required to try to control or eliminate the disease. The recent 
advances in molecular techniques have contributed towards identifying taxonomic 
groups at all levels (species, subspecies, populations, strains and isolates). 
Commonly, field samples are collected and stored using Whatman FTA cards. Many 
molecular epidemiological tools are available for detection and strain typing in 
trypanosomes. These tools include nested ITS-PCR, which is based on size variation 
of the ITS genes and MGE-PCR, which is based on variations in position of mobile 
genetic elements (MGEs). Although commonly used, these tools have not been fully 
validated. For example, the ITS-PCR has not been used or validated against blood 
samples obtained from sleeping sickness patients in Angola. Furthermore, the MGE-
PCR system has not been evaluated for use directly from FTA cards. 
The aim of this thesis is to develop improved molecular tools to assist diagnostic and 
epidemiological studies. In order to improve the molecular diagnostic use of Whatman 
FTA cards, an extraction method based on Chelex was investigated.  Using Chelex to 
extractT. brucei DNA from FTA cards, followed by a nested ITS-PCR detection 
system, allowed parasite DNA detection to 1ng/µl. To evaluate this tool on field 
samples, ITS-PCR amplification was carried on DNA eluted by Chelex extraction from 
36 FTA cards spotted with blood from Angolan patients tested positive for 
trypanosomiasis by the card agglutination test (CATT). Twenty four of these samples 
were successfully PCR amplified using mammalian tubulin primers.  Of these 24 
samples, 11 (= 45.8%) were confirmed as trypanosome positive utilising a specific 
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ITS-PCR based approach.  As such, this indicates that further work is necessary to 
improve the PCR-based reliability of diagnosis. 
To this end, an MGE-PCR approach was used to attempt parasite strain identification.. 
Although the MGE-PCR was found to be more sensitive than ITS-PCR in 
amplification of DNA from FTA cards, the resulting sequence data was not able to 
confirm that the amplicons were of trypanosome origin and hence further analysis, or 
approaches, are required. 
With a view to developing new diagnostic tools a bioinformatic analysis of mobile 
elements inserted in RHS/pseudogenes in the T.brucei genome was carried out. The 
aims of this were to locate variable regions of these genes that could be used as 
detailed markers for trypanosome strain identification. Sequences of the RHS genes 
were retrieved from the T.brucei brucei and T. brucei gambiense genomes to 
investigate positional diversity of MGEs within this family of genes. Differences were 
found in the presence/absence of RIME elements in one RHS gene between the two 
subspecies. More detailed investigation of all RHS gene classes in T. b. brucei showed 
six classes of RHS gene types and within each class, individual sequences showed 
evidence of insertion by MGEs. In some specific instances, evidence of pre-insertion, 
insertion and subsequent removal of MGEs was seen. This enabled a temporal 
evolutionary sequence of events to be interpreted. As such, the RHS genes offer the 
opportunity to develop specific molecular epidemiological tools for investigating the 
evolution of MGEs in field samples and to carry out temporally informed epidemiological 
tracking of isolates.
XII  
 Introduction 
 
Human African Trypanosomiasis (HAT) which is also known as sleeping sickness is 
a disease was associated with sleeping inappropriately. This is due to neurological 
disturbances associated with the second stage of the disease, when parasites have 
become manifest in the central nervous system (Barrett, 1999; Kennedy, 2005). The 
African trypanosomiases comprise a group of economically important animal 
diseases and medically important zoonotic diseases that affect much of sub Saharan 
Africa. With economic losses in cattle production alone being in the range of US$ 1.0 
- 1.2 billion (Daffala et al., 2013). HAT is considered as a serious public health 
problem that is caused by trypanosomes, protozoan parasites, transmitted by tsetse 
flies (Glossina). However, it is not considered as important on the world stage as 
diseases such as malaria and AIDS, but it is an important disease and responsible 
for an extensive degree of suffering and mortality in countries where it is endemic 
(Hide, 1999).  
In addition, it occurs in 36 African countries between latitudes 14° North and 29° 
south. Following the geographical distribution of the tsetse fly, more than 50 million 
people living in some 200 foci in this area are at risk of acquiring the infection 
(Kuzoe, 1993). 
The World Health Organisation (WHO) estimates suggest that 500,000 new cases of 
sleeping sickness occur each year with about 60 million people considered at risk, 
variations in the annual number of reported cases must be interpreted with caution 
due to the impact of the civil war on case-finding (TDR, 2004). Furthermore, according 
to TDR, (2002) less than 4 million people are under surveillance and only about 40,000 
are diagnosed and treated. 
However, thanks to an ambitious campaign led by WHO, many nongovernmental 
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organizations and a public private partnership with Sanofi- Aventis and Bayer 
donates and distributes the necessary drugs to WHO for use in affected countries 
(Simarro et al., 2011a). According to WHO (2012) in 2012 the number of reported 
cases was fewer than 8000, thus WHO have designed a road map to eliminate 
sleeping sickness as a public health problem by 2020. 
1.1 History of human sleeping sickness (HAT) 
 
The first report of human sleeping sickness is ascribed to Arabic historians describing 
the death of King Diata II, Sultan of Mali in 1373 (De Raadt, 1999), whereas, nagana 
of cattle has been known since 15th century (Nash, 1969). At the beginning of 1900, 
the importance of trypanosomes as pathogens was recognized by Timothy Richards 
Lewis and Griffith Evans in India and by Sir David Bruce in East Africa all of whom 
gave their names to species of trypanosomes (Goodwin, 1985). However, the first time 
that a trypanosome infection was reported in humans was by Forde in the Gambia in 
1901 (Forde, 1902) he managed to find the parasites in the blood of a European 
suffering from recurrent fevers. Furthermore, between 1900 and 1915 Portuguese, 
British, French, German and Belgian scientific teams were sent out to Africa. Their aim 
was to study the cause, the factors which help the spreading of the disease, and the 
severity of the problem in the respective colonies. Since then sleeping sickness has 
become part of the domains of biological and medical science (WHO, 2005). 
On the other hand, between 1895 and 1910 there were serious epidemics in several 
regions, mainly in the Congo basin, especially northern Angola and around the Lake 
Victoria basin for this epidemic period the total number of deaths due to 
trypanosomiasis in the Congo basin was estimated at 500,000 and in the Lake Victoria 
region at around 250,000 (TDR, 2004). 
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Moreover, by the end of 19th century, the colonial authorities in Africa had become 
more seriously concerned about the trypanosomiasis problems (livestock and 
human disease). Between 1939 and 1960 mobile teams in French colonies of west 
and central Africa had examined 73,000,000 individuals and detected 250,000 cases 
(Pépin and Méda, 2001). In the 1960s, tsetse and trypanosomiasis research and 
control services were well established throughout most of the endemic regions of 
Africa. The number of cases of human sleeping sickness decreased to an estimated 
level of no more than 15,000 and 25,000 per year for the whole continent (TDR, 2004). 
1.2 The pathogenic parasite- Trypanosoma brucei 
 
The trypanosome is a spindle-shaped cell (20 to 30 by 1.5 to 3.5 nm) with a single 
flagellum. The flagellum is structured as the posterior end, runs along the cell 
membrane, to which it is attached by an undulating membrane, and extends beyond 
the anterior part of the cell. The base of the flagellum is associated with the 
kinetoplast, a large particle containing the DNA of the single mitochondrion 
(Chappuis et al., 2005). 
Although there are many species of trypanosome, several species cause important 
veterinary diseases, and only two cause significant human diseases. In sub-
Saharan Africa, Trypanosoma brucei causes sleeping sickness, and in America, 
Trypanosoma cruzi causes Chagas disease, transmission of both species can also 
be via blood transfusion, contaminated needles, or the congenital route. 
Rarely, transmission of T cruzi by breastfeeding or through contaminated food has 
been reported (Barrett et al., 2003). On the other hand, cattle infections caused by T. 
congolense and T. vivax are by far the most serious, both for frequency and for 
economic influence (Flneile et al., 1983). Moreover, T. brucei is taxonomically 
divided into three subspecies; largely based on their geographical origin, infectivity to 
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humans and severity of disease T. b. brucei, T. b. gambiense and T. b. rhodesiense. 
 
T. b. brucei is distributed across sub-Saharan Africa, and is restricted to non-human 
vertebrates, in which it can cause nagana, a chronic wasting disease (Hoare, 1972). 
T. b. gambiense is restricted to West and Central Africa, where it causes a chronic 
form of sleeping sickness in humans the Gambian form of sleeping sickness caused 
by. T. b. gambiense, was traditionally viewed as primarily a human infection, but it 
has become clear that a broad range of wild and domestic animal reservoirs also 
harbor the parasite (Mehlitz et al., 1982; Cordon-Obra et al., 2009). T. b. rhodesiense 
is a human infective subspecies and is found in eastern and southern Africa and 
causes an acute form of sleeping sickness. T. b. rhodesiense is a zoonotic disease 
for which non-human vertebrates are the primary reservoir (Hoare, 1972). Since T. b. 
gambiense is less virulent than T. b. rhodesiense there is a widespread belief that T. 
b. gambiense is evolutionarily older than T. b. rhodesiense and T. b. brucei based on 
the hypothesis that parasites generally evolve towards becoming more benign as 
they adapt to their host, an assumption that is not necessarily supported by evidence 
(Bull, 1994; Ebert et al., 1996). 
Besides this, another hypothesis is that T. b. rhodesiense may evolve through 
frequent genetic exchange with sympatric T. b. brucei, leading to a mosaic of 
different T. b. rhodesiense genotypes distributed throughout endemic regions of 
eastern Africa (Komba et al., 1997; Gibson et al., 2002). Laboratory studies have 
demonstrated that T. brucei is capable of sexual reproduction (Jenni et al., 1986) 
and that crosses between T. b. brucei and T. b. rhodesiense can produce viable 
progeny (Gibson, 1985). Although, T. b. gambiense and T. b. rhodesiense shares 
99% of the genome sequence identity with T. b. brucei (Jackson et al., 2010), each 
has evolved distinct  mechanisms to escape lysis by human serum; these are the 
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causative agents of human African trypanosomiasis (Simarro et al., 2011a). In vitro 
tests, in which trypanosomes are incubated with human blood or serum (e.g. blood-
incubation- infectivity test (Rickman and Robson, 1970) or human-serum-resistance 
test (Jenni and Brun., 1980) are based on the trypanosome lytic factors (TLFs) 
present in human blood, which can lyse T. b.brucei but not T.b.rhodesiense (due to 
the presence of human-serum-resistance-associated (SRA) ) or T.brucei.gambiense 
(Raper et al., 2001). Surprisingly, African trypanosomes have more than one 
mechanism of human-serum resistance, because SRA was not detectable in T. b. 
gambiense by analysis of mRNA or DNA (Wellburn et al., 2001) Attempts to 
discover the corresponding mechanism in T.b.gambiense have not yet fully 
succeeded, although similar approaches to that used to discover the SRA gene in 
T.b.rhodesiense have been tried (Berberof et al., 2001). However, Berberof et al. 
(2001) have reported a gene which is absolutely specific to T. b. gambiense, termed 
as T. gambiense-specific glycoprotein (TgsGP). In contrast to SRA, TgsGP cannot 
confer normal human serum, progressive deletion of the TgsGP sub-telomeric 
region revealed that TgsGP is necessary for resistance to normal human serum 
(Uzureau et al., 2013). Genetic analysis indicated that T. b. brucei is closely related 
to T. b. rhodesiense. The hypothesis of a common ancestor for both T. b. 
rhodesiense and T. b. brucei was mentioned (Gibson et al., 1999). 
T. b. gambiense (chronic) is responsible for 95% of the current cases of HAT 
(WHO, 2012). Rhodesiense HAT has epidemic potential in humans, as it has been 
responsible for large outbreaks in the past (Köerner et al., 1995; Hide, 1999). As 
between 1900 and 1915   T. b. rhodesiense recorded the largest epidemic killed 
more than 250 000 people over 15 years (Langlands, 1999). Due to different 
factors, the geographical gap between the two forms has been reducing in 
Northwest Uganda and on the border between the United Republic of Tanzania and 
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the Democratic Republic of Congo, and in the future, an overlap of the two forms 
could occur (Piccozzi et al., 2005). The three subspecies share all the 
morphological features, which make the diagnosis and identification harder. Also 
these taxonomic criteria have some gaps, for instance it is clear that both T. b. 
gambiense and T. b. rhodesiense have animal reservoir hosts, thus by implication 
an isolate from animal is not necessarily non-human infective (Hide, 1999). 
T.b. gambiense is fatal which may lead to death if left untreated. In addition, it is 
found as two stages; first stage and second stage. First stage starts from the bite of 
testse fly which characterized chronic and intermittent fever, headache, pruritus, 
lymphadenopathy and, to a lesser extent, hepato-splenomegaly. Whereas, in the 
second stage is characterized by sleeping disturbances, neuro-psychiatric disorders 
and the rare presence of fever. Neurological symptoms in second stage is described 
by tremor, fasciculation, general motor weakness, paralysis of an extremity, 
hemiparesis, akinesia and abnormal movements such as dyskinesia or 
choreoathetosi (Kennedy, 2006). 
1.3 Life cycle of T. brucei 
 
Trypanosome life cycles can be considered relatively complex, and can be divided 
into two events in the tsetse fly and inside the mammalian (figure 1-1) (Vickerman, 
1985; Dyer et al., 2013). Firstly, the life cycle of the trypanosome inside the 
mammalian host; the life-cycle begins when the tsetse fly injects the metacyclic 
forms into the mammalian host, and then starts the adaption phase adapted for life 
in the bloodstream inside a tsetse. The metacyclic form is morphologically 
characterized including differentiating and proliferating into; long, slender 
bloodstream forms known as trypomastigote forms (infective form) (Vickerman, 
1985). During this form diagnoses can be carried in accordance with the presence of 
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the variant surface glycoprotein (VSG) coat that will protect the parasite in order to 
survive in the host. (Despommier et al., 2005; MacGregor et al., 2010). Then the 
blood form can enter into different body fluids, such as lymph and cerebrospinal fluid, 
and can also enter the placenta (WHO, 2013). From the fluids the parasite will 
migrate to the organs particularly the brain and central nervous system (CNS). 
T. b. rhodesiense establishes itself within the CNS within a few weeks (Odiit et al., 
1997) while T. b. gambiense takes an average of 300–500 days to manifest in the 
CNS (Checchi et al., 2008a). 
On the other hand, events occurring inside the vector begins when the tsetse fly 
takes a blood meal and the parasites are in bloodstream trypomastigote forms, then 
they migrate to the midgut. Next, once they arrive to the midgut, trypomastigote 
forms start to differentiate, via the oesophagus, proboscis, and hypopharynx they 
migrate to the salivary gland, where they are able to multiply and some of them can 
transform into infectious metacyclic forms (Sharma et al., 2009). During this 
migration from the midgut to the salivary glands, the parasite population size 
experiences a pronounced reduction (Oberle et al., 2010). The whole cycle in the 
vector takes 18–35 days, and once infected, a tsetse fly remains so for the rest of its 
lifespan (Vickerman et al., 2003). 
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Figure 1-1. The life cycle of T. brucei in the vector and in the host; numbers represent the number of 
stages in order 
 
1.4 Transmission cycle 
 
According to (WHO, 2013) HAT has two forms of transmission according to the 
form of the disease whether it is chronic that caused by T. b. gambiense, or it 
is acute form, caused by T. b. rhodesiene. Gambiense HAT is an infectious 
disease that involves a minor role for animal reservoirs, while Rhodesiense 
HAT is a zoonotic disease, affecting mainly animals; humans are only 
accidental hosts (Franco et al., 2014a). Although, the tsetse fly has a considerably 
low capability as vector for gambiense HAT, also the amount of parasitemias in 
human is usually low; the long duration of human infection with an extended few 
symptoms period is considered sufficient to maintain a human–fly–human 
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transmission cycle (Robays et al., 2004). However, rarely animals can play role 
in transmission of Gambiense HAT. As Njiokou et al., 2010 described that 
T.b.gambiense was found in domestic and wild animals, shows the transmission 
cycle of the T. b. gambiense. Some studies show that experimental infections of 
animals with T. b. gambiense are limited in time, always lasting less than 1 year 
(Schütt et al., 1981). Therefore, more data are needed to clarify the role played by 
the animal reservoir in maintaining gambiense transmission when the prevalence 
of human infection is low and elimination is envisaged. 
On the other hand, domestic and wild animals play a major role in T. b. rhodesiense 
sleeping sickness transmission cycle. Intensified man to man transmission occurs 
during epidemic. The strong zoonotic character of the T. b. rhodesiense form of the 
disease considerably complicates surveillance and control issues, requiring action on 
the fly or on the animals hosting the parasite. 
1.5 The vector- Tsetse fly 
 
Tsetse fly (Glossina spp.) is the only known biological vector of human 
trypanosomiasis. It can be described as brown in colour with an extended snout, the fly 
ranges from one-quarter to two-thirds inches (0.6 to 1.7 cm) long, the smaller 
varieties being slightly larger than a housefly. Of the 30 known living tsetse species, 
only eleven are of positive or possible epidemiological importance as trypanosome 
vector (Knight, 1971). Tsetse flies are subdivided into three subgenera based on 
morphological differences in the structure of the genitalia: Morsitans (Glossina), 
Palpalis (Nemorhina), and Fusca (Austenina) groups (Despommier et al., 2005). 
Tsetse flies are geographically restricted to sub-Saharan Africa, between the latitudes 
of 14°N and 29°S, south of the Sahel desert, and north of the Namibian and Kalahari 
deserts (Figure 1-2) (Fèvre et al., 2006). Some pockets of G. morsitans and G.fuscipes 
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have been reported in south western Saudi Arabia (Elsen et al., 1991). All the species 
of tsetse flies are potentially cyclical vectors of trypanosomes, but in nature the 
infection is carried almost exclusively by G. fuscipes, G. palpalis, and G. morsitans 
(Franco et al., 2014a). 
 
Figure 1-2. The distribution of T. b. gambiense (highlighted in yellow)   and T. b. rhodesiense 
(highlighted in blue) and subgenera of tsetse fly in Africa 
Source: Atlas of Human Infectious Diseases (2012) 
 
 
Recently the full genome of Glossina morsitans has been fully sequenced (Attardo et 
al., 2014). This breakthrough will certainly help in controlling the disease, by 
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understanding the pathways of transmission particularly those which occur in the 
tsetse fly saliva. As the authors have reported a family of genes, the tsal genes, which 
are particularly active in the salivary glands of the tsetse fly. This allows the tsetse fly 
to counteract the responses from the host to stop bloodfeeding. This finding and 
several others could be useful in developing new tools that could reduce or even 
eradicate tsetse flies.  
1.6 Epidemiology African sleeping sickness 
The first reported isolation of T. b. rhodesiense from a sleeping sickness patient was 
in 1908 (Hide, 1999). On the other hand, T. b. gambiense HAT at the turn of the 
twentieth century (1896– 1906), is estimated to have killed 800 000 people in 
equatorial Africa. The disease (HAT) resurged in the 1920s, threatening both West 
and Central Africa; the T. b. rhodesiense outbreak lasted for a decade in some 
localized areas and for much longer in larger countries. The epidemics are raging in 
the worn- torn areas of southern Sudan, northern Uganda, the Democratic Republic 
of Congo, and Angola (Hide, 1999). (Figure 1-3) shows the distribution of HAT across 
Africa reported in 2013. 
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Figure 1-3. The number of HAT (T.b.gambiense and T.b.rhodesiense ) cases and the geographical 
distribution in 2013. 
Source: http://www.who.int/mediacentre/factsheets/fs259/en/ (Accessed on 20/12/14). 
 
 
According to figure (1-3), out of the known 36 endemic countries, over 90% of the 
cases were reported from Angola, Democratic Republic of Congo, southern Sudan 
and Uganda. Thus, T. b. gambiense trypanosomiasis is considered one of the major 
public health problems in Central Africa, especially in the Democratic Republic of 
Congo (DRC), Angola and southern Sudan, where ongoing civil wars have negative 
effect on the control efforts to such an extent that national statistics give only a very 
incomplete view of the problem. Better information is available in DRC, the total 
number of people at risk is estimated by the national control programme to be 
12,500,000. The WHO Expert Committee on HAT control and surveillance in 1995 
estimated that the true prevalence of gambiense HAT was 300 000 cases. The 
number of cases reported annually increased noticeably from about 10,000 in 1980 
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to more than 27,000 in 1998 in DRC. About 2% of DRC’s population carries 
the disease, with prevalence in some communities reaching 70% (Barrett, 
1999). 
Moreover, Angola is considered as the second highest incidence of HAT; 
respectively 8275 and 6610 new cases were reported in 1997 and 1998 by the national 
control programme. The disease is endemic in the north-west provinces, the 
prevalence rates reported vary between 1.3% and 9.7% (Barrett, 1999).  
From 1997-2006 24 countries out of the 36 endemic countries showed greatest 
burden of the disease due to T.b.gambiense (WHO, 2006). In 2006 11 out of these 24 
countries have reported no cases (Wellburn and Maudlin, 2012). These data, 
especially for T.b. gambiense, illustrate an encouraging trend for countries where 
concerted efforts have been mounted (mainly Angola, DRC, and Sudan) to control 
HAT and the decrease in incidence in recent years is due in large part to enormous 
efforts involving active case detection (Fèvre et al., 2008). (Figure1-4) illustrate the 
number of HAT cases reported from 1997 to 2013. 
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 Figure 1-4. The number of cases of HAT reported from 1997-2013 
(Simarro et al., 2011; WHO, 2013) 
 
 Furthermore, Uganda is the only country where both sub-species are found as they 
are currently less than 100 km apart T. b. gambiense in the north –west and T. 
b. rhodesiense in the south-east. Between 1000 and 1200 T .b. gambiense cases 
were reported annually in 1995-2000. Whereas, T. b. rhodesiense cases it is less than 
T .b. gambiense, only 271 cases were reported in 1997. In addition, a major 
epidemic of Rhodesian HAT devastated south-east Uganda from the mid-1970s, with a 
cumulative total of about 40,000 new cases for 15 years (Pépin and Méda, 2001). 
Picozzi et al., (2005) have screened 231 blood samples were collected from the 
central Uganda (2001-2005) and 91 from northeast of Uganda (2003). The screening 
was carried based on the detection of SRA and TgsGP genes. The authors have 
reported that all the samples from central Uganda are classified as T.b.rhodesiense, 
where as all the samples from northeast Uganda are classified as T.b.gambiense  
Moreover, in Sudan where reliable statistics are not available, the foci of T. b. 
gambiense HAT are located in the southern part of the Equatorial region, west of the 
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Nile, within 100 kilometres of the borders with Central African Republic (CAR), the 
DRC and Uganda. Extrapolations suggest that there must be at least a few thousand 
cases per year. In other countries of Central Africa, HAT is more or less an emerging 
public health problem (Franco et al., 2014a). 
The increase of gambiense HAT cases in the first third of the 20th century, which 
reached, in some cases, epidemic levels, generated a response from colonial 
governments that were initially based on the application of vector control measures, 
and later on the deployment of mobile teams that visited the villages in the at-risk areas 
to conduct systematic screening of the entire population and to treat the detected 
cases (Ekwanzala et al., 1996; Moore and Richer, 2001). 
 
The trend in cases reported of gambiense HAT showed a decrease in the reported 
cases of the disease of 76% since 2000, with a number of around 7,000 cases 
reported in the last 3 years (WHO, 2013). Between 2000 and 2009, the annual case 
detection rate decreased by 63% at the same time as geographical and population 
coverage by active screening increased (Simarro et al., 2011a). This promising result 
continued in 2010 and 2011. In 2011, the number of new cases reported to WHO 
was 6631 (Simarro et al., 2013). The Democratic Republic of the Congo currently 
bears most of the disease burden. Nevertheless, HAT mainly affects remote rural 
communities where the health infrastructure is basic; furthermore, there are other 
endemic areas where accessibility is complicated because of security problems or 
topography constraints. Therefore, a certain number of cases are not recognized and 
diagnosed (Simarro et al., 2011a) despite the fact that epidemiological knowledge 
about the disease has improved considerably in the past decade there is still a gap 
between the number of cases declared and the number of actual cases. 
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Elsewhere in East and Southern Africa, the incidence of T. b. rhodesiense 
trypanosomiasis remains low. In West Africa, the disease has regressed or 
disappeared from several countries as ecological changes reduced the intensity of 
man-fly contact (Pépin and Méda, 2001). Reporting from most countries endemic T . b. 
rhodesiense trypanosomiasis is fairly irregular, as the disease is not regarded as 
priority. For instance Tanzania report between 200 and 400 cases per year, and there 
are several foci throughout the country. Additionally, lower figures are reported in 
Zambia and in Kenya, where the disease is seen essentially near the Ugandan border, 
in contrast fewer than 20 cases per year are reported in Rwanda, Mozambique, Malawi, 
Botswana, Zimbabwe (Pépin and Méda. 2001).  
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Furthermore, trypanosomiasis is not found equally in males and females, in some foci 
the incidence and prevalence is higher in males if the tsetse population is denser in 
areas of typically male activities (Pépin and Méda, 2001). Females often participate 
more regularly in case-finding sessions, which can lead to a higher number of cases 
(WHO, 2001). Which may causes a misleading if the estimation was only by the 
number of cases (Pépin and Méda, 2001). 
On the other hand, children under the age of 10 years usually have a three to five folds 
lower incidence than adults, and the reason is the differential exposure, as tsetse 
populations are often more abundant in fishing and farming sites than in the villages. 
Furthermore, individuals over 50 to 60 years of age are less risk to trypanosomiasis, 
than in middle-aged adults. Occupation is also related to exposure and to incidence, 
for example in Côte d’Ivoire HAT is more frequent in coffee and cocoa plantation 
workers or in people who fetch water than in other inhabitants. Nearly 80% of cases 
occur in people who not only work but live in small plantation settlements; a case 
control study showed that such people were five times more likely to develop 
trypanosomiasis, than their counterpart who lived in villages (Pépin and Méda, 2001). 
1.6.1 Sleeping sickness in Angola 
 
The total population of Angola is about 24 million (World Bank, 2014) Since gaining 
independence in 1975, Angola has seen a cruel civil war, which over nearly 30 years, 
has devastated the country, destroyed the infrastructure and left a severely 
traumatized population (Abel et al., 2004). Daily conditions of life throughout the 
country and specifically Luanda (population approximately 6 million) mirror the 
collapse of administrative infrastructure as well as many social institutions. Attempts 
were made by the United Nations (UN) to promote a process of peace and 
reconciliation failed (United Nations Department of Public Information 1995), and only 
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after the death of the UNITA opposition leader Jonas Savimbi in February 2002, has 
raised a new glimpse of hope. The peace agreement signed on 4 April 2002 between 
the Angolan government and UNITA, which have initiated a new era of stability and 
progress for the country (Abel et al., 2004). Since the adoption of a new constitution 
in 2010, the politics of Angola takes place in a framework of a presidential republic, 
whereby the President of Angola is both head of state and head of government, and 
of a multi-party system. Executive power is exercised by the government. Legislative 
power is vested in the President, the government and parliament. The health system 
has witnessed signs of improvements (constitution net [online]).  
Moreover, HAT was first considered as a health problem in Angola  in 1871. The first 
reported case of HAT in Angola was in the 
Quicama municipality province (Janssens, 1996).  However, it took several decades 
for the fight against the disease to be systematically organized. By 1926, the 
Portuguese colonial government had created the first specialized unit for HAT control. 
In 1949, the first mobile team was formed to screen the population in the affected 
areas. Less than 10 years later, nearly the whole population in the endemic zones 
was under constant surveillance. At the same time, antitrypanosomal treatment 
became available (Abel et al., 2004). In 1974, a year before the independence, only 
three cases were reported the entire country (Stanghellini and Josenando, 2001). 
Subsequently, due to the civil war  the number of population screening  fell 
dramatically. The level of professional performance of health workers declined 
constantly, as the activities of nursing schools and regular training programmes for 
laboratory technicians gradually came to a standstill. As a result, HAT returned to 
Angola in a devastating dimension, as the number of cases have risen from 3 in 1974 
(Abel et al., 2004) to 1274 in 1994 (WHO, 1998). However, a project was created in 
1995 and started its activities in 1996 under the name ANGOTRIP, an acronym 
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combining the two words Angola and trypanosomiasis. As part of Caritas de Angola, 
ANGOTRIP could make use of the widespread and sustainable infrastructure of the 
Catholic Church, which was of great advantage even during highly volatile periods, 
when the UN and international NGOs were no longer able to reach the local 
population. However, it did not have a major impact on reducing the reported number 
of cases, as the number of cases has increased dramatically to 6610 in 1998 
(Stanghellini and Josenando, 2001).  
Since 2001 in Angola, 80% of patients have been found to be in the 
meningoencephalitic stage of the disease (Truc et al., 2012). Moreover, in 2001, 
during a resurgence of the infection, WHO and partners established a public–
private partnership to bring the disease under control. This was effective within a 
short time, in terms of reducing the number of reported cases of HAT (Figure 1-4). 
Angola was not an exception as the number of cases fell to 4577 (WHO, 2013). 
Also, in 2004, therefore, the World Health Assembly passed a resolution 
(WHA57.2) to enhance control in order to move towards elimination. In 2011, in 
view of the 70% decrease in the number of cases reported to WHO in the previous 
decade. The resolution could be considered as a huge relief for Angolans as the 
number of reported cases kept falling. Finally, The Atlas was initiated in 2007 as a 
collaborative project between WHO and the Food and Agriculture Organization of 
the United Nations (FAO) in the framework of the programme against African 
trypanosomiasis. The Atlas is an excellent basis for monitoring changes in 
distribution and epidemiology and for using spatial analytical methods to estimate 
the size and location of populations at risk (WHO, 2013). Again Angola has majorly 
benefited from this project as the number of cases has decreased since the number 
of reported cases has fallen noticeably to 517 cases in 2008 (WHO, 2013). In the 
period from 2009–2013, 82% of gambiense HAT cases were reported from the 
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Democratic Republic of the Congo, 5.5% from the Central African Republic, 4% 
from Chad, 3.5% from South Sudan, 2% from Angola, and the remaining 3% from 
another five countries (Cameroon, Congo, Cote d’Ivoire, Equatorial Guinea, Gabon 
(Franco et al., 2014a).  The current trends of the number of cases has shown 
promising signs of controlling the disease in Angola since fewer than 100 cases 
have been reported per year in Angola (Table 1-1).  (WHO, 2015) 
 
Country 
2004 
2005 
 2006 
 2007 
 2008 
 2009 
 2010 
 2011 
 2012 
2013 
Angola 2280 1727 1105 648 517 247 211 154 70 69 
Table 1-1. The number of cases reported of T. b. gambiense sleeping sickness between 2004 and 2013 
in Angola (Simarro et al., 2008; WHO, 2013). 
 
Moreover, Angola (northwest region) is considered as high intensity transmission 
country along with Chad (southern region); the Central African Republic (Northwestern 
and Southeastern regions), Equatorial Guinea (Southwestern region), Gabon 
(Northwestern region), Congo (central and Southern regions), the Democratic Republic 
of the Congo (in Northern, Northwestern, central, and Eastern parts), South Sudan 
(Southwestern region), and Uganda (Northwestern region) (Simmaro et al., 2013). 
There are three subgenus of tsetse fly  responsible for transmitting HAT which are; G. 
palpalis, G. fuscipes and G. morsitans (Figure 1-5).   
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Figure 1-5. Geographical locations of tsetse fly sub-species in Angola, the circle highlights the 
provinces which are endemic for HAT. (Stanghellini & Josenando, 2001) and (Truc et al., 2011) 
Angola is divided into 18 provinces (see Figure1-5). The chronic form of HAT, caused 
by T.b.gambiense, occurs in seven of the 14 provinces where tsetse flies are present 
(in Bengo, Cuanza Norte, Uige, Cuanza Sul, Zaire, Malange, and the periphery of 
Luanda). The acute form of the disease, caused by T. b. rhodesiense transmitted by 
Glossina morsitans centralis, could once be found in the southern province of 
Cuando Cubango (where 30% of new Angolan HAT cases were diagnosed between 
1964 and 1974;  Josenando, unpubl. obs.) (Truc et al., 2011). 
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1.6.2 Current situation of HAT 
 
Although the current situation of the reported gambiense HAT number of cases is 
promising, but it should be observed with some caution. The infection affects 
mainly remote rural communities, where the health infrastructure is basic, and 
cases may be unrecognized or unreported. Some of the known active foci are 
difficult to access because they are insecure or the topography is challenging. 
When active case detection is conducted in previously inaccessible or neglected 
foci, gambiense HAT can be found, often at a substantial prevalence (Chappuis et 
al., 2010). Despite these gaps, knowledge of the current epidemiological situation 
has improved considerably in the past decade. In 1995, the gap between the 
numbers of reported and actual cases was estimated to be factor of 12 (WHO, 
1998) by 2006 the number has decreased to factor of three (Weekly 
Epidemiological Record, 2006). Despite these achievements, much effort is still 
required to gather more accurate data on HAT in order that its designation as a 
Neglected Tropical Disease may be eliminated (Fèvre et al, 2008). Out of 36 
countries listed as endemic, only 30 have received the exclusive support of WHO 
including assessing the epidemiological status of HAT or to establish control and 
surveillance activities, the 6 countries which have not received WHO support are; 
Botswana, Burundi, Ethiopia, Gambia, Namibia and Niger. (WHO, 2013). The 
support of WHO was given as; firstly technical assistance, which given by WHO 
staff. Secondly, provide  the patients easy access to diagnosis; this is can be given 
by providing the equipment, reagents, logistics, and funds which will allow the 
national teams to reach HAT transmission areas to perform active case-finding 
surveys and set up passive surveillance. Also, WHO gave support in form of 
facilitating the access to the treatment; this includes the provision of drugs as well 
as patient accessibility (Simarro et al., 2011a). 
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Furthermore, between 2000 and 2010, 94 HAT cases were diagnosed in 19 non- 
endemic countries, of which 72% were due to T. b. rhodesiense: of them, 82% were 
diagnosed at the first stage. For comparison, among 26 cases of T. b. gambiense 
HAT cases, 77% were diagnosed at the second stage (Simarro et al., 2011b). 
As for gambiense HAT, current trends in the number of cases reported by countries 
endemic for rhodesiense HAT are encouraging. Although, is difficult to make firm 
predictions about changes in the incidence of rhodesiense HAT. As long as 
reservoirs and environments for transmission exist, there will be a risk, and 
unpredictable ecological or social changes may result in extensive transmission 
(WHO, 2013). 
http://apps.who.int/iris/bitstream/10665/95732/1/9789241209847_eng.pdf). 
Finally, WHO have designed a road map to eliminate gambiense HAT by 2020, 
Elimination as a public health problem is defined as less than 1 new case per 10 
000 inhabitants in at least 90% of foci, with fewer than 2000 cases reported 
annually at continental level. The 2020 goal is an intermediate step. The final goal, 
in accordance with the recommendations of the Neglected Tropical Disease (NTD), 
is to interrupt transmission of gambiense-HAT by 2030 (WHO, 2012). 
In term of disease transmission risk, the risk is only limited to the foci of the disease 
and cannot be generalized on a national or continental scale. Based on new 
longitudinal analysis of the data included in the WHO Atlas of HAT and global 
population distribution layers, the extension and the location of different levels of risk 
has been estimated. Hence, it has been estimated that~70 million people live at 
different levels of risk for HAT infection. In addition to 57 million (81%) people 
distributed over an area of approximately 1.38 million km2 are at risk of gambiense 
HAT; this population is distributed in 14 of the 24 countries listed as endemic for 
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gambiense HAT. Moreover, 12.3 million people are at risk of contracting  
rhodesiense HAT, and they are distributed over an area of 0.171 million km2 
(Simarro et al., 2012). More than 5 million people live in areas classified as high or 
very high risk for contracting HAT. The Democratic Republic of the Congo has the 
greatest number of people at risk (36 million) for HAT and the largest risk area 
(790,000 km2) (Simarro et al., 2012) (Figure 1-6).  
 
Figure 1-6. Population at risk of HAT in Africa 
(Franco et al., 2014). 
1.7 Diagnosis of Trypanosomiasis 
 
Rapid and accurate diagnostic tools are vital in diagnosing HAT, also they play an 
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important role in meeting the “road map” set by WHO. The symptoms of the early 
stage of HAT including headaches, fever, fatigue and joint pain cannot considered as 
a definitive indicators of trypanosome infection, thus HAT is often mistakenly 
identified as other diseases such as influenza or malaria (Odiit et al, 2004)). Also, 
since the available drugs to treat sleeping sickness are either toxic or cumbersome 
to administer, and because symptoms are generally not specific enough to start 
treatment (Debaorggraeve and Büscher, 2010). The classical diagnosis of human 
African trypanosomiasis (HAT) is a 3-step approach: identification of suspects, 
parasitological confirmation, and disease staging. For the diagnosis of T. b. 
gambiense infection, relatively simple, reliable antibody tests can be used for 
screening (WHO, 2013). Most tests for detecting antibodies of T. b. gambiense 
contain selected VSGs of variable antigen types LiTat 1.3 and 1.5. Despite the 
abundance of VSG genes, most patients with T. b. gambiense infection appear to 
carry antibodies in their blood that react with at least one of the two VSGs. 
For the diagnosis of T. b. gambiense infection, a rapid agglutination test is available 
that can be used in mass screening. Individual rapid diagnostic tests have also been 
developed, which are more appropriate for passive screening and are under 
evaluation. Tests based on immunofluorescence and enzyme-linked immunosorbent 
assays (ELISAs) are more appropriate for laboratory testing (WHO, 2013). The 
immune trypanolysis test is considered to be for use in reference laboratories. 
Serological tests detect antibodies only 3–4 weeks after infection, which may be one 
of the reasons for false-negative reactions. Cross-reactivity with other parasitoses 
may occur, particularly in whole blood or at low serum or plasma dilutions. In some 
rapid diagnostic tests for HIV and malaria, cross-reactions with HAT blood 
specimens may occur, decreasing the specificity of those tests (4, 5). 
1.7.1 Parasitological Diagnosis 
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Microscopy is considered as the most widely used and simplest of diagnostic 
techniques and relies on direct observation (identification stage) of the parasites 
either in blood, lymph or cerebrospinal fluid. Although being widely used, these 
techniques are not considered sensitive enough to detect low parasite levels, 
especially in chronic cases (Luckins, 1992). The sensitivity of the microscopy 
examination can be increased; with haematocrit centrifugation technique (HCT) 
developed by Woo (1970) using centrifugation of microhaematocrit capillary tubes 
containing the blood sample and examination of the buffy coat/plasma junction under 
the microscope. In a positive diagnosis, trypanosomes are found wriggling at the 
junction of the buffy layer and the plasma (Woo, 1970), with an estimated detection 
threshold of 500 trypanosomes/ml (Chappuis et al., 2005). 
1.7.2 Card Agglutination Test for Trypanosomiasis 
The card agglutination test for trypanosomiasis (CATT) is a rapid, simple assay for 
the detection of specific antibodies in patients with gambiense HAT (Magnus et al., 
1978). Because of its simplicity, reliability and low cost, it is used in all control 
programmes for serological screening of populations at risk for T. b. gambiense 
(WHO, 2013). 
The antigens originate from particular variable antigen types (VATs) of T. b. 
gambiense that are highly conserved across the range of this species and they are 
expressed early with infection. Therefore, the majority of infected individuals develop 
antibodies that cause visible agglutination when whole blood or serum is mixed with 
the antigen on the card (Eisler et al., 2004). The CATT antigen consists of complete 
bloodstream forms of T. b. gambiense variable antigen type LiTat 1.3. To prepare 
the antigen, trypanosomes are purified from infected rat blood, fixed, stained with 
Coomassie blue and freeze-dried. Kits contain the reagent, positive and negative 
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control sera and materials for performing the test on whole blood (capillary tubes, 
test cards, stirring rods, suction bulbs, syringe and droppers) (WHO, 2013).The 
specificity of the test for T. b. gambiense varies between 87% and 98%, with an 
average of 95% (Robays et al., 2004). Despite a specificity of about 97%, the 
positive predictive value  remains limited when the test is used for mass screening in 
populations in which the overall prevalence of gambiense HAT is low (Checchi et al., 
2011). On the other hand, False-negative CATT results may be obtained for patients 
infected with strains of trypanosomes that do not express the LiTat 1.3 gene, 
resulting in lower sensitivity of CATT in some endemic areas (Dukes et al., 1992). 
False-negative CATT results in the presence of high antibody concentrations may 
also be found because of prozone (disequilibrium between the relative amounts of 
antibody and antigen) when undiluted blood, plasma or serum dilutions below 1/4 
are tested (WHO, 2013).  
However, decisions to treat should not be made when only CATT on undiluted blood 
is positive and parasite tests are negative. CATT titration on diluted blood, serum or 
plasma is imperative. Taking into account the disease prevalence and the feasibility 
of maintaining control activities, a cut-off point should be selected from a preceding 
study on serological characteristics in the area (Simarro et al., 1999). 
Simarro et al. (1991) have previously reported a sera from 124 parasitologically 
confirmed individuals from the same focus that yielded a positive  
CATT/T.b.gambiense in 120 individuals (97%)and the end titre point was 
determined optimal at 1/8.. The authors suggested on the basis of these results, 
non-parasitologically confirmed CATT-positives should be divided into three groups: 
individuals with an end titre of 1/4 were considered not infected and were not 
followed-up; those with end-titres of 1/4 or 1/8 were suspected of trypanosomiasis 
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and were included in group A for follow-up andindividuals with end titres above 1/8 
were strongly suspected of trypanosomiasis and were included in group B for follow-
up. However, according to a CATT/T.b.gambiense study  on  4753 individuals from 
the focus of Quiçama (Angola), it was concluded that the treatment should be given 
to all cases with an end titre > 1/8 even without parasitological confirmation, but 
always after lumbar puncture for staging and selection of the appropriate drug 
(Simarro et al, 1999). It should be kept in mind that some individuals could be 
treated unnecessarily, probablywith a not extremely toxic drug such as pentamidine, 
but many trypanosomiasis patients who otherwise would not have been detected 
would receive appropriate treatment. 
The diagnostic method regarding the T. b. rhodesiense disease is different from that 
for T. b. gambiense in several ways; first there is no involvement of serological 
screening test for T. b. rhodesiense, the detection of suspected cases depends on 
the non-specific clinical presentation and history of exposure. Second, since the 
density of blood circulating parasites is higher than for T. b. gambiense 
parasitological confirmation is easier for T. b. rhodesiense. A thin or thick blood 
smear is usually sufficient to confirm diagnosis. Third, biological indicators such as 
haemoglobin and platelet counts and coagulation tests are more frequently or 
substantially changed in African trypanosomiasis caused by T. b. rhodesiense than 
in that caused by T. b. gambiense, but these findings remain non-specific (Brun et 
al., 2010). 
1.7.3 Molecular Diagnosis 
 
The identification and surveillance of infectious agents and in determining sources of 
infection had a major boost by the involvement of molecular tools. 
Molecular identification is playing an important role in discriminating different 
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parasites with morphologically identical life cycle stages, include eggs or cysts, from 
faecal samples, or when attempting to match different life cycle stages of the same 
parasite from intermediate and definitive hosts (Crsione et al., 2005). For instance, 
Thomson et al., 2011 have reported that in some endemic areas of hookworm, 
human may be infected with more than one species. However, the identified eggs in 
the faeces are morphologically identical. 
Also, molecular tools play a major role in studying the epidemiology of infectious 
agents (Traub et al., 2005). According to Dorman (1992) the molecular definition is 
known as “a science that focuses on the contribution of potential genetic and 
environmental risk factors, identified at molecular level, to the aetiology, distribution 
and prevention of disease within families and cross populations”. 
The most used tool is the polymerase chain reaction (PCR), which allows direct 
examination of clinical or environmental isolates has had an enormous impact on the 
genetic characterization, diagnosis and taxonomy of parasite (Lymbery and 
Thompson, 2012). PCR is considered as a sensitive and speciﬁc method for the 
detection and identiﬁcation of human-infective trypanosomes .PCR also prevent the 
need for laboratory amplification of parasite isolates, as it was the major obstacle in 
characterising parasites refractory to in vitro culture (Lymbery and Thompson, 2012). 
Defined gene sequences of infectious agents can be detected from small quantities 
of material and the resultant data can be detected by PCR, which can be used not 
only for diagnosis, but also to assess the effect of interventions on the population 
structure of infectious agents, assessment of intra-species diversity, and 
transmission studies (Lymbery and Thompson, 2012). 
Furthermore, molecular tools play an important role in solving taxanomic issues that 
resulted in controversy in the past, when new species or strains were described on 
the basis of host occurrence, phenotypic characteristics and epidemiological 
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observations. Molecular applications function to solve such problems is can be 
described in two stages; first different genetic groups are found within what is 
ostensibly a single morphologically defined species, secondly these groups are 
defined as taxonomic categories, either at intraspecifc level or as different species or 
higher taxa (Lymbery and Thompson, 2012). 
Moreover, the first development of PCR use in identification and detection of 
trypanosome was first published in 1989 by Moser et al. (1989). They used PCR to 
amplify a 188-base pair (bp) segment of the repetitive 195-bp nuclear DNA 
sequence of T.cruzi that is the most abundant sequence in this organism. 
Kouadio et al. (2014) compared between buffy coat technique (BCT) and species- 
specific PCR to detect trypanosome species in 363 cattle samples from Côte 
d’Ivoire; out of 363 cattle examined with BCT, 33 were found positive with all 
trypanosome species accounting for an average of 9.09% prevalence whereas PCR 
using species-specific primers showed that 81 out of 363 cattle were infected with 
trypanosomes with an overall prevalence of 22.31%. Trypanosoma  congolense 
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savanah type, T.vivax and T. brucei sl. accounted for 28.39%, 49.38% and 23.45% 
of the infection rate respectively. 
1.7.3.1 Genetic Markers 
 
There are 11 different pathogenic trypanosomes in trypanosomiasis endemic regions 
of Africa which are can be identified by molecular methods, and which relies on 
species-specific markers (Njiru et al., 2005). In addition, the sensitivity and specificity 
of a diagnostic PCR is largely related to DNA sequence targeted by the primers. 
(Table 1-2 and Table 1-3) shows the number of markers designed for T.b.gambiense 
and T.b.rhodesiense respectively. Satellite DNA markers has been a common target 
used for detection and identification of Trypanosoma ( brucei spp., evansi and 
equiperdum), the species vivax and simiae, and the three main Trypanosoma 
congolense types (savannah, forest, and Kenya Coast) (Clausen et al., 1998). In the 
case of satellite DNA one pair of primers is needed to detect each subgenus, species 
or type, which leads to the processing of three to five different PCRs per sample. 
Thus, many attempts were tried to carry out multiplex reactions, but the   sensitivity   
of the tests decreased and some combinations of primers induced the synthesis      
of `non-specific (and non-expected) size products (Picozzi et al., 2008). 
Thus, the conserved sequences which are unique for the target group that occurs in 
multiple copies in the parasite genome, acts as templates in the diagnostic PCRs 
(Debaorggraeve and Büscher, 2010). Several DNA sequences have been used for 
the sensitive and specfic PCR-based detection of livestock trypanosome DNA in host 
blood and/or in tsetse flies (Masiga et al., 1992). T. b. gambiense has been 
characterized by another specific molecular marker, the T. b. gambiense TgsGP. 
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The sequence of the TgsGP which encodes a flagellar pocket glycoprotein, were 
found to be diagnostic for T. b. gambiense only (Berberof et al., 2001). Primers 
targeting this sequence were designed by Radwanska et al. (2002a) and were found 
to be specific for the amplification of TgsGP of T. b. gambiense when tested against 
non-T.b.gambiense populations revealing negative results. The detection limit of the 
reaction was evaluated; it reached 1000 trypanosomes/ml of blood after a single 
PCR.  
 
 
Target Size of 
amplified 
Products 
Primer Sequences Ref 
AnTat 11.17 VSG 
gene 
653 bp AnTA: 5’-CAC AGA CGA CAG 
AAG CGA TA-3’ 
(Bromidge et al., 
1993) 
AnTB: 5’-GAA AGT GGG AGT 
TGT TGCTC-3’ 
Non conserved 
sequence 
of kDNA 
930 bp MDF: 5’- CGC CCA TAA GAT 
TTC CGGTT-3’ 
(Mathieu-Daude 
et al., 
1994) 
MDR: 5’- GGT GTA ATA CTC 
ACC CGGTT-3’ 
Non conserved 
sequence 
of kDNA 
930 bp MDF: 5’- CGC CCA TAA GAT 
TTC CGGTT-3’ 
(Schares and 
Mehlitz, 
1996) 
MDR: 5’- GGT GTA ATA CTC 
ACC CGGTT-3’ 
MDN: 5’-CGA GGT ACT TCG 
AAA GGGTT-3’ 
TgsGP 308 bp Sense primers: 5’- GCT GCT GTG 
TTCGGAGAGC-3’ 
(Radwanska et 
al., 2002a) 
Anti-sense primers: 5’- GCC ATC 
GTG CTTGCC GCT C-3’ 
  Table 1-2. The primers developed for use in T. b. gambiense molecular diagnosis 
On the other hand, Moser et al. (1989) reported that T. b. rhodesiense universal 
primers that are used to prime the amplification of 177 bp sequences from 
Trypanozoon genomic DNA, are able to detect 0.1 pg of parasite DNA, this is about 
the amount of DNA calculated to be in a single trypanosome. On the other hand, the 
SRA gene marker which is found exclusively in T.b.rhodesiense allows the detection 
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of  T.b.rhodesiense in reservoir hosts, the tsetse fly and humans (Nijru et al., 2004). 
Nijru et al. (2004) concluded that SRA gene is highly valuable to detect and 
differentiate T.b.rhodesiense from other T.brucei in reservoir host, vector, and 
humans. Also, Wellburn et al. (2011) have reported the use of SRA gene as target 
for detecting T.brucei. According to the results of the study, the authors have 
suggested that SRA gene present a valuable marker to detect T b rhodesiense, in 
the domestic livestock reservoir. 
However, T.b.rhodesiense infections within animal reservoirs are often chronic with 
very low levels of parasitaemias, which is largely based on the PCR test accuracy. A 
negative result may indicate the absence of SRA or simply indicate too little genomic 
material is present (Picozzi et al., 2008). Thus, Picozzi et al. (2008) developed 
multiplex PCR to overcome this issue. This is a PCR reaction consist of two different 
sets of primers, therefore two different products will be amplified within the same 
reaction from the same starting material; one targeting the genus of parasite of 
interest, the second being sub species- speciﬁc. During each reaction, the PCR 
targets both SRA, and a single copy gene found within T. brucei s.l., namely a 
phospholipase C (GPI-PLC). A successful amplification of GPI-PLC indicates enough 
T. brucei s.l. genomic material is present to detect a single copy gene.  
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 Target Size of 
amplified 
Products 
Primer Sequences Ref 
SRA 
VSG 
743 bp 
1121 bp 
B537: 5’- CCA TGG CCT TTG ACG 
AAG AGC CCG-3’ 
Welburn et al., 
2001) 
B538: 5’-CTCGAGTTTGCTTTT 
CTGTATTTTTCCC-3’ 
 1.2 kb SRA A: 5’-GAC AAC AAG TAC CTT 
GGC GC-3’ 
(Gibson, 
2002) 
SRA B: 5’-CAG CAA CCA TAT TCA 
GAG CC-3’ 
 284 bp F: 5’-ATA GTG ACA AGA TGC GTA 
CTC AA CGC-3 
(Radwanska 
et al., 2002b) 
R: 5’-AAT GTG TTC GAG TAC TTC 
GGT CAC GCT-3’ 
 PLC: 239 bp 
SRA: 669 bp 
VSG: > 1 kb 
02: 5’- GGA GCC AAA ACC AGT 
GGG CAC ATC-3’ 
03: 5’- AAG TAG CGC TGT CCT 
GTA GAC GCT TC-3’ 
(Picozzi et al., 
2008) 
651: 5’- GAA GAG CCC GTC AAG 
AAG GTT TG-3’ 
652: 5’- TTT TGA GCC TTC CAC 
AAG CTT GGG-3’ 
    Table 1-3. The genetic markers used in diagnosing T.b.rhodesiense 
 
Moreover, Kabiri et al. (1999) developed PCR assay targeting expression-site- 
associated gene (ESAG) 6 and 7 DNA target sequences, to detect T. b. gambiense 
in blood samples. In T. brucei, the products of ESAG 6 and 7, located upstream of 
the variant surface glycoprotein gene in a polycistronic expression site. ESAG6 and 
ESAG7 are multicopy genes. The sensitivity of this assay was considerably high as it 
detected 87% of the 59 blood samples with specificity of 97%. 
Furthermore, a development which plays an important role in the diagnosis of 
trypanosomes; using the length variation of multiple fragments within the 18S and 
28S rRNA genes. Adams et al. (2008) have developed a new generic PCR method 
using fluorescent primers with the subsequent sizing of the products accurately and 
rapidly using an automated DNA sequencer. The authors have reported a 
comparison of the use of the new fluorescent fragment length bar-coding (FFLB) 
(Hamilton et al., 2007) and the using of ITS primers (below) (Adams et al., 2006)  in 
examining midgut samples that were collected from Tanzania. The comparison 
revealed  that using ITS primers, 78% of the examined flies were identified carrying a 
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parasite DNA of a different trypanosome species, while, using FFLB, 97% were 
found to be carrying trypanosome DNA. The authors suggested that the FFLB 
system is accurate, quick and has an extremely high level of identification of 
infection. Moreover, FFLB revealed the existence of a putative new species of 
trypanosomes that is most related to T. brucei 
s.l. by phylogenetic analysis. However, the costs of this technique can be the only 
obstacle since its requirement of expensive equipment and trained technical staff for 
application. 
1.7.3.1 Internal Transcribed Spacer (ITS)-PCR 
 
In trypanosomes, as in other eukaryotic organisms, the ribosomal RNA (rRNA) 
genes are transcribed as a large primary transcript, which is processed by stepwise 
endonucleolytic cleavage to yield the 18S, 5.8S and 28S units (Urakawa and Majiwa, 
2001). At least five PCR reactions using species-specific primers would be required 
for each sample depending on the host species and the geographic distribution of the 
trypanosome species compared to the convenience of a single test. 
Investigations have been carried to combine the species-specific primers in a 
multiplex reaction, but these trials have been shown to be less sensitive with some 
combinations of primers inducing the synthesis of non-specific and unexpected size 
products (Desquesnes et al., 2001). The most important obstacle of using species- 
specific primers is the lack of specific primers for all trypanosome species, leading to 
the inability of identifying new trypanosome species. For example, in a tsetse survey 
conducted in Tanzania, Lehane et al. (2000) failed to identify 13% of infections 
detected by microscopy using the available species-specific PCR. The development 
of the ITS region as a universal target for the diagnosis of different trypanosome 
species occurring in either the vertebrate host or the invertebrate vector, aimed to 
decrease the number of species-specific PCR reactions required for diagnosis and 
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allowed for the identification of new species infecting both the vector and vertebrate 
host. 
The internal transcribed spacer (ITS) region of rDNA is a favourite target for a 
universal test because of its highly conserved ﬂanking regions and size variability 
among trypanosomes species and subgroups. Also this locus has 100–200 copies 
and each transcribed unit is composed of 18S, 5.8S and 28S rRNA genes separated 
by two ITS regions (Njiru et al., 2005; Hernandez et al., 1993). The two spacers, 
(ITS) 1 and 2 are known to vary in size between species and occasionally 
subspecies (figure 1- 5). 
 
 
 
 
   
 
 
Figure 1-7. Generic structure of the ITS genes of eukaryotes. The white arrows show the annealing 
position for ITS3 (forward), within the 18S ribosomal small subunit and ITS4 (reverse), within the 5.8S 
ribosomal sub-unit. The black arrows represent outer primers, ITS1 and ITS2, designed to conserved 
regions within the 18S and 28S subunits (Cox et al, 2005). 
 
Njiru et al. (2005) reported sensitivity of the ITS single reaction PCR as; 
Trypanozoon (95%) and T. congolense savannah (90.9%) and (77.4%) for T. vivax 
on a blood samples was collected from 373 cattle and 185 camels. On the other 
hand, Cox et al. (2005) developed a new nested PCR targeted to include both ITS, 
that was capable of detecting trypanosomes in the presence of host DNA and the 
PCR inhibitors present in blood. This method is very sensitive, it has the ability to 
detect DNA concentration at 49 pg ml-1, which is considered as less than a single 
Small 
Sub- 
unit 
18S 
Internal Transcribed 
Spacer (ITS1) 5.8S 
Internal Transcribed Spacer 
(ITS2) 
Large sub- 
unit 28S 
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trypanosome. 
1.7.3.1 Mini- And Micro-Satellite Markers 
 
Another marker which provides the greatest prospect is the mini- and micro-satellite 
markers (Hide and Tait, 2009). Microsatellites have only become popular as a 
genotyping tool, for instance Plasmodium (Wooden et al., 1993). This is largely 
related with the increasing number of genome sequencing projects (Traub et al., 
2005). Micro-and-mini –satellite are repeated sequences vary in length or sequence 
between trypanosome strains and can be amplified and analysed by population 
genetic methods (Hide and Tait, 2009). 
In addition, PCR of microsatellite sequences is reported to be sensitive enough to 
detect trypanosome DNA in patients’ biological fluids, and to detect mixed infections 
(Koffi et al., 2007). In addition, Biteau et al. (2000) managed to use microsatellite for 
distinction of T.b.gambiense group 1 from other subspecies. Simo et al. (2010) 
reported that by using seven microsatellite markers they were able to characterize 
T.b.gambiense isolates from Central Africa sub-region in order to improve knowledge 
on the population genetic structure of this subspecies. These markers confirmed the 
low genetic polymorphism within Central African T. b.gambiense isolates from the 
same focus and strong differentiation between different foci. Moreover, there is 
evidence from microsatellite genotypes and kinetoplast (mitochondrial) DNA 
sequences of 142 samples species-wide that T. b. rhodesiense is a host range 
variant of T. b. brucei (Gibson,2007; Balmer et al., 2007). 
1.7.3.1 Random Amplified Polymorphic DNA (RAPD) 
 
Another application of PCR in epidemiology is known as random  amplified 
polymorphic DNA (RAPD). RAPD is a genetic fingerprinting tool for discriminating 
between strains that plays an important role in T. b. rhodesiense investigations. RADP 
uses random primers and low stringency conditions to amplify DNA and produce 
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fingerprint (Traub et al., 2005). 
This kind of approach is very useful with small amounts of DNA, which probably 
sampled the full extent of the genome rather than being restricted to certain genes or 
parts of the genome. However, the main disadvantage of this method is represented 
by it is highly susceptibility to contaminating host or other DNA – bands will be 
generated from any DNA template, it is not possible to interpret genetically and is 
unable to detect mixed infections of trypanosomes (Hide and Tait, 2009). 
1.7.3.1 Amplified fragment length polymorphism (AFLP) 
 
Many of the genetic typing assays have drawbacks in that they may require a 
relatively large amount of high-quality DNA or, as with RAPD technique, may be 
difficult to reproduce between laboratories (Jones et al., 1997). Many markers, 
especially isoenzymes, can evolve too fast for use as epidemiological markers, so 
that the result can be misinterpreted (Hide, 1999). Furthermore, in the majority of 
these methods, only a very limited part of the genome is covered through highly 
specific molecular targeting of one or more repetitive DNA elements. On the other 
hand, AFLP is an extremely useful and reliable technique for detecting 
polymorphisms and its reproducibility is reported to be very high (Vos et al., 1995). 
While the requirement for only small amounts of DNA makes it highly suitable for 
genotyping isolates on a large scale or for isolation of binary specific markers. Agbo 
et al. (2001) have used AFLP to investigate the genetic diversity of T. brucei 
isolates, and tested the technique for trypanosome genotyping in general.  The 
authors reported that the variation between 
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Human-infective T. brucei subgenus is beyond only geographical origin, since the T. 
 
b. rhodesiense seem to be genetically more diverse, while the T. b. gambiense are 
more clonal or genetically more stable over time. Also, they have suggested that 
AFLP fingerprinting may aid the identification of polymorphisms linked to parasite 
factors of host tropism, and contribute to the understanding of host-parasite 
interactions at the molecular level. 
1.7.3.2 Mobile Genetic Element PCR (MGE-PCR) 
 
Mobile Genetic Element PCR (MGE-PCR) was developed to overcome the obstacle 
of contaminating host DNA (Hide and Tait, 2009). MGEs exist in a wide range of 
organisms from protozoa to humans. As genetic markers they have two crucial 
functions which are; repetitiveness and variability, which is largely related to 
improving the discriminatory sensitivity of molecular epidemiological markers (Hide 
and Tilley, 2001). 
MGE-PCR is a single primer PCR technique that produces variable banding patterns 
using markers based on the trypanosomal mobile genetic RIME, which anneals to 
the 3′ end of the RIME sequence. RIME is a trypanozoon-speciﬁc mobile genetic 
element, present in the T. brucei genome at up to 400 copies (Tilley et al., 2003). 
Furthermore, the MGE-PCR amplifies the element flanking regions through different 
stages of priming including; specific priming within the element, priming with adjacent 
elements, and mispriming in flanking regions (Hide and Tilley, 2001). 
Tilley et al. (2003) used MGE-PCR on T.brucei stocks southeast Uganda, Kenya and 
Zambia, and they reported that MGE-PCR is highly speciﬁc to amplify trypanosomal 
DNA in the presence of host DNA, and detects high levels of variability within the T. 
b. brucei and T. b. rhodesiense groups and is therefore a powerful discriminatory tool 
for tracking individual T. brucei genotypes and strains. 
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Moreover, Nijru et al. (2011) used MGE-PCR in genotyping of Trypanosoma evansi, 
stocks that were isolated directly from camels and after their respective passage in 
mice were analyzed. Construction of a dendrogram using the MGE-PCR banding 
profiles revealed a clear distinction between T. evansi and T. brucei, as well as 
discriminating the T. evansi strains. 
Also, MGE-PCR is useful for biological samples which are contaminated with host 
DNA, as Terry et al. (2001) have applied MGE-PCR Toxoplasma gondii which were 
directly isolated from sheep placental tissue. The MGE-PCR gel bands were absent 
in uninfected tissue. However, MGE-PCR gives some very complex multi-band 
patterns making the interpretation of result difficult, especially in mixed infection 
cases (Koffi et al., 2007). 
1.7.3.4 Loop-Mediated Isothermal Amplification (LAMP) 
 
Residual co-amplification of irrelevant sequences still cause general drawback in 
nucleic acid amplification, especially for diagnostic use. Even though in the use of 
multiple primers such as nested PCR, which has improved amplification specificity 
for the target sequence. However, this consumes a lot of time, materials and 
reagents. Thus, a novel method has been developed called loop-mediated 
isothermal amplification (LAMP). LAMP has the ability to amplify a few copies of DNA 
to 109 copies in less than an hour under isothermal conditions 60- 65Cº with greater 
specificity (Notomi et al., 2000). LAMP utilizes four to six primers DNA polymerase 
Bst to specifically recognize six to eight regions of the target DNA sequence. 
Furthermore, the principle of LAMP is based on auto-cycling strand displacement 
DNA synthesis performed by DNA polymerase with high strand displacement activity 
and a set of two specially designed inner and two outer primers. An inner primer 
containing sequences of the sense and antisense strands of the target DNA initiates 
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LAMP(Notomi et al., 2000). 
In addition, LAMP can be applied directly on tissue such as serum without extracting 
the DNA, also the visualization of the generated products can be done by the 
inclusion of fluorescent dyes for instance SYBR green (Adams and Hamilton, 2008). 
However, Wastling et al., (2010) have developed several simple endpoint detection 
methods have been developed for LAMP including;  (i) visualization of turbidity; (ii) 
addition of hydroxynaphthol blue before incubation; (iii) addition of calcein with MnCl2 
before incubation and (iv) addition of Quant-iT PicoGreen after incubation. These 
four methods were applied to four LAMP assays for the detection of human African 
trypanosomiasis LAMP. The authors have concluded that hydroxynaphthol blue was 
the best of the compared methods for easy, inexpensive, accurate and reliable 
interpretation of LAMP assays for HAT. LAMP demonstrated to be a potential tool in 
the staging of HAT which is critical for therapeutic decisions (Namangala et al, 2012).  
Moreover, Nijru et al. (2008) have used LAMP to identify important members of 
subgenus Trypanozoon. They reported that the technique is not highly sensitive; but 
the sensitivity and reproducibility of the LAMP assay is indicated by the ability to 
detect the results visually without the need for sophisticated equipment, which 
indicates that the technique has strong potential for detection of HAT in clinical 
settings. In addition, Thekisoe et al. (2007) have used LAMP to identify human and 
animal trypanosomes, and they reported LAMP has the ability to detect as little as 1fg 
trypanosomes DNA, which is equivalent to ∼0.01 trypanosome. They have concluded 
that LAMP has great potential of being used for diagnosis of trypanosomiasis in the 
laboratory and the ﬁeld, particularly in countries that cannot afford modern molecular 
diagnostic techniques. 
29 
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 1.8 Treatment of HAT 
 
The treatment for HAT is selected by first establishing the stage of infection; most of 
the affected countries use broad guidelines for the treatment of sleeping sickness as 
recommended by WHO (WHO, 2001). The chemotherapy of HAT has historical roots 
that date back to the pioneering work by Paul Ehrlich on dyes and arsenicals. Until 
recently, chemotherapy of HAT is given in form of three drugs; pentamidine, 
introduced in 1937, is currently available as pentamidine isethionate and is effective 
against early stage of the T. b. gambiense infection. Suramin which was introduced in 
1916, is effective against early stages of both T. b. gambiense and T. b. rhodesiense. 
However, its use has been confined to T. b. rhodesiense infections. Melarsoprol a 
trivalent arsenical, was introduced in 1946 and until 1990, had been the only drug 
available for the treatment of late-stage T. b. gambiense and T. b. rhodesiense 
infections (Kuzoe, 1993), and eflornithine, was introduced in 1977, is the drug of 
choice for treatment of late-stage HAT caused by T. b. gambiense, but it is not 
recommended for T. b. rhodesiense (Fairlamb, 2003). (Figure 1-6) shows the 
different drugs involved in treatment of HAT and their chemical structures. 
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Figure 1-8. The chemical structures of drugs used in treatment of HAT. (a) Suramin and Pentamidine 
drugs used in the early stage of HAT, and (b) Melarsoprol, Eflornithine, and Nifurtimox used in the late 
stage of the HAT (Fairlamb, 2003). 
Currently, according to Eperon et al. (2014) there are two anti-trypanosomiasis drugs 
that are still at clinical trial phase. Which are fexinidazole and SCYX-7158 for 
gambiense HAT. Should the trials record a success, fexinidazole and/or SCYX-7158 
would be the first oral treatments to be used for both stage 1 and stage 2 sleeping 
sickness, thereby replacing the complicated diagnosis and treatment paradigm, 
which includes systematic lumbar punctures of every diagnosed patient to determine 
the stage of the disease before deciding which treatment to administer (DNDi, 
2014). DNDi aims to deliver 2 new treatments that are safe, effective, easy- to-use 
(oral) and affordable for HAT stage 1 and 2 patients by 2018 (DNDi, 2014). 
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1.9 Aims 
In this research study ways to improve the molecular field diagnosis of 
trypanosomiasis will be tackled. This study will be carried on 36 human patient blood 
samples collected on FTA card from Angola. The samples are positively confirmed 
for trypanosomiasis by CATT. Initially, nested ITS-PCR that was developed by Cox  
et al. (2005). The authors have suggested that testing a single punch from FTA card 
by ITS-PCR may lead to false negative, due to the uneven distribution of the 
parasite. Thus, alternative approach will be followed, which targeting more than a 
single punch for Chelex DNA elution prior the PCR amplification. To overcome the 
false negative limitation of the molecular tool in studying the epidemiology and 
diagnosis of sleeping sickness. Then, the use of different molecular tool (MGE-PCR) 
developed by Tilley et al. (2003) in the field diagnosis of HAT will be investigated on 
the eluted DNA from the Angolan samples, in interest of comparing the sensitivity 
and specificity between ITS-PCR and MGE-PCR. Finally, a gene family known as 
retrotransposon hot spot (RHS) genes/pseudogenes, that act as favourable target for 
mobile elements insertion in T.brucei (Brigaud et al., 2002), will be investigated 
through a serial of bioinformatical experiments. In order to find a potential marker to 
aid the epidemiology studies of HAT, and improve the prospects of MGE-PCR. 
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 Materials and Methods 
 
To execute different types of studies different protocols and materials were 
followed and used, the diagram below (figure 2-1) illustrates the protocols that 
were used in this project. 
 
 
Figure 2-1. The methods that were followed in this study; the protocols are arranged in numerical 
order. 
(2) Sample treatment 
(3) DNA extraction 
(4) Serial dilutions of 
DNA 
(5) Different types of 
PCRs 
(1) Sample collection 
(6) Post-PCR products purification 
(7) DNA sequencing 
(8) Restriction enzyme digestions 
(9)  Bioinformatics 
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2.1 Sample collection 
 
Thirty six blood samples were collected on FTA cards from different geographical 
parts of Angola, by the Sleeping Sickness hospital in Luanda, Angola in 2001. All 
these samples were infected with T. brucei; 21 were females and 16 were males and 
trypanosomiasis infection was confirmed by CATT.  The blood of the patients was 
collected by a clinical official - Maria Giovetty. Blood samples from each patient were 
collected on FTA cards, preserved at room temperature and made available for the 
present study. By using a lancet the whole blood samples were taken from an 
auricular vein and then it was applied immediately in a spiral pattern on a Whatman 
FTA® card, as a part of routine diagnostic procedures. The cards were allowed to dry 
thoroughly at ambient temperature. Furthermore, Trypanosome genomic DNA 
(T.b.rhodesiense) in its liquid format will be used as positive control in the 
experiments, and to be diluted for sensitivity tests. 
2.2 Sample Processing 
 
Whole blood possesses potential PCR inhibitors including immunoglobulin G in 
plasma, haemoglobin in erythrocytes and lactoferrin in leukocytes (Al-Soud, 2000). 
Thus, it is crucial to treat the selected discs from the card in the following way prior 
DNA extraction and molecular investigation. Five 2.2mm discs were cut from the 
each spotted FTA® cards with a Harris Micro Punch ™ tool (Whatman Bioscience). 
Each disc was chosen randomly, but in preferential to the most spotted areas of the 
card and transferred to an eppendorf tube. After each time a punch was taken from 
the FTA card the Harris Micro Punch was cleaned on a filter paper to avoid any cross 
contamination. The selected discs from each sample were washed three times for 10 
minutes in 200μl of FTA® purification reagent (Whatman Bioscience, Cambridge, UK) 
and rinsed twice for 5 minutes in 200μl of 1 mM Tris-EDTA buffer (Sigma Aldrich, 
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Dorset, UK) to remove traces of FTA® buffer. Discs were dried, preferably overnight. 
2.3 DNA Chelex extraction 
 
To carry out the designed molecular experiments the DNA was extracted from the 
dried discs by Chelex kit (Invitrogen). 5% Chelex® 100 suspension was used to extract 
the DNA from the discs; 5% Chelex® 100 suspension was prepared by dissolving 2.5g 
of Chelex® 100 in 50 ml of sterile water in 100ml autoclaved bottle, an autoclaved  
stirbar was placed inside the bottle then the bottle was placed on magnetic stirrer. 
Then, DNA was eluted by adding  60µl of 5% Chelex® 100 directly to the eppendorf 
tube that contains the treated disc, then heated for 30 minutes at 90Cº in a heat block. 
2.4 Trypanosome DNA serial dilutions 
 
In order to investigate the sensitivity of nested ITS-PCR the protocol was carried out 
on the different serial dilutions of trypanosomes DNA. The dilution serial was 
arranged from neat trypanosome DNA concentration of 80ng/µl to a dilution of 1:12. 
After each dilution the concentration of the DNA was measured by using Thermo 
Scientific 2000c nanodrop at 260nm. 
2.5 PCR Amplification 
 
Confirmed trypanosome genomic DNA (T.b.rhodesiense), in aqueous format, was 
used as the positive control in all PCR based approaches.  The Chelex eluted DNA 
samples were tested by different molecular tools as described below.; 
2.5.1 Nested ITS PCR 
 
ITS-specific nested PCR was carried to detect the trypanosomes in the Angolan 
FTA card samples, and also it was carried on different concentrations of 
trypanosomes DNA to study the sensitivity of the protocol as described by Cox et al. 
(2005) by using the following primers. The outer primer sequences were ITS1 (5’- 
GAT TAC GTC CCT GCC ATT TG-3’), and ITS2 (5’-TTG TTC GCT ATC GGT CTT 
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CC-3’) (MWG Biotech), and inner primer sequences ITS3 (5’-GGA AGC AAA AGT 
CGT AAC AAG G-3’), and ITS4 (5’-TGT TTT CTT TTC CTC CGC TG-3’) (MWG 
Biotech) (Cox et al., 2005). PCR amplification was performed using a Robocycler 
(Stratagene). The reactions were carried in a volume of 25µl and included; 1.25U of 
Biotaq (Bioline), 2µM of each outer primer ITS1 and ITS2, 1µM of dNTPs and KCl 
buffer (Bioline) (final concentration of 10 mM Tris-HCl pH 9.0; 1.5 mM MgCl2 ; 
50mM KCl; 0.1% Triton X100; 0.01%(w/v) stabilizer). The reaction  conditions were 
structured as; 1 cycle of 95 ºC for 7 minutes, followed by 35 cycles of 94 ºC for 1 
minute, 55 ºC for 1 minute and 72 ºC for 2 minutes. Furthermore, 1µl of the first 
round was added to the second round reaction (nested PCR) which was placed in a 
fresh PCR tube and 24µl of the reaction mixture added. In the second round the 
outer primers (ITS1 and ITS2) were substituted by inner primers ITS3 and ITS4. 
The same reaction conditions used for  the first round were applied in the second 
reaction. 
2.5.2 MGE-PCR 
 
MGE analysis was carried using a single primer (REV B) technique, through the 
analysis of the flanking regions of the element.  The REV B sequence (5’CAG GGC 
TCT ACG GTG ATG GCT 3’) anneals to the 3’ end of the trypanosomal mobile 
genetic element RIME. The reaction was performed using a Robocycler (Stratagene). 
The reaction volume of 50 µl was used and contained 2 µM of REV B, 1 µM of dNTP 
mix containing 0.25 µM of each dNTP , 2U (5 U/µl) of Supertaq DNA polymerase, 
and 1.5mM MgCl2 (Bioline) . The reaction conditions were as followed; 1 cycle of 94 
ºC for 10 min, 10 cycles of 94 ºC for 45 s, 60 ºC for 1 min and 72 ºC for 2 min, 
followed by 25 cycles of 94 ºC for 45 s, 56 ºC for 1 min and  
72 ºC for 2 min (Tilley et al., 2003). 
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2.5.3 RIME A and RIME B Amplification 
 
To study the of length variation of the RIME element, RIME A and RIME B primers 
were used (Tilly et al., 2003): RIME A (5′ AGC GTC TTG CTG GGA CAC CGT 3′) 
and RIME B (5′ AGC CAT CAC CGT AGA GCC CTG 3′). PCR amplification was 
performed using a Robocycler (Stratagene). Reaction volumes of 50 μl contained 2 
μM of each primer, 1 μM of dNTP mix containing 0.25 μM of each dNTP,  2 U (5 
U/μl) of Taq DNA polymerase (Bioline UK) and 1.5 mM MgCl2. PCR cycles were as 
follows; a single cycle at 94 °C for 5 min, followed by 30 cycles at 94 °C for 45s, 
55°C for 1 min and 72 °C for 2 min. 
 
2.5.4 Mammalian specific tubulin PCR 
 
This protocol is designed to target the mammalian tubulin gene. Tubulin genes are 
located in thousands of copies throughout the mammalian genome and the 
sequences of the primers are specific to mammalian tubulin only. This protocol was 
applied to verify if DNA was extracted from the FTA punches by Chelex extraction, 
as 18 samples from Angolan samples failed to amplify with the nested ITS-PCR. The 
PCR was carried out as described by Terry et al. (2001) using the following primer 
sequences: MtubF (5’- GTGAGTGCATCTCCATCCAT-3’) and MtubR (5’-
GCCCTCACCCACATACCAGTG-3’). Each PCR was carried out using 25µl volumes 
containing the following  components: 10mM Tris-HCl pH 9.0, 1.5mM MgCl2, 50mM 
KCl, 0.1% TritonX-100, 0.01% (w/v) stabilizer, , 2μM of each primer, 1mM total 
dNTPs and 1.25 Units of Biotaq (Bioline Ltd). The reaction conditions were as 
follows; one cycle of 94°C for five minutes, 40 cycles of 94°C for 50 seconds followed 
by 55 °C for 1 minute, 72°C for 1 minute 30 seconds with a final step of 72 °C for 10 
minutes. 
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2.6 Visualization 
 
A 10 μl aliquot of the final PCR products were mixed with 5µl orange loading dye 
(Thermo Fisher), and then were loaded into the wells of a 1.5% (w/v) agarose gel 
and electrophoresed at 110V for 1.5hr. The 1.5% (w/v) agarose gel was prepared by 
dissolving 1.5 g of agarose powder (Bioline, UK) in 100ml of 1xTBE buffer within a 
conical flask placed into a microwave oven at highest setting. The resulting agarose 
solution was then placed on a shaker to allow it to cool to approximately 50 0C and 
then 100µl of gel red (Biotium) was added to the mixture and it was poured into a gel 
casting tray with comb inserted.  Following gel electrophoresis, DNA was observed 
using a ultraviolet light and images were captured. 
2.7 DNA extraction from agarose gels 
 
DNA was extracted from selected bands of the agarose gel using the PureLink® 
Quick Gel Extraction Kit (Invitrogen UK). After cutting the selected bands, they were 
transferred to an eppendorf tube and this was weighed to calculate the amount of 
buffer to be added to the tube. The protocol for purification is described in detail in 
the manufacturer’s instructions (Invitrogen, UK). However, two important steps need 
to be taken into account;  the band of  interest was removed from the gel using a 
sterile blade  to avoid any cross contamination and also, it is important to excise  as 
little as possible of the agarose gel when cutting out the DNA band. 
2.8 DNA sequencing of the PCR product  
 
After successfully extracting the DNA from the gel as described above, the DNA 
concentration and purity were measured  using  a Nanodrop (2000/c, Thermo 
Scientific) at 260/280nm absorbance ratio. Before sending the samples to the 
sequencing company (Source Bioscience, Nottingham), the samples were calibrated 
according to the requirements specified  by Source Bioscience . The samples were 
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sent by special delivery post to avoid any potential DNA, or primer degradation. The 
resulting DNA data was analysed by Finch TV. 
2.9 Restriction enzyme digestion 
 
Due to the complication related with the sequencing of REV B amplified products, 
restriction enzyme digestion was carried to cut the amplified products. The digestion 
was carried out in a 20µl reaction as follows: 7 µl DNA, 1.5 unit restriction enzyme 
(Mbo I and AlwNI, NEB UK), 2 µl 10 x digestion buffer and 9.5 µl water. Initially the 
MboI reaction was incubated at 37Cº for 2 hours, then it was incubated overnight; 
however, it failed to digest the PCR products. Consequently, AlwNI was added to the   
and then reactions were incubated overnight. 
2.10 Bioinformatics and analysis of the T.brucei genome TREU927 
 
Due to the challenges with MGE-PCR a further study into MGEs was required since 
retrotransposon hot spot genes (RHS) are favourable target for mobile elements 
insertion including RIME. Thus, they were targeted in this study in order to 
understand the behaviour of the mobile elements and to assist development of a 
diagnostic marker. 
2.10.1 Data source 
 
The T.b.brucei TREU 927 strain was used in this study and the RHS genes of TREU 
927 sequences were accessed through the NCBI database 
http://www.ncbi.nlm.nih.gov/mapview/) and also tritrypdb 
(http://tritrypdb.org/tritrypdb/). Two terms were used in the search for RHS genes in 
T.b.brucei; "RHS" and "retrotransposon hot spot”. Amino acid sequences of RHS 
genes were retrieved from GeneDB (http://www.genedb.org/Homepage).  In addition,  
 
RHS nucleotide sequences were also extracted. The insertion ingi/RIME was 
investigated in more detail and hence mobile element RIME and ingi sequences 
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were obtained from NCBI (http://www.ncbi.nlm.nih.gov/nuccore) under the accession 
numbers K01801.1 and JQ917146.1 respectively. These were subsequently used as 
reference sequences to screen for RIMEs inserted in the obtained RHS genes. 
 
2.10.2 Multiple sequence alignment 
 
The retrieved amino acid and nucleotide sequences of RHS genes were aligned 
with RIME sequences. Multi- alignment of DNA sequences or protein sequences 
were performed online using the ClustalW2 programme (Multiple Sequence 
Alignment tool, version 2.1) from the EMBL-EBI web server 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) with the default settings (Larkin et al., 
2007). Also, Mview from EBI (http://www.ebi.ac.uk/Tools/msa/mview/) (McWilliam et 
al., 2013) was used to study the multiple sequence alignments. 
2.10.4 Bioinformatics software 
 
Various computer software, including molecular evolutionary genetics analysis 
version 5.0 (MEGA 5) (Tamura et al., 2011), was used to construct phylogenetic 
trees.   Alignments were manually edited, and regions containing more than 50% 
gaps, or those were low sequence conservation precluded accurate alignment, were 
removed. Support for the inferred topology was estimated from 100 bootstraps. Snap 
Gene (2.4.3) was used for sequence viewing and extracting schematic diagrams, 
and nonsynonymous and synonymous substitution rates (denoted as Ka and Ks, 
respectively) were estimated using the KaKs Calculator (1.2) (default setting) (Zhang 
et al., 2006). 
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 Identification of African trypanosome species from 
FTA card using ITS-PCR 
 
 
3.1 Introduction 
 
The control of sleeping sickness is highly related to our knowledge of the 
epidemiology of the disease, which is based on highly specific and sensitive 
screening and surveying methods (Hutchinson et al., 2003). Sleeping sickness in 
Angola is currently on the decrease as less than 100 cases been reported in 2015 
(WHO, 2015). The full background of sleeping sickness in Angola is mentioned in 
(Chapter 1).  
PCR has the ability to detect the presence of DNA sequences specific to the 
organism in question. The advantage of this technique is that it can specifically 
amplify a very small amount of parasite material which will help in identifying low 
parasitaemias with high sensitivity. For example, Masake et al. (2002) reported a 
successful detection of one trypanosome per 10 ml of cattle blood. 
Three different types of PCR are used for the diagnosis of trypanosomes, including 
conventional, multiplex and nested reactions. Conventional PCR reactions mainly 
depend on the use of primer sets targeting a specific DNA sequence. In multiplex 
reactions, more than one primer set can be used which allows more than one DNA 
sequence to be targeted. Finally, nested PCR depends on the running of two 
separate reactions where the amplification product from the first reaction is used as 
a template for the second reaction (e.g. Cox et al., 2005). 
However, in some cases, PCR assays have been linked to sampling issues, 
including samples that are mouse-passaged, and thus mouse adapted, a process 
which can cause a lowering of the epidemiological studies. In these cases some of 
the parasite isolates do not survive (Masiga et al., 1992) leading to a loss of species 
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or strains, and a selection and sampling bias (Welburn et al., 2001). 
 
Thus, breakthroughs in matrices designed to improve sample collection and archiving 
such as the FTA card have been introduced. FTA cards have been designed           
to fix and store nucleic acids directly from tissues, allowing the collection and 
archiving of nucleic acids (Belgrader et al., 1995; Picard-Meyer et al., 2007). The FTA 
matrix is infused with protein denaturants that cause lysis of cells and any organisms 
on contact. In addition, these chemicals have the ability to inhibit saprophytes when 
drying to ensure the safe handling of cards without risk of biohazard (Belgrader et al., 
1995; Rogers and Burgoyne, 1997). FTA technology also includes chelating agents 
and a free-radical trap that is designed to deal with atmospheric pollutants, therein 
protecting the trapped nucleic acids for at least six years at room temperature 
(Rogers and Burgoyne, 1997). Therefore, the use of FTA cards has been extended 
to include DNA detection from pathogenic protozoa and pathogenic organisms 
isolated from foods and clinical specimens using PCR (Orlandi and Lampel, 2000). 
FTA cards have been used for blood storage (Devost and Choy, 2000; and 
Gutierrez-corchero et al., 2002), as well as in detecting bacterial pathogens (Lampel 
et al., 2000; Rogers and Burgoyne, 1997), the detection of free living protozoa in 
water samples (Hide et al. 2003), the detection of viral genomes (Owor et al., 2007; 
Picard-Meyer et al., 2007) and in forensic human biology (Hsiao et al., 1999). 
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Furthermore, in trypanosome diagnosis, FTA cards have been used for the storage 
of many materials including blood, buffy-coat and extracted DNA for the detection of 
trypanosomes using PCR (Becker et al., 2004; Cox et al., 2005). FTA cards have 
aided the diagnosis process in terms of time, storage and in field diagnostic 
laboratories. Adams et al. (2006) have reported the use of FTA cards for storage of 
midgut material originating from tsetse flies. In their research they noticed that the 
detection of trypanosomes using PCR was lower than expected (56.9%), due to 
various possible factors including the sub-optimum binding of trypanosome DNA to 
the FTA cards, and the uneven binding of the trypanosome DNA throughout the card 
due to competition with midgut material. However, the results have been improved, 
reaching 78% after storage of the midgut samples in 100% ethanol and purification 
of DNA using ammonium acetate precipitation. 
 
 
In conclusion, the advantages of using FTA card technology rather than other 
methods include; lower sample volume (100 μl), safer handling, easier 
immobilisation of the DNA, less storage space being needed, ease of transportation 
and reduced financial costs (Gutierrez-corchero et al., 2002). However, there are 
various obstacles in terms of using FTA cards including the notable possibility that 
the punch that is punched from the FTA card may contain a small volume of the 
material estimated to be 1% of the total blood sample captured on the FTA card 
(Ahmed et al., 2011 ). For PCR based applications the minimum required volume to 
be assayed is typically only a single microlitre. Based on this there is a possibility 
that the punch samples taken from FTA cards for PCR-testing may result in an 
underestimation of the prevalence in the host population, particularly when that 
population comprises individuals with very low parasitaemias (Becker et al., 2004). 
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In addition, Chelex 100 is known as a chelating resin that possesses a high affinity 
for polyvalent metal ions. The Chelex resin consists of styrene divinylbenzene 
copolymers containing paired iminodiacetate ions, which function as chelating 
groups. Singer-Sam et al. (1989) have suggested that the presence of Chelex in high 
temperatures prevents the degradation of DNA by chelating metal ions that may act 
as catalysts in the breakdown of DNA at high temperatures in low ionic strength 
solutions. In addition, Singer-Sam et al. (1989) state that the use of Chelex 100 has 
led to an increase in the signal from the PCR amplification of small amounts of DNA 
released from small numbers of tissue culture cells that have been boiled. 
 
 
The protocol is simple, rapid, involves no organic solvents and does not require 
multiple tube transfers for most types of samples; these factors reduce the chances 
of cross contamination. The use of Chelex DNA in the extraction of semen and very 
small bloodstains using Chelex 100 has proven to be as efficient as or more efficient 
than using proteinase K and phenol-chloroform extraction. The DNA extracted from 
bloodstains has been found to contain less PCR inhibitors when prepared using the 
Chelex method (Walsh et al., 1991). 
 
 
In this chapter the internal transcribed spacer nested PCR (ITS-PCR) will be tested 
on extracted DNA from blood samples spotted onto the FTA cards by Chelex 
extraction. ITS –PCR is a method which detects the inter-specific length variation of 
the ITS regions of ribosomal genes producing a unique size of PCR product for each 
species - as reported by Cox et al. (2005). ITS region of rDNA is a favourite target for 
a universal test because of its highly conserved ﬂanking regions and its size 
variability among trypanosomes species and subgroups. Also this locus has 100– 
200 copies and each transcribed unit is composed of 18S, 5.8S and 28S rRNA 
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genes separated by two ITS regions (Hernandez et al., 1993; Njiru et al., 2005). The 
two spacers, (ITS) 1 and 2 are known to vary in size between species and 
occasionally subspecies (figure 1-5). 
The main advantage of using nested ITS-PCR is its ability to identify and differentiate 
all clinically relevant African trypanosome species. The high copy number located 
within inter-species variation in the length of the ITS region allows for identification 
and, importantly, species differentiation of trypanosomes (Desquesnes et al., 2001; 
Cox et al., 2005). This is in contrast to several molecular Trypanosoma identification 
methods, such as minisatellite markers, microsatellites or RAPD. These were outlined 
in detail in Chapter 1. 
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3.1.1 Aims and Objectives 
 
The aim of this chapter is to investigate the use of specific molecular diagnostic tools 
on a set of diagnosed Trypanosome brucei gambiense patient samples, collected on 
FTA cards, from Angola. The detailed objectives are as follows: 
 
 
1. To conduct an analysis of the demographics and characteristics of the group of 
Angolan sleeping sickness patients used in this study 
2. To investigate and validate the use of ITS-PCR as a diagnostic tool for the 
detection of infection in the Angolan patients. 
3. To investigate the use of Chelex extraction in improving and optimising the 
performance of the ITS-PCR on the samples collected from the Angolan patients. 
4. To investigate the relationship between the performance of the ITS-PCR and 
the demographics and known infection status of the samples collected from the 
Angolan patients. 
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3.2 Methods 
 
In this chapter one of the molecular diagnoses of HAT protocols (chapter 2) will be 
carried out on thirty six blood samples taken from patients who have tested 
positively for trypanosomiaisis by CATT collected on FTA cards from Angola. After 
the DNA elution from five punches from each FTA card by Chelex, the samples 
underwent a mammalian tubulin PCR was carried out to confirm successful DNA 
elution and suitability for PCR. Detection of trypanosomes was carried out using 
nested ITS- PCR. The correlation between the performance of the ITS-PCR and the 
demographics and known infection status of the samples collected from the Angolan 
patients will be studied using statistical tests. 
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3.3 Results 
 
To investigate the usefulness of FTA cards as a method of collecting, storing and 
diagnosing human sleeping sickness, a collection of samples from sleeping sickness 
patients in Angola was studied. Specifically, the aim was to evaluate the role of Chelex 
eluted DNA as a method of detecting and differentiating trypanosome species from 
blood samples spotted onto FTA cards. Blood samples from thirty six parasitologically 
confirmed patients, were tested using a nested ITS PCR which amplified the variable 
ITS region of the ribosomal genes. 
3.3.1 Description of the samples of infected blood immobilised on FTA cards 
from human trypanosomiasis patients in Angola 
Blood from thirty-six human patients all of which were infected with Trypanosoma brucei 
gambiense were collected FTA cards using blood that was taken for diagnostic 
purposes. These patients were all confirmed as testing positive for sleeping sickness 
using the Card Agglutination Test for Trypanosomiasis (CATT) and also microscopic 
analysis of a lymph node aspirate (Lymph node puncture, LNP) (see Appendix 1). Some 
patients were also confirmed as testing positive for Lumbar Puncture (Appendix 1), 
known as “liquide céphalo-rachidien” (see Appendix 2 -LCR – Cerebro-spinal fluid 
aspiration) and also for CATT Titration (Appendix 1, TIT). Data on previous treatments, 
the location of patients and other demographic profile factors were obtained (see 
Appendix 1). 
(Figure 3-1) shows the locations where the patients lived at the time of the blood 
samples being taken and (Table 3-1) is a summary of the sampled patients and other 
relevant profile information. (Full details can be found in Appendix 1.) As can be seen 
from the map, the patients sampled were resident in different regions of Angola, and the 
number of collected samples varied from region to region depending on who presented 
themselves to the clinic on the days the researcher was present. A significant majority 
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of the patients came from Cuanza Norte. 
 
 
Figure 3-1. Angolan map showing the locations of the samples. Locations are represented by red stars. 
Scale: 1cm=100mile. The map was generated by National Geography Map Maker 
(http://mapmaker.education.nationalgeographic.com/?ar_a=1&b=1&ls=000000000000) 
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 Patients 
number 
Age/Gender Pre- 
treat (3 
days) 
Treatment 
(days) 
Vector 
(Cattle/testse) 
Location 
 
 
1 20/female None None Present Luanda 
2 27/female Yes Pentamidine 
 
Present Zanga 
3 45/female Yes Melarsoprol (8) 
 
Present Uige 
4 25/female Yes Melarsoprol (8) 
 
Present Uige 
5 20/female Yes Melarsoprol 
 
Present Malange 
6 42/female Yes Pentamidine 
  
Present Malange 
7 38/female Yes Melarsoprol 
  
Present Kuando 
8 17/female None None Not Present Uige 
9 25/female Yes None Present Gulungo 
10 22/female None Pentamidine Not Present Lukala 
11 12/female Yes Melarsoprol (1) 
 
Present Bengo 
12 71/female Yes Melarsoprol 
 
Present K-Norto 
13 21/female Yes Melarsoprol (8) 
 
Not present Kinxassa 
14 50/female Yes Melarsoprol 
 
Not Present Uige 
15 40/female Yes Melarsoprol 
  
Present Malange 
16 9/female Yes Melarsoprol 
  
Not Present Malange 
17 38/female Yes Melarsoprol (6) 
 
Present Malange 
18 25/female Yes Melarsoprol 
  
Present Bengo 
19 32/female Yes Melarsoprol 
  
Present Bengo 
20 10/male Yes Melarsoprol 
  
Present K-Norte 
21 13/male Yes Melarsoprol (7) 
 
Present Zaire 
22 23/male Yes Melarsoprol (2) 
 
Present Bengo 
23 25/male Yes Melarsoprol (6) 
 
Present K-Norte 
24 12/male Yes Melarsoprol 
  
Present K-Norte 
25 33/male Yes Melarsoprol 
  
Present Bengo 
26 35/male Yes Melarsoprol (2) 
 
Present Malange 
27 45/male Yes Pentamidine 
  
Present Bengo 
28 15/male Yes Melarsoprol (4) 
 
Present Malange 
29 26/male Yes Melarsoprol (4) 
 
Present Huambo 
30 42/male yes Melarsoprol (4) 
 
Present Moxico 
31 32/male Yes Melarsoprol (3) 
 
Present K-Norte 
32 32/male None None Present Uiege 
33 21/male None None Present K-Norte 
34 32/male None None Present K-Norte 
35 15/female None None Present Bengo 
36 47/male None None Present Bie 
Table 3-1. Demographic data for the Angolan patients. This table shows the demographic details of 
patients’ blood collected on the FTA cards. 
3.3.1 Analysis of the patient collection 
 
When the blood samples were collected a range of patient profile information was 
recorded, including the following information: gender, age, family medical history, and 
place of residence, recent geographical movements and any mobility/disability issues 
the patients may experience (see Appendix 1). To facilitate a valid interpretation of 
the final outcome of the present study, it was important to obtain a comprehensive 
understanding of the patients’ profiles in order to compare these variables with the 
DNA diagnostic data (see subsequent section). 
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Several key demographic features are worthy of note. Firstly, the majority of the 
patients were females - out of the 36 collected samples, 20 were from females. 
Moreover, the ages of the patients varied, with a reasonably spread out 
representation of each age group occurring and the youngest patient being nine 
years old. (Figure 3-2) shows the ages of the samples according to age-range 
groups in a pie chart. 
 
Figure 3-2. The age groups of the Angolan patients who participated in the study 
 
 
According to (Figure 3-2) the majority of the cases were represented by 19-25 age 
group and the least was represented by the elderly (50-80 age group).Patient no. 16 
who was nine years old, to patient no. 12 who was 71 years old at the time the blood 
samples were taken (62 years) (Table 3-1). 
In addition, the samples were analysed according to medical history including 
familial history and also patients’ past receipt of medical treatment for sleeping 
sickness. (Figure 3-3) shows that 63.8% of the patients had no family history of 
sleeping sickness, whereas 13.8% had family members who had experienced 
sleeping sickness and 19.3% had received previous treatment having been 
diagnosed with sleeping sickness 
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Figure 3-3. Angolan patient medical history.  The number of cases that have sleeping sickness (SS) in 
the family, that have no family history (NFH) and the patients that in the past have received treatment 
against sleeping sickness 
 
. 
Although patient nos. 26, 29, 30 and 31 did not report having a family history and nor 
had they been treated in the past, they have travelled to different provinces in Angola 
as part of their work in the army. 
Finally, the period during which the patients reported experiencing symptoms ranged 
from just a few months to a matter of years, as shown in (Figure 3-4).  One of the 
longest periods of symptom experience reported, which stands out in the sample 
overall, was reported by patient no. 8 who had experienced symptoms for over 
seven years. 
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To summarise, the samples were collected and stored on FTA cards. The samples 
were analysed according to the available information on the patients as outlined 
above. The analysis of the sample showed that the patients were resident in different 
parts of Angola, with the majority of the patients being female. The oldest patient 
was a female of 71 years old (patient no. 12) but children were also included in the 
sample with the youngest being just 9 years old (patient no. 16). The sample showed 
a reasonable degree of variation in terms of the duration period in which symptoms 
had occurred before the collection of blood took place in the clinic. Finally, the 
patients showed a reasonable degree of variation in the duration period of symptoms 
before the collection of the blood. Patient no. 9 showed the longest symptomatic  
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Figure 3-4. Duration of symptoms for each patient. The duration of symptoms for all patients is 
presented in years, except for patients 31 and 35 (marked by green colour) whose symptomatic 
duration is measured in months. 
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period (seven years) with the shortest period being for just six months (patient 31 and 
35). It is not clear why there was such variation but it might be simply that it was 
difficult for some patients to get to the hospital as Angola was in the throes of a civil 
war at the time. For example, patient 31 resides in Uige which is 210 miles from the 
sleeping sickness hospital in Luanda, and this may likely have affected her ability to 
turn up to the screening. 
 
3.3.2 DNA amplification and diagnosis of trypanosomiasis 
 
In order to effectively detect the Trypanosoma, the application of the nested ITS-
PCR on DNA eluted from field samples and the efficacy of the Chelex protocol will 
be examined. 
3.3.2.1 Sensitivity of nested ITS-PCR 
 
As far as is currently known, the sensitivity of the nested ITS-PCR has not been 
tested on Chelex eluted DNA from FTA card punches. However, the findings of Cox 
et al. (2005) which indicate that the PCR amplification from a single punch may lead 
to false results will be tested. Nested ITS-PCR was carried out on a single punch 
from FTA cards spotted with neat known trypanosome DNA and blood from patients 
who tested positive for trypanosomiasis by CATT collected from Angola. The ITS 
primers failed to amplify all the samples except the positive control (liquid 
trypanosome DNA) (see Figure 3-5).
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Figure 3-5 Nested ITS-PCR of trypanosome DNA and blood spotted on FTA cards. The upper and 
lower gel images represent the first and second reactions of nested ITS-PCR respectively. (M) 
Represent the 1kb DNA marker (Bioline). (+Ve) indicates the positive control (aqueous trypanosome 
DNA).Lanes 1 and 2 indicate the single punch taken from FTA card spotted with known trypanosome 
DNA and the blood of a patient who positively tested for trypanosomiasis respectively. (-Ve) is the 
negative control (water). 
From (Figure 3-5), the sensitivity of the nested ITS-PCR can be seen to be 0%. 
However, it is worth noting the advantage of using nested ITS-PCR rather than a 
single round PCR, as the assay failed to amplify all the samples including the 
positive control in the first reaction. In the second round of the PCR the amount of 
the target DNA was increased by the second set of primers, whilst the number of 
potentially inhibitory factors was decreased. 
Subsequently, in order to determine the sensitivity of Chelex/ITS PCR, known 
trypanosome DNA at different concentrations was spotted onto a FTA card and five 
punches were selected to be eluted by Chelex; then ITS-nested PCR was carried on 
the eluted DNA. As can be seen from (Figure 3-6) DNA was successfully amplified 
in 67% of the twelve dilutions. Positive DNA amplification was detected at a 
concentration of ~1ng/µl which is estimated as being equivalent to a single 
trypanosome (Cox, 2007). 
M +Ve 1 2 -Ve 
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Figure 3-6 Nested ITS-PCR of trypanosome DNA spotted on FTA cards at different concentrations and 
then extracted using the Chelex protocol. (M) represents the 1kb plus DNA marker, ( +Ve) represents T. 
brucei DNA and lanes 1-12 represent trypanosome genomic DNA at different dilutions rom 10-1 to 10-
12 respectively . 
 
Moreover, the relationship between the concentration of the DNA before 
amplification and the detection of the trypanosome DNA after amplification is shown 
in (3-7). Which shows that nested ITS-PCR was able to detect trypanosome at 1ng 
concentration of DNA. 
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To test the method on the Angolan samples a few pre-tests need to be carried out. 
Firstly, it is vital to confirm that the elution of the DNA from the Chelex samples 
produces DNA that is suitable for amplification using the nested-ITS PCR. Therefore, 
mammalian tubulin PCR (detects the tubulin gene from the human DNA in the 
sample) was carried out in the interest of confirming the successful elution of DNA by 
the Chelex from all Angolan samples. This protocol is often used to verify the 
integrity of DNA samples. After amplification, it can be seen from (figure 3-8 and 3-9) 
that 24 out of 36 samples have shown bands of DNA. (Table 3-2) shows the samples 
that have been successfully amplified. Thus, it can be concluded that a high 
proportion of the samples are suitable for PCR. 
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Figure 3-7.  The relationship between the concentration of the DNA and generation  of the 
trypanosome nested ITS-PCRproduct. 
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Figure 3-8. Mammalian tubulin PCR amplification of the Angolan samples.  Positive DNA control (mouse DNA) 
is indicated by (+Ve),  lanes from 1 to 17 represent the number of the Angolan samples, negative control 
(water) is indicated by (-Ve) and M represents the 1 Kb (Bioline) DNA marker. 
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Figure 3-9. Mammalian tubulin PCR amplification of the Angolan samples.  DNA positive control 
(mouse DNA) is represented by +Ve, lanes from 18 to 36 represent the number of the Angolan 
samples, negative control (water) is indicated by (-Ve), and M represents the 1 Kb (Bioline) DNA 
marker.  The bands show the successful Chelex DNA elution from the punches of the FTA cards. 
 
 
 
 
Sample numbers Tubulin Positive Tubulin 
Negative 
Total 
1,2,3,6,17,18,19,23,30,33,35,36  √ 12 
4,5,7,8,9,10,11,12,13,14,15,16, 
 
20,21,22,24,25,26,27,28,29,31,32,34 
√  24 
Table 3-2. Interpretation of mammalian tubulin PCR amplification 
Moreover, all the samples that were collected from Angola were positively tested for 
trypanosomiasis by CATT. Following the confirmation of DNA elution by Chelex 
using mammalian tubulin PCR. Although, it confirms that out of the 36 samples only 
24 have shown bands in the gel electrophoresis image following the tubulin 
amplification (Table 3-2). However, the nested ITS-PCR was carried on the all 36 
samples. Out of the 36 samples only 13 were successfully amplified, and 63.8% of 
the samples have failed to amplify. Of the 13 amplified samples, three samples (1, 3, 
and 17) were recorded as negatives in mammalian tubulin PCR (Table 3-2). The 
sensitivity of the nested ITS-PCR is measured in accordance with the prevalence of 
detection of trypanosomes and the positivity of the tubulin PCR. (Table 3-4 below).
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Where the prevalence of detection of trypanosomes by nested ITS-PCR was 
recorded as 11 out of 24 samples, as the samples that have failed to amplify by 
mammalian tubulin PCR and nested ITS-PCR were excluded. As the failure of the 
nested ITS-PCR could be due to the absence of template DNA from the samples, 
which may have caused false negative (figures 3-10 and 3-11). Therefore, the 
sensitivity of the nested ITS-PCR is measured as (45.8%). 
 
 
M   +VE   1 2 3 4 5 6 7 8 9 10   11   12   13    14    15  16 1 7  -ve 
 
Figure 3-10. Nested ITS-PCR amplification of DNA that was extracted from 5 punches from the FTA cards of the 
Angolan patients using Chelex® 100. (+ve) represents the positive control of the PCR amplification 
(T.b.rhodesienserhodesiense DNA), lanes 1-17 represent the number of the patient sample, (-ve) 
represents the negative control (water) and M represents the DNA marker hyperladder 1 (Bioline). 
Note, samples 4, 5, and 6 amplified an unexpected size of PCR product.  
 
 
Moreover, considering that only five punches were selected from the FTA card for 
the Chelex DNA elution. The efficiency of the Chelex DNA elution can be noted from 
(figures 3-10), as the majority of the DNA amplification of the eluted DNA can be 
considered as highly concentrated with an exception of sample 1 and 10. 
1000 
800 
600 
 
200 
 
100 
bp 
84  
M +Ve   18  19   20   21  23  24  25  26   27  28  29  30   31  32  33   34 35  36 -VE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1500 
 
 
 
1000 
 
800 
 
 
600 
 
 
 
400 
 
 
 
 
 
200 
 
 
 
 
bp 
 
 
 
Although, all the cards were prepared in the same way and collected from confirmed 
sleeping sickness patients, according to (table 3-2) 12 samples out of the samples in 
(figure3-11) have been positively tested for DNA presence using mammalian tubulin 
DNA and the successful PCR reaction as the positive control DNA was successfully 
amplified after the second reaction. Yet the ITS primers failed to amplify all of the 
Angolan samples in (figure3-11). 
Figure 3-11. Nested ITS-PCR amplification of DNA that was extracted from 5 punches from the FTA cards of the 
Angolan patients using Chelex® 100 method. (+ve) represent the positive control of the PCR amplification(T.b. 
rhodiense DNA) , lanes 18-36 represent the number of the Angolan patient sample, (-ve) represents the PCR 
negative control (water).and M represents the DNA marker hyperladder 1 (Bioline) 
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However, at this stage a final judgment on whether it is real negative or false 
negative cannot be decided. Thus, further investigation is required. Furthermore, the 
nested ITS-PCR was again carried out on the 17 negative samples (figure 3-11) but 
this time the number of punches was increased from five to ten punches. This was 
done to confirm the negativity or positivity of these previously negative samples. 
However, as shown in (figure 3-12) the post amplification gel electrophoresis image 
still shows no sign of amplification despite the positive control amplifying correctly. 
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Furthermore, a different approach was followed by increasing the annealing 
temperature to 57 Cº. As the GC-rich PCR products are difficult to amplify, 
increasing the annealing temperature will increase the specificity of the primers. 
This procedure also failed to produce any amplification (data not shown). 
+VE                                           -ve 
Figure 3-12. Nested ITS-PCR amplification of DNA that was extracted from 10 punches from the FTA cards of 
the Angolan patients using the Chelex® 100 method from the 18 negative patient samples (Figure 3-11). 
Marker is represented by (M), +Ve represents the T.b rhodiense DNA that was used as the positive control, 
lanes from 18-35 represent the number of the Angolan sample and –ve represent the negative control (water). 
Note, although the number of punches has been increased from 5 to 10 in this nested ITS-PCR amplification 
there remains no trypanosome PCR product. 
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On the other hand, the results of the PCR amplification using ITS PCR of the 
extracted DNA showed specific size bands for T.b. brucei, which was in complete 
compliance with the expected band size from NCBI database (Table 3-3). 
However, other unusual sized bands of 600 base pairs were seen in some 
samples. 
 
Sample Number Band Size (bp) Expected Band size/ Species 
1 1230 1224/ T. brucei 
2 
3 1230 1224/ T. brucei 
4 600          1224/ T. brucei 
5 600           1224/ T. brucei 
6 600            1224/ T. brucei 
7 1230 1224/ T. brucei 
8 1230 1224/ T. brucei 
9 1230 1224/ T. brucei 
10 1230 1224/ T. brucei 
11 1230 1224/ T. brucei 
12 1230 1224/ T. brucei 
13 1230 1224/ T. brucei 
14 1230 1224/ T. brucei 
15 1230 1224/ T. brucei 
16 1230 1224/ T. brucei 
17 1230 1224/ T. brucei 
Table 3-3. Expected and observed band sizes resulting from nested ITS-PCR from Angolan patient 
samples 1-17. The expected sizes were obtained from NCBI database (Cox et al., 2005).  Patient 
samples 18 to 36 failed to produce any amplicons (Figure 3-11).
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According to (table 3-3) the amplicon sizes resulted from ITS primers amplification of 
the samples are in complete agreement with the expected band sizes, with exception 
of samples 4, 5, and 6. Hence, the one of them (sample 4) was sequenced to be 
identified (below). The prevalence of the detection rate using Chelex/ITS nested PCR 
and the summary of the results in relation to the patient’s occupation, treatment,   
and staging of the trypanosomiaisis information are illustrated in (Table 3-4).            
The staging of the disease is measured based on the variation of the symptoms 
duration information (Figure 3-4). As Checchi et al. (2008b) have reported that 
duration of stage 1 of Gambian trypanosomiasis is 1.5 years, whereas stage 2 is 
reported as 3 years.  It is worth noticing that patient 8 has 7 years of symptoms 
duration. Laveran and Mesril (1904) have reported that HAT symptoms can rise to 
up to seven years. Whereas more recent Sudarshi et al. (2014) have reported the 
longest duration of gambian form of sleeping sickness  symptoms (29 years). 
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 Patient 
Number 
Tubulin 
PCR 
ITS 
PCR 
Positive Detection of 
trypanosomes by ITS-PCR 
Occupation Treatment Staging 
1 - + + Farmer         No 2 
2 - - N/A Farmer Yes 2 
3 - + + Farmer    No 2 
4 + + - Farmer Yes 2 
5 + + -  Yes 2 
6 - + - Farmer Yes 1 
7 + + + Farmer Yes 2 
8 + + + Student Yes 2 
9 + + + House wife    No 2 
10 + + + Student         No 1 
11 + + + Student Yes 2 
12 + + + Farmer Yes 2 
13 + + + Farmer         No 2 
14 + + + House wife Yes 2 
15 + + + Farmer Yes 1 
16 + + + Student Yes 2 
17 - + + Farmer         No 1 
18 - - N/A Farmer Yes 2 
19 - - N/A House wife Yes 2 
20 + - - Student         Yes 2 
21 + - - Farmer Yes 2 
22 + - - Soldier Yes 1 
23 - - N/A          No 2 
24 + - - Teacher Yes 1 
25 + - - Soldier Yes 1 
26 + - - Farmer Yes 1 
27 + - - Student Yes 2 
28 + - - Soldier Yes 1 
29 + - - Soldier Yes 1 
30 - - N/A Soldier Yes 2 
31 + - - Farmer No 1 
32 + - - Traveller No 2 
33 - - N/A  No 1 
34 + - - Student No 1 
35 - - N/A Farmer No 1 
36 - - N/A Student No 2 
Table 3-4. Summary of the detection of trypanosomes by Chelex/ITS nested PCR on Angolan patient 
samples.  Patient occupation, treatment history and staging of the trypanosomiasis is specified (1 = 
early stage; 2 = late stage). (+) and (-) indicate successful and unsuccessful PCR detection respectively, 
(N/A) not applicable. 
 
According to (table 3-4) overall the Chelex/ITS nested PCR have shown the 
potentials in term of the sensitivity in detecting the trypanosomes, considering the 
age of the samples, number of punches and the costs. Further improvements are 
required to improve the sensitivity. 
All the samples that were positively detected by Chelex/ITS-PCR (13 samples) 
belong to female patients. This could be due to the high intensity of the 
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parasitemia, because of their occupation as seven out of the 13 (females) works 
as a farmers, which means high exposure rate to the parasite. Whereas, 3 males in 
this study were farmers. Also, we cannot be sure whether if the patients have 
received a treatment or not, have an impact on the detection rate by Chelex/ITS-
PCR. Since 7 out of the 13 samples who were positively tested by nested ITS-
PCR have received a treatment. Finally, the not applicable is referred to samples 
who have failed to be amplified in both detection protocols (i.e. tubulin or nested 
ITS-PCR). These samples will be excluded from the statistical analysis (below). 
3.3.3 Identification of nested ITS-PCR amplified products (DNA 
sequencing)  
 
The nested ITS-PCR amplification produced band sizes of the correct size for T. 
brucei in the majority of positive cases; however three samples (4, 5 and 6) 
produced a different band size (of 600bp).  To find out what these bands were, 
sample 4 as well as samples 1 and 14 were purified from the agarose gel and 
sequenced using the internal primers (ITS3 and ITS4). The obtained DNA 
sequencing results were visualised using the software program Finch TV. Following 
the viewing of the nucleotides resulting from the DNA sequencing, the sequences 
were compared to the sequences available on the NCBI database, and a BLAST 
search was conducted using the National Centre of Biotechnology Information 
(NCBI) website facility (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi?). 
 
 
The results of the BLAST search showed that sample 1 (which had the T. brucei 
sized band of 1224bp) shared 98% nucleotide similarity with the Trypanosoma 
brucei gene for 5.8S ribosomal RNA (Accession number X02483.1) (Figure 3-13). 
Sample 14 was in the second band (600bp band) and shared 92% nucleotide 
similarity with Trypanosoma evansi genes for 18S ribosomal RNA gene (accession 
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number AB551922.1) (Figure 3-14).  This confirmed that both of these sequences 
were derived from the correctly amplified DNA. (Table 3-5) summarises the closest 
matches for each sequence. Sample 4 (at the unusual 600bp band) detected 
Malassezia genomic DNA containing the 18S rRNA gene (accession number 
JX993625.1) when exposed to a BLAST search (Figure 3-15). 
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X02483.1 TGATATCCATTATACAAAAAAGAGACTATTTATGTGCATGTATAATTGCACAGTATGCAA 60 
 
Sample1 TGATATCCATTATACAACAAAGAGCATATTTATGTGCATGTATAATTGCACAGTATGCAA 
***************** ****** ********************************** 
60 
X02483.1 CCAAAAATATACATATATGTTTTACATGTATGTGTTTCTATATGCCGTTTGACATGGGAG 120 
Sample1 CCAAAAATATACATATATGTTTTACATGTATGTGTTTCTATATGCCGTTTGACATGGGAG 
************************************************************ 
120 
X02483.1 ATGAGGGATGTTATATATAGTTCTGTTATTTTCTAATATGTATGTGTGTTAGAGTGTCTG 180 
Sample1 ATGAGGGATGTTATATATAGTTCTGTTATTTTCTAATATGTATGTGTGTTAAAGTGTCTG 
*************************************************** ******** 
180 
X02483.1 TGTTAATATACTTTTTAATGCGTGCTCTACATAATATACAGTAGTAATAACACAGAGAAT 240 
Sample1 TGTTAATATACCTTTTAATGCGTGCTCTACATAATATACAGTAGTAATAACACAGAGAAT 
*********** ************************************************ 
240 
X02483.1 ACGTATGTAATGCGTATCTCTCTATATCTATATATATATGTATATATGCTATGTGTATAT 300 
Sample1 ACGTATGTAATGCGTATCTCTCTATATCTATATATATATGTATATATGCTATGTGTATAT 
************************************************************ 
300 
X02483.1 AAACCTCGCATATTTTCTCCCTGTTGACCACGGCTCCCACAACGTGTCGCGATGGATGAC 360 
Sample1 AAACCTCGCATATCTTCTCCCTGTTGACCACGGCTCCCACAACGTGTCGCGATGGATGAC 
************* ********************************************** 
360 
X02483.1 TTGGCTTCCTATTTCGTTGAAGAACGCAGCAAAGTGCGATAAGTGGTATCAATTGCAGAA 420 
Sample1 TTGGCTTCCTATTTCGTTGAAGAACGCANCAAAGTGCGATAAGTGGTATCAATTGCAGAA 
**************************** ******************************* 
420 
X02483.1 TCATT-CATTGCCCAATCTTTGAACGCAAACGGCGCATGCCCGACGCTCTCTCGAGC-AT 478 
Sample1 TCATTTCATTGCCCAATCTTTGAACGCAAACGGCGCATGGGAGAAGCTCTCTCGAGCCAT 
***** ********************************* ** ************ ** 
480 
X02483.1 CCCCGTACATACCACATTTCTCAGTGTCGAATATAAAAACAAAACACACACCTATTTTTT 538 
Sample1 CCCCGTGCATGCCACATTTCTCAGTGTCGAATATAAAAACAAAACACACACCTATTTTTT 
****** *** ************************************************* 
540 
X02483.1 GTGTTGTTCAACGCACGCACAAAATTCCGCCACCTCTTCTCCTCGTGTGGTGCATATTCA 598 
Sample1 GTGTTGTTCAACGCACGCACAAAATTCCGCCACCTCTTCTCCTCGTGTGGTGCATATTCA 
************************************************************ 
600 
X02483.1 TGTTTGTGAGTGTGCACATATACGATATCATTCTTCTCTTTCTACACGCACGATTGTATA 658 
Sample1 TGTTTGTGAGTGTGCACATATACGATATCATTCAACTCTTTCTACTCGCACGATTGTATA 
********************************* ********** ************** 
660 
X02483.1 TGTCACGCATGTACGTGTGTGTAGTGAGTGATATGGAAGAGAAATGGGAAAGGCATATAT 718 
Sample1 TGTCACGCATGTACGTGTGTGTAGTGAGTGATATGGAAGAGAAATGGGAAAGGCATATAT 
************************************************************ 
720 
X02483.1 
Sample1 
ATGTATATGTATATACGTGAT 739 
ATATATATGTATATACGTGAT 741 
** ****************** 
 
Figure 3-13. DNA sequence  alignment between X02483.1 (Trypanosoma brucei 5.8S ribosomal RNA 
gene) and sample 1. The nucleotide substitutions are highlighted in red and deletions are indicated by 
(-). 
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 AB551922.1 AAACACACACCTATTTT--GTGTTGTTCAACGCACGCAAAAAATCCCGCCACCTCTTTCT 58 
Sample14 AAACACACGCGTATTTTTTGTGTTTTACACCGCCCGCAAAAAATCGCGCCACCTCTT-CT 
******** * ****** ***** * ** *** *********** *********** ** 
59 
AB551922.1 CCTCGTGTGGTGCATATTCATGTTTGTGAGTGTGCACATATACGATATCTTTCAACTCTT 118 
Sample14 CCTTGTGGGGCGCATACTCATGTGTGAGAGTGCGCACATATACGATATTTTTCCTCTCTT 
*** *** ** ***** ****** ** ***** *************** **** ***** 
119 
AB551922.1 TCTACTCGCACGATGGTGTATGTCACGCATATACGTGTGTGTAGTGAGTGATATGGAAGA 178 
Sample14 TATACTCCCACGGGTGTATGTCTCACACATACGCGTGTGTGTAGTGAGAGATAGAGAAGA 
* ***** **** ** * * **** **** *************** **** ***** 
179 
AB551922.1 GAAATGGGAAAGGCATATATATATATGTATATACATAATATATATGTGTGTGGATTTGTG 238 
Sample14 GAAAGGGGAAAGGCATATATANATAT--ATATACATAATATATATGTGTGTGGATTTGTG 
**** **************** **** ******************************** 
237 
AB551922.1 TGTTGAGCACATATAAGGAAAAAGGTTGTGTGTATATACAGAGAGTCTGTGGCGGTTGGG 298 
Sample14 TGTTGAGCACACATAAGGAAAAAAATGGTGTGTATATACAGAGAGTCTGTGGCGGTTGGG 
*********** *********** * ********************************* 
297 
AB551922.1 ACATGTGTATAAATATATATATGTATATGTGTGTGTTCCGCTGTGGAGATTTTATATCTT 358 
Sample14 ACACGTGTATAAAAATATA--TGTATATGTGTGTGTTCCCCNGTGGAGATTTTATATCTT 
*** ********* ***** ****************** * ****************** 
355 
AB551922.1 ACGGAGAGTGTTCATATATATATGTTTGTACGCATGTATTTTGGCGCCCCGTATAGAGAT 418 
Sample14 TCGGAGAGTGTTCATATATATATGTTTGTAGGCATGTATTTTGGCGCCCCGTATGGAGAT 
***************************** *********************** ***** 
415 
AB551922.1 TAAAAAAGAAGAGAAAAAGTATGCAAAAGAGGCGGCGGATAGTGTGTATGTGTGTATTCA 478 
Sample14 TAAAAAAGAAGAGAAAAAGTATGCAAAAGAGGCGGCGGATAGTGTGTATGTGTGTATTCA 
************************************************************ 
475 
AB551922.1 CAGCAAGCAACTATATTTTGCTGCTTGTGAGTATATGCATATATGTACATTATGTGCTTG 538 
Sample14 
 
AB551922.1 
CAGCAAGCAACTATGTTTTGCTGCTTGTGAGTATATGCATATATGTACATTATGTGCTTG 
************** ********************************************* 
TGCTTCTTTCGTGTACGCTTCACTTTTTTATATTGCATTTTTCAGACCTGAG--- 590 
535 
Sample14 TGCTTCTTTCGTGTACGCTTCACTTTTTTATATTGCATTTT-CAGACCTGAGGGG 589 
***************************************** **********  
Figure 3-14. DNA sequence alignment between AB551922.1 (Trypanosoma evansi evansi 18S 
ribosomal RNA gene) and sample 14. The nucleotide substitutions are highlighted in red and 
deletions are indicated by (-). 
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 JX993625.1 ----------------------GTGTCCCTGGCCGCCTACACCCACTATACATCCACAAA 38 
Sample4 CANGCCCTACCGAACCCCATCCGTGTCCCTGGTCGCCTACACAAACTATTGATCCG-GAA 59 
********** ********* ***** **** ** 
 
JX993625.1 CCCGTGTGCACTGTCTTGGAGAAAGGCTTCAGAGAAGTTTTTTGTGGCCTCTCTTGGGGT 98 
Sample4 CACGTGTGCACTGTCTTGGAGAATGGCTTCCGAGAAGCCATTTGTGGCCTCGCTTGTTGT 119 
* ********************* ****** ****** *********** **** ** 
 
JX993625.1 CTTTCTTCGCTACAAACTCGAATGGTTAGTATGAACGTGGAACTTGGTTGGACCGTCACT 158 
Sample4 CTTTCTTCATTACTCACTCAATTGGGCAATATGAATTACCTACTTGGTTGGACCGCCACT 179 
******** *** **** * *** * ****** ************** **** 
 
JX993625.1 GGCCAACAAACTATACACAACTTTCGACAACGGATCTCTTGGTTCTCCCATCGATGAAAA 218 
Sample4 GGCCAACAAACTATAACCAACTTATCNNAACTGATCTCTTGGTTCTCCCATGTTGGAAAA 239 
*************** ****** *** ******************* ***** 
 
JX993625.1 ACGCAGCGAAACGCGATAGGTAATGTGAATTGCAGAATTCCGTGAATCATCGAATCTTTG 278 
Sample4 ACACAGCCCAACCCGATTCCACGTGTGAATTGCAAAATTCCGTGAATCATCAAATCTTTG 299 
** **** *** **** *********** **************** ******** 
 
JX993625.1 AACGCACCTTGCGCTCTATGGCAATCCGTAGAGCATGCCTGTTTGAGTGCCATGAAATCT 338 
Sample4 AACGCACCTTGCACTCTATGGTTCTCCGAAGACTTTGCCTGTTACAGTGCCCTGAAATCT 359 
************ ******** **** *** ******** ****** ******** 
 
JX993625.1 CCCACCCCAAGCGGTTTTTAAATGAAACGGCTTGGCGGATGGGGTCTGGATGGGTGCCTC 398 
Sample4 CCCACCCCATACGGGTTTTAAATGAAACGGCTTGCTTGATGGGGTCTGGATGGGCGCCTC 419 
********* *** ******************* ***************** ***** 
JX993625.1 TGCCTGCGCTACCTAGCACAGGCTCGCCCGAAATGCATGAGCGCCTTG ------------ 446 
Sample4 TGCCTGCCCTACCTAACACATGCTCACCCTAAATGCATGAAACCCTTGTTACAANTTTTG 479 
******* ******* **** **** *** ********** ***** 
 
JX993625.1 ------ 
Sample4 CTTCAA 485 
 
Figure 3-15. DNA sequence alignment between sample 4 and JX993625.1(Malassezia restricta 
strain 99B internal transcribed spacer 1).  
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 Sample 
Number 
Band size 
(bp) 
Sequence 
Length (bp) 
Length of 
covered 
reference 
sequence 
 
(bp) 
Percent 
identity to 
the T. 
brucei 
reference 
 
(%) 
1 1230 741 919 98 
14 600 589 590 92 
4 600 485 446        0 
Table 3-5. BLAST search results of nucleotide sequences of the ITS-PCR amplified products from three 
Angolan samples.  
 
According to table 3-5 it can be noticed the resultant sequence length of sample 1 
is shorter than the amplified product size. Which could be due to impurities still 
exist within the purified sample, or mis-priming. 
3.3.4 Analysis of positive and negative infections in the Angolan samples 
 
The agreement between the trypanosome detection between the two diagnostic tools 
(CATT and ITS-nested PCR) was analysed using KAPPA test using Graphpad Prism 
software; the Kappa value was used to determine the level of agreement between the 
diagnostic tests. The explanation of Kappa value is described in (Altman, 1991). The 
KAPPA value was calculated for samples that proved to be positive in the mammalian 
tubulin amplification. KAPPA value was calculated by Graph Pad Prism 
6 and it was found as K= 0.471 which indicates moderate agreement between 
CATT and nested ITS-PCR/Chelex. 
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Furthermore, an interesting outcome of this study is that all the positive tested 
samples by ITS-PCR were females (13 females). In order to find if there is a 
significance difference between the detection rate in males and females, the P 
value was calculated to analyse the detection of trypanosomes between the males 
and females using fisher exact test (95% confidence intervals). P= 0.0001 (<0.05) 
which indicates significant difference between the detection of trypanosomes in 
females versus the males, (figure18). 
 
Figure 3-16. The number of trypanosome positives detected by nested ITS-PCR/Chelex between the 
two genders that participated in this study.  
 
 
Moreover, according to table 3-4 the majority of the samples that were positively 
tested by nested ITS-PCR belong to patients that works as a farmers, which agrees 
with the work that was reported by Truc et al., (2011), where the authors have 
reported 35% out of the 200 patients infected by gambian HAT were farmers.. 
Which may have an impact on the detection rate of trypanosomes by nested ITS-
PCR. Thus, to test hypothesis of whether the occupation has an impact on the 
trypanosomes detection rate using nested ITS-PCR. The P value was calculated 
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using fisher exact test (with 95% confidence intervals) to analyse if there is a 
significant difference in term of trypanosomes detection between the agricultural and 
non-agricultural occupations. The P value was calculated as P=0.7051 which 
indicates there is no significant difference between the mentioned occupations in 
term of trypanosome detection by ITS-PCR. 
A further parameter was investigated which is the relationship between the 
treatment history (patients who received treatment versus patients who have not 
received a treatment) and detection of trypanosomes by nested ITS-PCR. (Figure 3-
17) shows the detection of trypanosomes by nested ITS-PCR, versus the number of 
patients who have received a treatment and who have not received a treatment. 
The P value was calculated using fisher exact test, to determine to see if there is a 
significance difference between the patients treatment history and trypanosomes 
detection rate by nested ITS-PCR. The P value was calculated as P=0.228 
indicating there is no significant difference between the detection rate of 
trypanosomes by nested ITS-PCR and patients treatment history. 
 
Figure 3-17. The detection of trypanosomes  by nested ITS-PCR in relation to patient treatment history. 
 
Finally, the according to (table 3-4) the patients symptoms duration varies, which 
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reflect the stage of the disease. In interest to study if there is a correlation between 
the trypanosomes detection rate by nested ITS-PCR and the disease staging, the P 
value was calculated using fisher exact test (with 95% confidence intervals). The P 
value was calculated as P=0.434 (P>0.05), which indicate there is no significance 
difference between the prevalence of detection rate of trypanosomes by nested 
ITS- PCR and the staging of trypanosomiasis in the studied patients. 
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3.4 Discussion 
 
Microscopic methods have been used here to detect and differentiate trypanosomes, 
and these methods have encountered disadvantages in term of sensitivity and time 
consumption when a large number of samples is involved. This is despite the fact 
that molecular tools used in diagnosing sleeping sickness have been said by some 
scholars to be highly sensitive, more specific and less time costly (Desquesnes, 
1997; Masake et al., 2002). Ahmed (2009) has reported on 84 cattle samples that 
were tested for any trypanosomes using microscopic methods and PCR; the results 
were 15.5% and 72.6% detection rates respectively; this constitutes a huge 
discrepancy in detection. 
 
 
Previous protocols were only able to target internal ribosomal genes (Mclaughlin et 
al., 1996) through a single round of ITS-PCR on an extracted genomic DNA. Cox et 
al. (2005) have reported that when this protocol was followed on a blood sample 
spotted onto a filter paper it failed to amplify the DNA. Thus, Cox et al. (2005) 
developed an ITS-nested PCR that was initially found to assist the epidemiological 
investigations of African trypanosomiasis. ITS-nested PCR has offered a great deal 
of benefits in terms of cost reduction, and the process is now considered to be a 
reliable and powerful tool. 
 
 
The nested ITS-PCR method has not been used on Chelex eluted DNA from FTA 
cards. The current study was carried out to test the sensitivity and specificity of ITS- 
nested PCR on trypanosome DNA extracted using the Chelex extraction protocol. 
The study has thus sought to test the effectiveness and usefulness of this tool using 
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the Chelex extraction protocol which could be considered to be an alternative and 
viable method for extracting DNA from FTA cards. 
 
 
The decision to use a nested PCR was based on the need to increase the sensitivity 
of the reaction with an increase in the target amount and a potential dilution of the 
inhibitory factors (Cox, 2007). Initially, to evaluate the nested ITS-PCR, the nested 
ITS-PCR was carried out on a single punch taken from an FTA card spotted with 
neat trypanosome DNA, and from FTA cards spotted with blood from patients who 
have tested positively for trypanosomiasis using CATT (all the sample were from 
Angola). This resulted in a (0) detection, however, PCR reaction positive control 
(T.b.rhodesiense DNA) have been successfully amplified. This accords with the 
findings reported by Cox et al. (2005) which showed that a single punch from an FTA 
card can cause false negative PCR results due to the uneven distribution of the 
genomic material on the FTA card matrices. The sensitivity of the nested ITS-PCR 
increased suddenly by using the Chelex DNA elution approach. Chelex/nested ITS-
PCR was studied on serial dilutions (1:12) of neat trypanosome DNA which was 
spotted onto FTA card and eluted using the Chelex, whereby it recorded a sensitivity 
of 67% out of the twelve dilution. Which could be due to the absence of template 
DNA, which may be due to the failure of Chelex DNA extraction.  From Figure 3-7 it 
can be clearly seen that nested ITS-PCR was highly sensitive and trypanosome was 
detected at a concentration of 1ng/µl.  
 
 
Based on the tubulin mammalian PCR results it can be concluded that using Chelex 
to extract DNA is a reliable and convenient approach. The key advantage of using 
Chelex®100 is that it is cheaper when extracting DNA, with an estimated cost of less 
than US$0.16 per sample for the reagents compared to US$1.23 per sample for 
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InstaGene Matrix (Strøm et al., 2014). Moreover, Chelex®100 possesses metal ions 
which might act as catalysts in the breakdown of the DNA at high temperatures in 
low ionic conditions, and this can provide protection to DNA from degradation 
resulting from high temperatures. 
 
 
Only 24 samples out of the total of thirty six were positively confirmed in terms of the 
presence of DNA using mammalian tubulin PCR. The Chelex/nested ITS-PCR was 
carried on the 36 Angolan samples. The samples that tested negative when using 
mammalian tubulin PCR were excluded from the analysis of the detection rate by 
nested ITS-PCR, as they could lead to false negatives. This was due to the 
uncertainty of the presence of the template DNA. Thus, out of the 28 final samples 
(see Table 4), only 11 (45.8%) samples were successfully amplified, whereas 15 
(53.6%) failed to amplify.  The results recorded a higher detection rate in contrast 
with the results that were reported by Thumbi et al. (2008) who tested 103 cattle 
blood samples infected with trypanosomes, using ITS single PCR and nested ITS 
PCR and species-specific PCR; these detection rate results were 26.2%, 28.1% and 
10.7% respectively. The ITS nested PCR method was able to detect 3.8% of the 
mixed infections compared to 1.9% when using a single ITS PCR. These findings are 
comparable to the results reported by Ahmed et al. (2011) whereby the authors used 
Chelex elution to elute DNA from 300 cattle blood samples infected by trypanosome, 
to be tested using TBR-PCR (The TBR universal primers developed to amplify  the 
177 bp sequences from Trypanozoon genomic DNA). Ahmed et al (2011). Reported 
a 56.4% sensitivity. 
 
The Chelex/ITS-PCR failed to amplify all the samples (as in Figure 3-11), despite 12 
out of the 18 samples in (Figure 3-11) having tested positive for DNA presence using 
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mammalian tubulin DNA. According to Becker et al. (2004) a single punch 
“contain”1.34μl of template DNA. Ahmed et al. (2011) have reported an increase in 
sensitivity from 5.9% to 35.6% resulting from an increase in the number of punches 
from 5 to 10 punches respectively, using TBR-PCR to detect trypanosomes. Thus, 
the number of selected punches was increased to 10 punches, in order to ascertain a 
false or genuine negativity.  The negative samples still failed to amplify despite this 
increase in sample size. Thus, a different approach using an increased annealing 
temperature (raised to 57C°) was used (data not shown); this also failed to amplify. 
The negative results can be explained by several different factors; firstly, according 
to Becker et al. (2004), storage time has an impact on the FTA cards, as the DNA 
faces difficulties when released from the FTA matrix. Also, removing all the sample’s 
impurities was a challenge, because this study’s samples were collected in the 
2001. Moreover, the results may have been due to the presence of PCR inhibitors in 
the blood samples such as immunoglobulin G in plasma, haemoglobin in 
erythrocytes and lactoferrin in leukocytes. Secondly, the results may be due to the 
contamination of the sample by exogenous DNA or DNases which would provoke a 
destruction of the DNA (Desquesnes, 1997; Desquesnes and Davila, 2002; Solano 
et al., 2002). Reithinger et al. (2000) have detected leishmania species in dog blood 
using PCR in Chelex®100 extracted samples. The authors reported that washing the 
FTA cards before PCR amplification did not remove all the PCR inhibitors, since 
none of the Chelex®100 extracted samples amplified the target DNA. They attributed 
this failure to the presence of PCR inhibitors that were not successfully removed 
using Chelex®100. In addition, Singh Bal et al. (2014) have detected T. evansi DNA 
from infected mice blood and purified trypanosomes, the authors have reported a 
higher sensitivity of using ESAG6/7 primers than nested ITS-PCR. The authors 
have suggested that this could be due to a higher similarity between the ESAG6/7 
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primers and the target sequence in the genomic DNA of T. evansi. Considering that 
copy number of ITS regions is (~100) higher than ESAG (20). Furthermore, Truce et 
al. (2012) have reported that the low parasitemia in the blood and CSF is well 
known for T. b. gambiense. Therefore, the amount of parasite DNA extracted from 
body fluids should be a key factor in terms of sensitivity of PCR using 
microsatellites, which has been postulated to be a major factor for the analysis of 
blood samples from patients (Koffi et al., 2007). 
The first demographic parameter was tested is the occupation (agriculture and non-
agriculture) of the patients. According to the subsequently calculated P value 
(P=0.705>0.05) the statistical analysis indicated there was no significant difference 
between samples from agricultural workers and those from non-agricultural workers in 
trypanosomes detection using nested ITS-PCR. The enormous variation in the 
detection rate of trypanosomes between male and female patients using nested ITS-
PCR may be due to the patients’ different stages of trypanosomiasis. Truc et al. 
(1999) have demonstrated the valuable role of PCR in studying the staging of 
Gambian trypanosomiasis when using cerebrospinal fluid (CSF) samples from 20 
patients from the Côte d'Ivoire. According to the white blood cell counts, five patients 
out of the 20 were at an early stage of trypanosomiasis. The authors reported that 
Trypanosoma brucei-specific PCR failed to detect the trypanosomes in the 5 patients 
who were at the early stages of trypanosomiasis. By staging the disease (stage 1 or 
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stage 2) in the thirty six patients in accordance with their symptoms duration, the P 
value was calculated to determine if there is a correlation between the trypanosome 
detection rate using nested ITS-PCR and the disease stage. The P value was 
recorded as >0.05, which indicates there is not significant correlation between the 
staging of the disease and molecular detection of trypanosomes by nested ITS-PCR. 
Which agrees with a study carried by Deborggraeve et al. (2010) where the authors 
reported non-significant difference between stage 1 and stage 2 of patients infected 
with T.b.gambiense (P= 0.184)  which indicates the drawback of PCR in staging of 
gambien HAT .The  final demographic parameter (treatment history) was studied in 
relation to the trypanosomes detection rate in patients when using nested ITS-PCR. 
Although the positive detection rate was recorded as relatively equal between 
patients who have received treatment and those who have not received treatment 
the P value was calculated as >0.05, indicating that there is not a significance 
difference between patients who have received treatment and those who have not in 
terms of trypanosomes detection using nested ITS-PCR. 
 
 
Many publications e.g. (Daniel and Linardi, 2010; and Morrison et al., 2007) have 
suggested that PCR sensitivity can be increased through Multiple Displacement 
Amplification (MDA). MDA is a protocol that uses the bacteriophage ø29 DNA 
polymerase and exonuclease-resistant, thio-phosphate-modified and degenerate 
hexamers to amplify DNA from crude or pure sources. Daniel and Linardi (2010) 
compared the PCR amplification of DNA from siphonapterids before and after MDA, 
and the authors found that out of 26 samples only 15.4% were amplified, whereas 
after the involvement of MDA the sensitivity had increased to 92.2%. Interestingly 
one of the amplified samples after the MDA was collected as far back as 1909. 
Morrison et al (2007) have reported on the use of MDA on extracted DNA from FTA 
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cards spotted with blood infected with trypanosome before PCR amplification. The 
authors found that by using 5 discs from the FTA card the nested PCR was only able 
to detect 1 trypanosome per reaction without the use of MDA, whereas when the 
MDA was applied before the amplification, the sensitivity increased by twenty fold 
(~0.05 trypanosome per reaction). 
 
Several approaches can be considered for increasing the sensitivity of the negative 
results of the nested ITS-PCR, such as lysing the whole blood before applying it onto 
the FTA card. Ahmed (2009) compared the sensitivity of DNA elutes from whole and 
lysed blood extracts, and the author reported that the PCR on 5 μl lysed blood elute 
was 1.3 times more effective than PCR on 5μl whole blood elute.  This was said to 
 be due to the fact that the lysing protocol led to an increase of the genomic material, 
and this resulted in a greater degree of homogeneity in the distribution of trypanosome 
DNA across the FTA card. 
 
Cox et al. (2005) have confirmed the specificity of the ITS primers, but samples 4, 5 
and 6 have produced amplicons with unexpected sizes after ITS-PCR amplification 
(see Figure 10a). A DNA sequencing of sample 4 shows the produced band belongs 
to the Malassezia genomic DNA containing the 18S rRNA gene. Malassezia are 
known as commensal yeasts and are found on the sebaceous areas of human skin. 
Although very resilient, they are generally found as human skin flora, but these can 
also be considered as a pathogenic organism which is related to several 
dermatological conditions with substantial cosmetic consequences (Levin and 
Delano, 2011). It is presumed that somehow this DNA or these organisms made it 
onto the FTA cards, perhaps from the sleeping sickness patients themselves. 
This reflects the evident ability of the ITS primers to detect non-trypanosome DNA. 
DNA sequencing of the selected bands confirmed the detection of T.b. brucei. The 
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nucleotides of the sequenced sample 1 have shown a high percentage of alignment 
with Trypanosoma brucei gene for 5.8S ribosomal RNA. All the positively detected 
samples when using nested ITS-PCR have produced more than one band, except 
samples 1 and 8. This reflects the usefulness of nested ITS-PCR in detecting mixed 
trypanosoma species. The second band was produced in sample 14 of 600bp size 
have been sequenced. Which have shown high similarity with Trypanosoma evansi 
genes for 18S ribosomal RNA gene. 
 
In summary, the objectives of this study was to determine the usefulness of nested 
ITS-PCR in detecting trypanosomes from FTA cards, to evaluate the use of FTA 
cards in collecting samples in field diagnostic laboratories, the efficiency of Chelex 
in overcoming the obstacle of false negative results and the correlation between the 
demographic information and the detection rate of trypanosome by nested ITS-PCR 
It is concluded that FTA cards are more convenient for collecting larger samples and 
nested ITS-PCR is a simple, more economically viable, less time consuming and 
more sensitive process for detection because it has the ability to detect mixed 
infections. Furthermore, protocols such as MDA and blood lysing could contribute to 
an increase in the sensitivity of the nested ITS-PCR. Future work is required to test 
this provisional hypothesis. 
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 . Identification of trypanosomes from FTA cards 
spotted with blood using MGE-PCR 
 
4.1 Introduction 
 
Trypanosomiasis is known to be a complex disease as the human-infective and non- 
human-infective strains of Trypanosoma brucei overlap in the same transmission 
cycles. The epidemiology of HAT is largely based on the identification and tracking of 
strains involved in the generation of epidemic and endemic foci (Fevre et al., 2001; 
Welburn and Odiit, 2002). Previous studies have introduced molecular tools for 
tracking trypanosome strains including the use of isoenzyme characterisation 
(Gibson et al., 1980; Tait, 1980, Tait et al., 1983, 1985; Stephens et al., 1993) and 
RFLP analysis (Hide et al., 1989, 1991, 1994, 1998, 2000). Although these tools 
have a successful track record in studying trypanosomiasis, they are not efficient 
when large-scale uses of samples are involved, as they require a significant amount 
of time for the growth and amplification of parasites in experimental cultures or 
animals. Thus, they lack the ability to enable a sensitive discrimination of strain type 
directly from the infected sample. 
Hasan et al. (1984) have reported the discovery of mobile genetic elements (MGEs) 
including the ribosomal inserted mobile element (RIME) in trypanosomes. The 
mobile genetic element PCR (MGE-PCR) was developed as a tool for strain 
identification of trypanosomes (Tilley et al., 2003) and for the diagnosis of 
Toxoplasma gondii (Terry et al., 2001). MGEs are found present in an extensive 
variety of living organisms from protozoa to humans (Hartl et al., 1997). The 
importance of MGEs relates to their repetitiveness and variability, which can help in 
improving the efficiency of molecular epidemiological investigations (Hide and Tait, 
2009). Also, the ability of MGEs to move to a new chromosomal location can be 
deployed to study the shaping of the evolutionary process of the genome 
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(Bhattacharya et al., 2002). Moreover, MGEs can be found in high frequencies 
(Hartl et al., 1997) as about 35% of the human genome consists of MGEs and they 
occupy 10% of the Drosophila genome (Labrador and Corces, 1997). On the other 
hand, about 5% of the T. brucei genome consists of MGEs (INGI/ RIME) 
(Bhattacharya et al., 2002). Therefore, MGEs constitute an attractive marker to be 
used when studying the variability and characterisation of strains of parasites. 
Based on the fact that MGEs can be used as genetic markers in epidemiological 
studies, Hide and Tilley (2001) and Tilley et al. (2003) have developed a tool known 
as MGE-PCR, which is a simple and sensitive technique that can be used to detect 
genetic variability in Trypanosoma brucei ssp. MGE-PCR utilises a single primer 
that produces variable banding patterns in a one-step PCR approach. It is based on 
using markers derived from the trypanosomal mobile genetic RIME and detecting 
positional variation in these elements. The MGE-PCR approach is based on the 
technique of PCR using a single PCR primer method that was reported by Screaton 
et al. (1993) and which facilitates the amplification of unknown ends of genes from 
known internal fragments. MGE-PCR is considered considerably more specific than 
the RAPD method, since it is not affected by contaminating DNA to the same extent 
(Hide and Tait, 2009). It can be used to detect the positional variation of MGEs by 
enacting PCR amplification from within a known piece of DNA (the MGE such as 
RIME) into an unknown flanking sequence. This is because there are specific 
annealing requirements for the annealing of the single MGE-based primer on at 
least one end of each PCR-amplified fragment (Hide and Tilley, 2001). 
Furthermore, Tilley et al. (2003) have reported the successful use of MGE-PCR in 
producing a clear distinction between human-infective and non-human-infective 
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isolates from T.brucei stocks collected from southeast Uganda, Kenya and Zambia in 
the presence of vertebrate (hosts) DNA. Moreover, Njiru et al. (2011) have reported 
that with MGE-PCR the author was able to distinguish between T. evansi and T. 
brucei. In addition, Simo et al. (2005) applied MGE-PCR to T.b.gambiense isolates 
from Central Africa and they were able to report micro genetic differences between 
T. b. gambiense isolates. The adaptability of this approach is demonstrated by 
additional studies that have reported the use of MGE-PCR in studying the genetic 
variability in Toxoplasma gondii (Terry et al., 2001) and the trematode Clonorchis 
sinensis (Lai et al., 2008). 
Moreover, one of the advantages of MGE-PCR is its reproducibility as Tilley et al. 
(2003) have reported that an identical banding pattern was generated from DNA 
extracted from procyclic isolates collected from Tororo in 1989 and bloodstream 
isolates collected in 2000 from the same focus. This is an important part of such 
studies that involve comparing strains from new and established foci (archived DNA), 
in order to determine the origin(s) of outbreaks, the spread of diseases and the 
establishment of new foci. Another technique, RAPD, can produce the same level 
variation but it can only work on purified parasite DNA preparations. MGE has the 
advantage of specifically amplifying the trypanosome DNA in the presence of the 
host DNA (Simo et al., 2005). MGE-PCR has thus been widely used as a technique 
using extracted DNA as the source of DNA. However, many recent studies now use 
blood samples stored on FTA cards as a method of sampling. There are no reports, 
as far as we know, of MGE-PCR being successfully used to amplify trypanosome 
DNA and genotype it directly from FTA cards. 
There are certain sampling problems associated with the detection of trypanosomes 
using FTA cards. As Cox et al. (2010) have reported, Multiple PCR samples taken 
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from single FTA cards have demonstrated that a single punch from an FTA card is 
not sufficient to confirm the infectivity status of an individual animal, as parasite DNA 
is unevenly distributed across the card. At low parasite densities in the host, this 
stochastic sampling effect results in an underestimation of the disease’s prevalence 
based on a single punch PCR test. However, Ahmed et al. (2011) have reported an 
increase in the sensitivity of PCR amplification after DNA elution from the FTA card 
by Chelex. The sensitivity increased from (35.6%) to (56.4%) respectively. 
Therefore, in this present study the Chelex elution approach will be carried out on 
blood spotted on FTA cards of patient samples collected from Angola, prior to the 
MGE-PCR amplification. 
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4.2 Objectives 
 
 
1. To execute a detailed analysis of MGEs in relation to the trypanosome 
genome and strain types in a collection of samples from Angola. 
2. To investigate and develop the use of MGEs for field trypanosomes samples 
collected on FTA cards 
3. To compare the Chelex-nested ITS PCR and the MGE-PCR as methods for 
trypanosome detection and strain evaluation 
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4.3 Methods 
 
In this chapter a different trypanosome molecular identification approach (MGE- 
PCR) will be carried out. Detection of trypanosomes was carried out using MGE- 
PCR, using a REV B primer to amplify the RIMEs from the eluted DNA from FTA 
cards. The samples were taken from 36 patients who had tested positively for 
trypanosomiasis by CATT collected from Angola. Furthermore, the resultant 
amplicons from the PCR amplification will be sequenced to identify the generated 
bands. Detailed materials and methods can be found in chapter 2. 
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4.4 Results 
 
Although all the samples, obtained on FTA cards from a hospital in Angola, were 
confirmed as positive for trypanosomiasis by CATT (see Chapter 3), there were 
variable results when the samples were tested using the ITS PCR-based diagnostic 
tests. Adequate DNA extraction from the FTA card punches was confirmed using 
tubulin PCR, however, nested ITS-PCR failed to detect 14 of the tubulin positive 
samples. To further examine this issue, it was therefore decided to test the samples 
by MGE- PCR, as a way of comparing another molecular detection system to CATT. 
4.4.1 Development of the use of MGE-PCR in FTA cards 
 
As far as we know, MGE-PCR has not been successfully used directly from FTA 
cards. There have been attempts made to get this to work from single punches in the 
past, but these have been unsuccessful. Based on the problems identified by Cox et 
al. (2010) on sampling trypanosomes from FTA cards and the solutions based on 
Chelex extraction provided by Ahmed et al. (2011), Chelex-based approaches were 
investigated as a method for improving the use of FTA cards for MGE-PCR. Thus, as 
a first step it was important to evaluate and optimise the technique, before testing the 
samples. Initially, the basic protocol (Tilley et al., 2003) was followed for the use of 
MGE-PCR amplification from DNA eluted by Chelex from FTA cards. This involved 
using eluted trypanosome DNA from the FTA card as a positive control. The REV B 
primer failed to amplify the samples including the positive control (Figure 4-1). This 
could have been due to the genomic DNA of the host being present on the spotted 
FTA card causing the REV B primer to encounter difficulties in annealing with the 
template. A possible solution, therefore, could be to increase the primer 
concentration to try to optimise the PCR reactions. The concentration of REV B was 
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doubled to 20pmol. This increase in the REV B primer concentration helped to 
amplify the positive control samples only (Figure 4-2). 
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The results of the MGE-PCR using double primer concentrations (as in Figure 4-2) 
shows that the amplification when using a single primer works efficiently with an 
increased concentration but it still fails to amplify from the real samples eluted from 
the FTA cards. However, the MGE-PCR have successfully worked in the latter 
experiments with an increased concentration of the primer (below). 
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Figure 4-1. MGE-PCR amplication using 10pmol of primer REV B.  (M) contains 
the DNA size marker (1kb), ,  lane 1 is the positive control (eluted trypanosome 
DNA from the FTA card), lanes 2-4 (Angolan samples 4, 10 and 20 respectively) 
and (-ve) is the negative control (water) 
 
 
Figure 4-2. MGE-PCR amplification using REV B primer at the increased primer concentration of 
20pmol. (M) contains the DNA marker (1kb),  lanes labelled 1, 2 and 3 indicate the positive control 
trypanosome DNA that was eluted from FTA cards by Chelex, lanes 4, 5 and 6 represent the 
Angolan samples (4, 10 and 20 respectively), and (-ve) is the negative control (water).  
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               4.4.2 Chelex-MGE-PCR detection of trypanosomes in FTA cards 
 
After this initial evaluation of the technique, whereby the concentration of the REV B 
primer was increased to 20pmol rather than 10pmol, MGE-PCR amplification was 
carried on eluted DNA from FTA cards collected from sleeping sickness patients in 
Angola. At a concentration of 20pmol, MGE-PCR using primer REV B resulted in a 
variation in the banding patterns (Figures 4-3 and 4-4). Of 36 samples, only 21 were 
successfully amplified using REV B, which was nevertheless higher than the number of 
the amplified samples using Chelex / ITS nested PCR (Chapter 3). DNA molecular size 
was measured based on the migrated distance of the band, illustrated by comparing 
each band against its size in the DNA marker (see Table 4-1). It can be clearly seen 
from (Figure 4-3 and 4-4) that all the samples share the same banding pattern, which is 
different to the positive control as it was a T. b. rhodesiense stock from Uganda, not a 
T. b. gambiense  isolate that would be expected in Angola. 
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Figure 4-3. MGE-PCR of FTA card samples from Angolan sleeping sickness patients. . (M) 
represents the Hyperladder 1 size marker (Bioline), (+Ve) represents the positive control 
(T.b.rhodiense DNA), lanes 1-17 represents the number of the patient samples and (-Ve) indicates 
the PCR negative control (water). 
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Figure 4-4. MGE-PCR of FTA card samples from Angolan samples sleeping sickness patients. (M) 
represents the Hyperladder 1 size marker (Bioline), (+Ve) represents the positive control (T.b.rhodiense 
DNA) and lanes 18-36 represent the number of the patient and (-Ve) represents the negative control 
(water). Bands selected for DNA sequencing are highlighted by the white arrows. 
 
118  
 
Table 4-1. Summary of the MGE-PCR data from the Angolan samples. The presence and the absence of the bands between 200bp and 2000bp are 
represented by + and – respectively.  
DNA 
Maker 
Sizes (bp) 
2 
0 
0 
2 
2 
0 
2 
4 
0 
2 
6 
0 
2 
8 
0 
3 
0 
0 
3 
2 
0 
3 
4 
0 
3 
6 
0 
3 
8 
0 
4 
0 
0 
4 
2 
0 
4 
4 
0 
4 
6 
0 
4 
8 
0 
5 
0 
0 
5 
2 
0 
5 
4 
0 
5 
6 
0 
5 
8 
0 
6 
0 
0 
6 
2 
0 
6 
4 
0 
6 
6 
0 
6 
8 
0 
7 
0 
0 
7 
2 
0 
7 
4 
0 
7 
6 
0 
7 
8 
0 
8 
0 
0 
8 
2 
0 
8 
4 
0 
Sample 
Number 
+Ve + - - + + + - - - + + + - + - + - - - - + - - - - - - - - - + + - 
1 - + + - - + + + - - + - - + - - - - - - - - -  - - - - - - - - - 
2 
3 
4 
5 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
6 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
7 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
8 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
9 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
10 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
11 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
12 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
13 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
14 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
15 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
16 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
17 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
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. 
DNA Maker 
Sizes (bp) 
8 
6 
0 
8 
8 
0 
9 
0 
0 
9 
2 
0 
9 
4 
0 
9 
6 
0 
9 
8 
0 
1 
0 
0 
0 
1 
1 
0 
0 
1 
2 
0 
0 
1 
3 
0 
0 
1 
4 
0 
0 
1 
5 
0 
0 
1 
6 
0 
0 
1 
7 
0 
0 
1 
8 
0 
0 
1 
9 
0 
0 
2 
0 
0 
0 
Sample 
Number 
+Ve - - - - - - + - - - + - - - + - - + 
1 - - - - - - - - - - - - - - - - - - 
2 
3 
4 
5 - - - - - - - - - - - - - - - - - - 
6 - - - - - - - - - - - - - - - - - - 
7 - - - - - - - - - - - - - - - - - - 
8 - - - - - - - - - - - - - - - - - - 
9 - - - - - - - - - - - - - - - - - - 
10 - - - - - - - - - - - - - - - - - - 
11 - - - - - - - - - - - - - - - - - - 
12 - - - - - - - - - - - - - - - - - - 
13 - - - - - - - - - - - - - - - - - - 
14 - - - - - - - - - - - - - - - - - - 
15 - - - - - - - - - - - - - - - - - - 
16 - - - - - - - - - - - - - - - - - - 
17 - - - - - - - - - - - - - - - - - - 
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DNA 
Maker 
Sizes (bp) 
2 
0 
0 
2 
2 
0 
2 
4 
0 
2 
6 
0 
2 
8 
0 
3 
0 
0 
3 
2 
0 
3 
4 
0 
3 
6 
0 
3 
8 
0 
4 
0 
0 
4 
2 
0 
4 
4 
0 
4 
6 
0 
4 
8 
0 
5 
0 
0 
5 
2 
0 
5 
4 
0 
5 
6 
0 
5 
8 
0 
6 
0 
0 
6 
2 
0 
6 
4 
0 
6 
6 
0 
6 
8 
0 
7 
0 
0 
7 
2 
0 
7 
4 
0 
7 
6 
0 
7 
8 
0 
8 
0 
0 
8 
2 
0 
8 
4 
0 
Sample 
Number 
+Ve + - - + + + - - - + + + - + - + - - - - + - - - - - - - - - + + - 
 
 
18 
19 
20  
21            -      +    +   -     -    +    +    +  -     -     +   -     -     +   -    -     -     -    -     -     -    -     -    -    -     -    -     -    -    -    -      -    -        
22 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
23 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
24 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
25 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
26 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
27 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
28 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
29 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
30 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
31 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
32 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
33 - + + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
34 
35                   
36 
- 
 
+ + - - + + + - - + - - + - - - - - - - - - - - - - - - - - - - 
  
13  
 
 
DNA Maker Sizes 
(bp) 
8 
6 
0 
8 
8 
0 
9 
0 
0 
9 
2 
0 
9 
4 
0 
9 
6 
0 
9 
8 
0 
1 
0 
0 
0 
1 
1 
0 
0 
1 
2 
0 
0 
1 
3 
0 
0 
1 
4 
0 
0 
1 
5 
0 
0 
1 
6 
0 
0 
1 
7 
0 
0 
1 
8 
0 
0 
1 
9 
0 
0 
2 
0 
0 
0 
Sample Number 
+Ve - - - - - - + - - - + - - - + - - + 
18 
19 
20 
21 - - - - - - - - - - - - - - - - - - 
22 - - - - - - - - - - - - - - - - - - 
23 - - - - - - - - - - - - - - - - - - 
24 - - - - - - - - - - - - - - - - - - 
25 - - - - - - - - - - - - - - - - - - 
26 - - - - - - - - - - - - - - - - - - 
27 - - - - - - - - - - - - - - - - - - 
28 - - - - - - - - - - - - - - - - - - 
29 - - - - - - - - - - - - - - - - - - 
30 - - - - - - - - - - - - - - - - - - 
31 - - - - - - - - - - - - - - - - - - 
32 - - - - - - - - - - - - - - - - - - 
33 - - - - - - - - - - - - - - - - - - 
34 - - - - - - - - - - - - - - - - - - 
35 - - - - - - - - - - - - - - - - - - 
  36   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   -   
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According to Table 1 all the amplified samples share the same pattern. The Angolan 
samples appeared to have very low molecular weight bands, with 460bp constituting 
the highest molecular weight, as compared to the T. brucei control. 
4.4.3 Investigation of REV B specificity using DNA sequencing to 
confirm band sizes 
 
To our knowledge, this is the first time that RIME positional variation has been 
demonstrated using a field sample (FTA cards). Thus, it is vital to analyse the 
amplicons generated by REV B amplification by sequencing so to ensure that they 
are the desired product. Selected bands from sample 31 (in Figure 4-4 marked with 
white arrows) were cut and purified to be identified through DNA sequencing (see 
Figure 4-5). 
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Figure 4-5. Screen shots of the DNA sequencing of REV B amplified products 1, 2 and 4 (see Figure 
4-4) derived from Angolan sample 31. The figures are arranged in accordance with the molecular 
weight of each band (from the highest to the lowest).   The DNA sequencing was analysed using 
FINCH TV software. In all cases, the DNA sequencing was of very low quality. 
 
As can be seen from (Figure 4-5), the DNA sequencing of the MGE-PCR products 
was not efficient or readable. This could perhaps have been due to REV B mis-
priming during the sequencing process, the samples being contaminated, or the 
primer binding in a non-specific way. 
4.4.4 Improving DNA sequencing of REV B amplified products using 
restriction enzyme digestion to semi-purify fragments 
 
Since the specificity of REV B amplified products could not be determined through 
the DNA sequencing of the MGE-PCR amplified products, a different strategy for 
sequencing them was required. Since Rev B is a single primer that is designed 
against part of the mobile genetic element and appears at both ends, any PCR 
124  
amplified product would have that sequence at each end. This can potentially create 
problems with the sequencing reaction as forward and reverse sequences can 
overlap and this could explain the mixed peak sequences shown in Figure 4-5. 
Fragments can be generated by amplification between elements (see Figure 4-6A) 
or from a single element by means of mis-priming in the flanking region of the 
element (see Figure 4-6B). Differences in the position of the elements in different 
trypanosome stocks will generate different banding patterns. Thus we hypothesised 
that the generated bands from REV B amplification contained a RIME element 
sequence, and by cutting (digesting) the bands into smaller and specific sizes this 
will lead to successful DNA sequencing by single primer (REV B), whereby REV B 
will only have to  sequence the digested DNA rather than the whole region of the 
amplified DNA. 
 
Figure 4-6. Schematic representation of MGE-PCR using the REV B primer to amplify the mobile 
element RIME. The red line in B indicates the restriction enzyme digestion site. 
The sequence of the RIME element was put into a computer program (NEB Cutter 
http://nc2.neb.com/NEBcutter2/) to predict suitable restriction enzymes to cut the 
amplified fragment into two. Initially the digestion of the post REV B amplification 
products of sample 31 was carried out using MboI restriction enzyme. However, 
MboI failed to digest the REV B amplified products even with an extended incubation 
period overnight.  
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MboI failed to digest the MGE-PCR fragments that were produced by REV B 
amplification at two different incubation periods. The REV B amplified products failed to 
show up on the gel image, which could be due to there not being enough purified DNA, 
or could be due to the long period of incubation during which the DNA might have been 
degraded. Thus, at this point we cannot be sure if there were issues related to the 
enzyme and its components such as the buffer. 
 
 
However, a different restriction enzyme was then used (AlwNI) to cut the post REV B 
amplification products. After overnight digestion in the water bath at 37ºC., AlwNI 
produced 1 cut (i.e. 2 bands) (see Figure 4-7) for all the selected bands except band 4 
from sample 31. 
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M 1 2 3
800 
600 
400 
 
200 
bp 
Figure 4-7. Restriction enzyme (AlwNI) digestion of MGE-PCR products. Overnight digestion by 
AlwNI for bands 1, 2, and 4 from Angolan sample 31 (highlighted in white arrows Figure 4-4). Lanes 
1, 2 and 3 represent bands 1, 2 and 4 respectively. Bands 1 and 2 were successfully digested 
whereas band 4 failed to be digested. (M) represent the 1kb Bioline DNA marker. Red and green 
arrows indicate the selected bands for subsequent DNA sequencing 
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Subsequent to the successful digestion of the MGE PCR products by AlwNI, the 
digested bands from lane 1 (highlighted in red and green arrows respectively) were 
cut from the agarose gel and purified to be sequenced. The purified DNA was sent to 
Source Bioscience in Nottingham, UK for sequencing. 
 
 
The sequencing data was analysed using the program FINCH TV. However, the DNA 
sequencing results of the digested bands produced still yet unreadable results (see 
Figures 4-8 and 4-9)  
 
Figure 4-8. The DNA sequence of the AlwNI digested band (highlighted by the red arrow in Figure 4-7) 
by. The sequence data is unreadable. 
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Figure 4-9. The DNA sequence of the AlwNI digested band (highlighted by the green arrow in Figure 4-7) 
. The sequence data is unreadable. 
 
As can be seen from Figures 4-8 and 4-9 the results of the post sequencing of the 
digested REV B amplified products did not record any sign of improvement from the 
initial REV B sequencing results (as in Figure 4-5). The nucleotides of both bands 
were blasted in NCBI database to determine whether they were related to T.brucei or 
not, and the outcome was that the nucleotides were not significantly similar to any of 
the organisms present in NCBI. 
 
 
4.4.5 Negative control amplification by REV B 
 
Due to the failure of the DNA sequencing of the amplified products by MGE-PCR 
using the REV B primer, REV B was then tested on negative blood in order to 
determine whether REV B is only specific to trypanosomes. Control, uninfected, 
blood (fingertip) was spotted on a FTA card; following the treatment of the FTA card, 
DNA Chelex extraction was carried out on the punches taken from the FTA card. 
Then the eluted DNA was amplified with REV B. However, after the amplification 
REV B 
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appeared to not be a specific primer to trypanosome, as it managed to amplify the 
negative blood sample (see Figure 4-10). Thus a further investigation into mobile 
elements was required, in the interests of designing a primer that was specific to 
trypanosomes. 
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4.4.6 Alternative approach to improve DNA sequencing data 
 
Since there had been a failure of the sequencing of the REV B amplified products, 
including after the digestion of REV B amplified products by AlwNI, a different 
approach was carried out. The strategy here was to amplify the length variation of 
RIME element from the Angolan patient FTA cards using both by RIME A and RIME 
B primers, in order to obtain improved DNA sequencing data. This amplification 
Figure 4-10. REV B amplification of a negative blood control. Lane 1 represents trypanosome DNA 
(positive control), lane 2 represents he FTA card punch spotted with trypanosome DNA, lanes 3 
and 4 are Angolan samples (8 and 9 respectively), lane 5 is trypanosome-free blood and -Ve is the 
negative control (water). 
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product will provide DNA sequences for a larger region of the gene, providing more 
precise sequences. It is more specific as the amplification products can be 
sequenced with different primers from each end. 
The results show that out of the 36 Angolan samples only 7 samples were amplified 
which were 6, 7, 8, 9, 10, 12 and 31 (see Figures 4-11 and 4-12). 
 
M   +Ve 1   2 3 4 5 6 7 8    9 10 11   12    13   14   15   16   17 -Ve 
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Figure 4-11. RIME A and B amplification of Angolan samples1-17. All the amplified samples share the same 
banding pattern, and this pattern is different from the positive control banding pattern (+ve). (M) represents 
the1kb Bioline DNA marker, +ve represents  the positive control (T.b.rhodiense DNA), lanes 1 to 17 represent 
the number of the Angolan samples and –ve represents the negative control (water). Note, the low 
concentration of the DNA has an impact of the banding densities. Red arrows highlight the selected bands 
for DNA sequencing. 
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 4.4.7 Post RIME A and RIME B amplification analysis (DNA sequencing) 
 
To study the amplicons generated by RIME A and B amplification, the amplified bands 
were cut and purified and sent for sequencing. Bands that were marked with red arrows 
including the positive control from Figure 4-12 and the bands (marked with red arrows) 
generated from the amplification of the Angolan samples (sample 8 Figure 4-11) were 
selected for DNA sequencing. The DNA sequencing was carried out by Source 
Bioscience in Nottingham (UK). 
After obtaining the DNA sequence data, the data was analysed using Finch TV software. 
However, unfortunately the results yet again failed to be readable. (Figures 4-13 and 4-
14) show the screen shots of the DNA sequences of the positive control 
(T.b.rhodesienseDNA) and the amplified Angolan sample 8 respectively using Finch TV 
software; the screen shots are arranged in accordance with the molecular weight of each 
band (from the highest molecular weight to the lowest). 
M  +Ve  18  19  20  21  22  23  24  25  26   27  28  29  30  31  32  33   34   35  36 -Ve 
   
   
   
   
Figure 4-12. RIME A and B amplification of Angolan samples 18-36. (M) represents the 1 Kb Bioline 
DNA marker, lanes 18 to 36 represent the Angolan samples, +ve represent the positive control 
(T.b.rhodiense DNA) and –ve represent the negative control (water). Red arrows highlightthe selected 
bands for DNA sequencing. 
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Figure 4-13. Six screen shots of DNA sequences of RIME A and RIME B amplification products (see 
Figure 4-12).  
 
 
 
 
 
The above diagram illustrates the sequencing of positive control sample DNA by 
RIME A. According to the molecular weight of this band which is 1000bp only 200bp 
have been sequenced, and the peaks of the sequencing are mixed which has led to 
unreadable results. 
 
 
 
 
 
The above diagram shows the sequencing of positive control sample (trypanosome 
DNA) by RIME B. The second band molecular weight is estimated to be 1000bp, and 
again only 200bp have been sequenced. Due to this incomplete and bad sequence 
alignment between RIME A and Reverse RIME B was not possible. 
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The above diagram shows the DNA sequencing of the second highest molecular 
weight band of positive control sample; the sequencing was carried with RIME A 
primer. The estimated molecular weight of this band is 800bp. 
 
 
 
 
 
The above diagram shows the DNA sequencing of the second highest molecular 
weight band of positive control sample; the sequencing was carried with RIME B 
primer. The estimated molecular weight of this band is 800bp. 
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The above diagram illustrates the DNA sequencing of the third largest (molecular 
weight) band of the positive control sample. RIME A was used in this sequencing, 
the estimated band size is 600bp. Only around 200bp that have been "sequenced". 
 
 
 
 
The above diagram shows the DNA sequencing of the RIME B amplification of the 
third band of the positive control sample from (see Figure 4-12). However, it failed to 
result in good sequencing. 
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Figure 4-14. Four screen shots of the DNA sequencing of RIME A and RIME B PCR products from 
Angolan sample 8 (see Figure 4-11).  
 
 
The above diagram illustrates the DNA sequencing of the first band of the Angolan 
sample no. 8. This sequencing was carried using RIME A primer, and again the 
sequencing is relatively similar to the sequencing of the positive control in term of the 
low quality. 
 
 
 
 
The above diagram illustrates the DNA sequencing of the first band of the Angolan 
sample 8. This sequencing was carried by using RIME B primer; again the 
sequencing is very badly sequenced with a very low quality. 
136  
  
 
This diagram (above) illustrates the DNA sequencing of the second band of the 
Angolan sample 8. This sequencing was carried using RIME A primer, again the 
sequencing is relatively similar to the sequencing of the positive control in terms of 
the low quality. 
 
 
 
The above diagram illustrates the DNA sequencing of the second band of the 
Angolan sample no. 8. This sequencing was carried using RIME B primer, and the 
quality of the sequencing is poor. 
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According to the above screen shots of the DNA sequencing by RIME A and RIME 
B, the quality DNA sequences of either the positive control or the Angolan sample is 
very poor. The extraction protocol was nonetheless carried out carefully in 
accordance with the booklet for the extraction kit. Also, before sending the purified 
DNA to the sequencing company, the concentration of the purified DNA was 
measured by a nanodrop spectrophotometer at 280nm, to comply with the 
requirements that are set by Source Bioscience. Overall the sequences have 
recorded a sign of small improvement particularly in the control sample amplified 
DNA. The sequences of readable sections (i.e. good quality of nucleotides run 10- 
70bp) were subject to a BLAST search to attempt to identify them. The resultant 
organisms were completely irrelevant to trypanosome. The conclusion is that it was 
not trypanosome DNA that was amplified. These poor results could be due to several 
reasons including the following: low template concentration - particularly in the case 
of the Angolan samples, the template may not be completely purified so it still carries 
unincorporated nucleotide such as dNTP or excessive agarose gel; or nonspecific 
primers can cause the primers to bind to more than one site and the resultant 
readings are overlapped. To rule out the possibility of the low template concentration, 
the Angolan sample no. 8 was re-amplified with RIME A and RIME B                        
in order to increase the concentration of the amplified DNA. Yet the DNA sequencing 
resultant readings were still of poor quality (data not shown). 
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4.5 Discussion 
 
Recently, the World Health Organisation (2012) has established a road map on 
neglected tropical diseases, especially focused on the elimination of human African 
trypanosomiasis as a public-health problem by 2020. Thus, a better understanding of 
epidemiological principles and the development of new control and surveillance tools 
will certainly help in achieving the goal of elimination. 
 
 
In this present study one of the molecular tools (MGE-PCR) used to study and detect 
the trypanosome has been investigated in great detail, in order to compare the two 
detection methods - ITS-PCR (Chapter 3) and MGE PCR - in terms of specificity and 
sensitivity. Previously, MGE-PCR has been proven to be specific in differentiating 
between trypanosome strains when using purified DNA. However, to our knowledge 
MGE-PCR has not been applied on field samples that contain host DNA applied to 
FTA cards. Thus, MGE-PCR was carried out on DNA extracted using a Chelex 
extraction protocol from 36 blood samples spotted onto FTA cards which were 
collected from Angola that were infected with T.brucei as tested by CATT. 
 
 
Initially a single primer REV B was used to amplify the samples. However, the initial 
concentration of the primer (10pmol) had a negative impact on the amplification, 
since the samples including the positive control failed to amplify. Czerny (1995) has 
suggested that the primers have to compete with the accumulating product in finding 
their target sequence, which could lead to limiting the reaction at late cycles. He 
tested whether the ratio between primer and product concentration influences the 
product yield as he performed reactions with increasing concentrations of primers 
but in otherwise identical conditions. He observed an increase from between 2- and
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almost 20-fold depending on variation in primer concentration from 1 to 20 pmol. 
Therefore, the concentration of the primer (REV B) was increased to 20pmol, which 
led to a successful amplification of the samples. 
 
 
In term of sensitivity MGE-PCR appeared to record a higher degree of sensitivity 
than the nested ITS-PCR (Figure 4-3 and 4-4), with 58.3% (21 samples) have been 
amplified. Single primer PCR allows amplification from both known and unknown 
regions of the DNA and this means that there is a considerably greater chance of 
non-specific amplification. An initial indicator that the MGE-PCR was behaving non-
specifically came from the fact that the samples were collected from different parts 
of Angola and yet they shared the same banding patterns (although they did differ 
from the positive control). 
 
 
It was clear from the DNA sequencing that specific amplification products were not 
being obtained. Thus the REV B primer was behaving non-specifically within the 
MGE-PCR when in the presence of host DNA on the FTA cards. The quality of the 
sequencing of the amplified products was poor. This could be due to different 
reasons including: (i) non-specificity in the primer, or (ii) the low concentration of 
DNA yielded after the amplification, as can be noticed from Figures 3 and 4 where 
the amplification has resulted in smears. Also the number of PCR cycles plays an 
important role in generating the number of copies produced after the amplification, 
so another factor is (iii) the purity of the DNA before it is sent for sequencing, as well 
as (iv) the age of the sample as the samples are believed to have been collected in 
the 2001. One common feature of ancient DNA samples is the presence of 
miscoding lesions which cause the incorporation of incorrect nucleotides during DNA 
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amplification. In 2001, Hofreiter et al. showed for the first time that most of these 
damage-derived errors are caused by hydrolytic deamination of cytosine into uracil 
leading to apparent C to T or G to A substitutions in DNA templates sequenced after 
PCR amplification. A further factor could be (v) the extraction protocol that was used 
to extract the template DNA prior MGE-PCR. Mseddi et al. (2001) have reported a 
comparative study between Chelex extraction and urea Chelex extraction on 
Cryptococcus samples that were collected between 2005 and 2009. When they had 
incubated the samples in 2ml of urea buffer for 3h the latter protocol of extraction 
gave a higher DNA concentration (16,03 μg/ μl) than the Chelex extraction (7.54 μg/ 
μl).  
A different approach was thus followed, which involved digesting a selected band 
from the agarose gel using AlwNI, which cut the amplified DNA into specific sized 
pieces that would result in the primer sequence only being on one end of the 
amplicon thus reducing the chances of mis-priming and the generation of a false 
sequence. However, yet again the quality of the DNA sequencing was poor. A final 
attempt was made to study the specificity of REV B since the DNA sequencing failed 
to produce any acceptable results; the REV B was used to amplify a negative blood 
(uninfected blood) sample to determine whether it would amplify it or not. 
Unfortunately REV B appears to be nonspecific to trypanosomes when used on FTA 
cards as the negative control blood was clearly amplified and produced relatively 
similar banding pattern that was produced by trypanosome DNA. 
 
 
Finally, due to the obstacles relating to single primer PCR (REV B) mentioned 
above, another protocol was carried out on the Angolan samples, involving 
amplifying them with forward and reverse primers (RIME A and RIME B). This could 
increase the number of copies produced post amplification, and determine whether 
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the age of the samples have had an impact on the poor quality sequencing results 
generated from REV B. Firstly the number of the amplified samples was less (8 
samples) than with the REV B amplification. After the amplification the specificity 
of RIME A and RIME B primers have been studied by sequencing the amplified 
samples including the positive control. Yet the quality of the produced sequencing 
results  still poor; this could be due to two or more templates being present in the 
reaction, the PCR fragment not being purified of leftover primers before 
sequencing or poor quality PCR templates containing multiple DNA fragments 
being used. On the other hand, in the positive control sample where short DNA 
sequencing read lengths are observed this could be due to too much template 
DNA, or too much primer. 
 
 
In summary, the development of control and genotyping tools for HAT plays an 
important role in efforts aimed at eliminating the disease. MGE-PCR has in the 
past proved to be one of the most powerful tools that can be used in studying the 
epidemiological aspects of HAT. For the first time MGE-PCR has been carried out 
directly on a field sample and it shows potential although currently the technique 
appears to be behaving non-specifically. Further study is required into the 
behaviour of mobile elements and their properties for the purpose of strengthening 
the use of MGE-PCR in terms of specificity as a molecular epidemiological tool.
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 Investigation of Mobile Genetic Elements Found 
Inserted in Retrotransposon Hotspot Genes (RHS) in the T. 
brucei TREU927 Genome 
 
5.1 Introduction 
 
 
As discussed in Chapter 4 mobile genetic elements can be used as markers to study 
the epidemiology of sleeping sickness. However, MGE-PCR cannot be used to provide 
data on samples that contain mixed genotypes, because traditional DNA sequencing 
using a single primer that recognises mixed sequences will return unreadable 
sequences. The identification of these sequences is also not possible because the 
Rev B single primer will be found at both ends of the PCR product. Thus, a further and 
more detailed investigation into the mobile gene elements is required to better 
understand their role and behaviour and in order to overcome the sequencing 
challenges by developing a marker based on the MGEs and a single PCR primer. 
Repetitive sequences can be artificially divided into two groups: interspersed repeats 
and tandemly repeated DNA. Interspersed repeats mainly represent inactive copies of 
presently or historically active transposable elements (Wickstead et al., 2003). MGEs 
are also known as transposable or retrotransposons elements (TEs) due to their 
mechanism of mobilisation (Bringaud et al., 2008). TEs are defined as 'parasitic' 
genetic elements that are spread by replicating themselves within the host genome 
(Kofler et al., 2012). TEs were first described in 1950 by Barbara McClintock, and 
she suggested that although TEs are considered to be junk DNA they play a 
significant role in genome evolution (Piskurek and Jackson, 2012). However, there is 
now a growing body of evidence which suggests that TEs may be functionally 
important and not just ‘‘junk,’’ ‘‘selfish,’’ or ‘‘parasitic’’ DNA sequences that make as 
many copies of themselves as possible (Biemont and Vieira, 2006). For example, 
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there is a considerable number of domesticated TE copies which act as transcriptional 
regulatory elements or contribute to the protein coding of cellular genes (Shapiro, 
2005). They can contribute to genome plasticity and to genome architecture. For 
example, the mosquitos Aedes aegypti and Anopheles gambiae have genomes 
significantly larger than the model organism Drosophila. Most of this genome increase 
is due to the high proportional content of repetitive DNA and transposable DNA. This 
feature can be used to study genome evolution, shaping both genes and genomes in 
terms of function and structure (Blaxter et al., 2003). Also, since most MGEs are non-
autonomous, since they exist in large number, and since their transfer usually occurs 
vertically, they can shape the evolution of distant parts of the genome. Mobile elements 
are involved in creating mutations and genomic rearrangements and, in many 
eukaryotes, these effects can be regulated through a RNA silencing mechanism 
such as RNA interference (RNAi) (Girard and Hannon, 2008). In addition, based 
on the mobilisation mechanisms, TEs can be classified into two major groups: firstly, 
those that move via reverse transcription using an RNA intermediate and are known 
as retrotransposons, or class I. Two to five percent of the trypanosomatid genome 
contains class I elements. The second class is known as DNA transposons or class 
II, and they move using a DNA intermediary. Approximately 65% of the human 
genome contains class II TEs (Thomas et al., 2010). In addition, class I is further 
subdivided into long terminal repeat retrotransposons (LTR) and non LTR 
retrotransposons (Bringaud et al., 2008) 
 
 
Since the genome of T.brucei was sequenced in 2005 (Berriman et al., 2005) much 
more information is known about these. It is reported that the trypanosome genome 
contains hundreds of copies of apparently dead retrotransposable elements and 
probable reverse transcriptase pseudogenes. Many copies of these elements 
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appear to be interspersed with VSG genes (Cross, 2003). The Non-LTR 
retrotransposons are found to be the most abundant mobile elements described in the 
genome of T.brucei (RIME, ingi and SLACS) (Hasan et al., 1984; Kimmel et al., 1987; 
Aksoy, 1991). Kimmel et al. (1987) reported ingi to be randomly distributed in the 
T.brucei genome. The ingi is 5.25 kb and is characterized by its autonomous features. 
RIME is 0.5 kb and appears to be truncated version of ingi. The ends of the ingi are 
bordered by two separate fragments of RIME (RIME A 0.25kb and RIME B 0.25kb), at 
the 5' and 3' ends respectively (see Figure 5-1). RIME elements are short non- 
autonomous reteroelements (Bringaud et al., 2004). Moreover, it is estimated that the 
T.brucei genome contains ~400 copies of ingi that is approximately equal to 5% of the 
genome, and the RIME is estimated as being at 86 copies per haploid genome of 
T.brucei (Donelson et al., 1996; Bringaud et al., 2002). Only 2.5% are considered as 
potentially active (Bringaud et al., 2008).Furthermore, Ingi/RIME are only located in 
the megabase chromosomes. In addition, ingi/RIME are found at the end of telomeres 
as they proceed or are within most of the expression sites for the VSG genes. In 
addition, it is still unclear whether either ingi or RIME gave rise to one or the other and 
we do not fully understand the mechanism by which this may have occurred 
(Bhattacharya et al., 2002). 
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Figure 5-1. A schematic illustration of ingi (Accession M16068.1) and RIME elements. .  Functional domains of the ingi are colour coded as following: endonuclease 
domain transcriptase domain (orange), Rnase H domain (grey) and Zinc finger domain (light blue). The 0.5kb RIME flanked on the 5' and 3' ends of the 5.25kb ingi are 
colour coded as red and green for RIME B and A respectively. Diagram was constructed by Snap Gene 3.43 
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RIME has proven to be a marker for differentiating between individual strains from 
species of trypanosomes collected from different geographical locations (Tilley et al., 
2003). However, in this present study the use of RIME in differentiating between two 
sub-species will be investigated. Wickstead et al. (2003) have reported that no two 
organisms can share a common mobile element with the exception of T.brucei and 
T.cruzi. However, the trypanosomal mobile elements in the two species vary 
significantly in genomic location. Furthermore, the diversification characteristics of the 
mobile element can be entirely restricted to a species such as TARE-2 and TARE-3 
elements in P. falciparum (Figueiredo et al., 2000). Thus, it can be concluded that 
MGEs possess evolutionary features that could enable them to be used as tools to 
track the spread of infections by following particular evolutionary variants through 
populations of parasites. Also, the relatively small size of RIME (0.5kb) can make 
RIME a useful marker in differentiating between T.brucei sub-species. 
Although, ingi/RIME are previously thought to have been distributed randomly around 
the genome, Bringaud et al. (2002) reported that the distribution of ingi/RIME are 
associated with a number of highly repeated gene families including rRNA genes, 
tandemly repeated tubulin gene arrays and retrotransposon hot spot (RHS) genes. 
RHS genes are divided into six sub-families (RHS1-6) on the basis of the divergent C- 
terminal domain of their gene product. RHS genes are highly repetitive multigene 
families and are composed of about 280 copies per diploid genome of the T.brucei. 
About 60% of them are non-functional pseudogenes. The RHS (pseudo) genes appear 
to be frequently located in the subtelomeres adjacent to VSG expression sites 
(Bringaud et al., 2002). Moreover, Bringaud et al. (2002) have reported that about one- 
third of RHS pseudo genes contains ingi/RIME inserted mobile elements inserted in 
the relatively same position in the RHS genes usually at a 12-mer sequence 
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(TACTGTTATACA). 
 
 
The relationships between taxa in the T. brucei complex are not fully understood (Koffi 
et al., 2009; Balmer et al., 2011). The current subdivision of T. brucei is based on host 
range, pathogenicity and geographic origin, but it does not reflect genetic or 
evolutionary distinctions (Gibson, 1986; Balmer et al., 2011). However, the genomic 
variation between T.b.brucei and T.b.gambiense is only limited to less than 1%. This 
limited genomic variation suggests that the observed functional differences could be 
due to features shared between subspecies, which vary in either structure or 
expression (Jackson et al., 2010). T. b. gambiense strains have the smallest genomes 
in the T. brucei species complex, having 71-82% of the DNA content measured for T. b. 
brucei (Kanmogne et al., 1997). 
In this study a bioinformatics investigation will be carried out on the mobile elements 
that are found inserted in the RHS pseudogenes of the TREU 927 genome. This is in 
order to understand their behaviour and evolution with a view to discerning how they 
can be used as differentiating markers between different T.brucei species and 
strains. 
148  
5.2 Objectives 
 
 
• To comparatively investigate the genomes of T.b.brucei and T.b.gambiense to 
determine the presence and absence of MGEs inserted within the RHS genes. 
• To identify RHS genes and their families present in the TREU 927 genome. 
 
• To classify RHS genes via a phylogenetic analysis of RHS genes and an 
investigation into possible evolutionary time progression events in the RHS 
genes. 
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5.3 Methods 
 
This study applied a series of bioinformatical protocols including: multiple sequence 
alignments using CLUSTAL W (EBI), and MEGA 5, designed to classify the RHS 
genes/pseudogenes according to their subfamilies. In addition, MEGA5 was used to 
build the phylogenetic tree of the RHS genes. Finally BLAST searches were used to 
identify the RHS genes’ subfamilies, and to execute a retro-analysis comparing the 
T.brucei and T.b.gambiense.  
Details of the bioinformatics methods are either included in Chapter 2, (program 
instructions) or, are applied, within the results section of this chapter. 
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5.4 Results 
 
Since REV B MGE-PCR (see Chapter 4) failed to be specific enough as a 
primer/amplification system for the detection of trypanosomes when used directly on 
FTA cards. A bioinformatics approach was used to investigate more specific 
sequences (based on MGEs) that could be used for trypanosome molecular 
epidemiology. It is important to study the genetic background of mobile elements, in 
order to study their behaviour, their role as mobile elements and their potential for use 
as epidemiological markers. A sequence of bioinformatic “experiments” was 
undertaken  to investigate the characteristics of mobile elements and their interaction 
with the RHS genes which function as hotspots for the insertion of mobile genetic 
elements. 
 
 
 
5.4.1 Identification of retrotransposon hot spot (RHS) genes in the 
TREU927 genome 
RHS genes are known as sub-telomeric genes, located at the telomere ends of the 
T.brucei chromosomes. Figure 5-2 shows an example of this for Chromosome 2. A 
search was conducted on NCBI map viewer using two terms - "RHS" and 
"retrotransposon hot spot" - and this resulted in 59 RHS genes being reported 
throughout the 11 chromosomes of the TREU927 strain. RHS genes were found in all 
chromosomes with the exception of chromosome 8. There are sub-families of each of 
the RHS/pseudogenes (RHS 1 – 6) mentioned in the database and an alignment 
was carried out on each RHS gene with a representative distribution of RHS gene 
families (1- 6) present in the database under the following accession numbers: 
AY046887 (RHS1), AY046888 (RHS2), AY046889 (RHS3), AY046890 (RHS4), 
AY046891 (RHS5), and AY046892 (RHS6) (Data not shown). Out of the 59 RHS 
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amino acid sequences there were 29 RHS genes and 24 pseudogenes. This contrast 
with the findings of Bringaud et al. (2002) who have reported the presence of RHS 
genes (21 copies) and pseudogenes (24 copies). T he search resulted in 6 
degenerate copies in which amino acid sequences did not belong to any of the RHS 
genes’ sub- families. Degenerate copies were excluded from phylogenetic analysis 
(see below) due to their high divergence, with the exception of a RHS degenerate 
gene (Tb927.2.1150) which was included to see how it fitted into phylogenetic trees 
of the RHS gene family. Eleven of 59 RHS genes were interrupted by mobile element 
insertions (see Figure 5-3) and all were pseudogenes. Multiple alignments of the 
amino acid sequences for the retrieved RHS/pseudogenes were carried out using EBI 
clustalW2 and assembled for comparison (appendix 2) 
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Figure 5-2. RHS /pseudo genes found in chromosome 2 in the TREU927 genome using NCBI map viewer. RHS pseudo gene accession numbers are boxed 
in grey.  The diagram was constructed with SnapGene 3.4.3. 
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In addition to the RHS 1-6 families, the analysis using NCBI map viewer showed that 
among the 59 RHS genes there were 8 RHS genes and 1 RHS pseudogene in 
chromosome 7 that do not belong to the RHS families as reported by Bringaud et al. 
(2006). These were defined as “unclassified” but all possessed the retroelement 
insertion target. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4.2 Evolutionary relationship of RHS genes: 
To study the relationship between the RHS genes present in the TREU927 genome, 
a phylogenetic tree (using a Maximum Likelihood algorithm) was constructed using the 
MEGA5 programme and based on the multiple alignment of amino acid sequences 
for each RHS gene which were retrieved from the GeneDB database and the reference 
RHS gene families (1-6) (see Figure 4). According to the phylogenetic tree there are 
two clades of RHS genes which include RHS3 / RHS4 and RHS5 / RHS6 respectively. 
These clades were formed based on the fact that an intergroup alignment of the 
RHS3/RHS4 is estimated to be 43%, whereas RHS5/6 is estimated to be at 50% 
(Bringaud et al., 2002). 
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Figure 5-3. The number of the RHS genes according to their families in TREU927 genome. 
The most abundant RHS/pseudogene family is RHS4 
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Figure 5-4. Molecular phylogenetic analysis of the TREU 927 RHS genes using the Maximum Likelihood 
method. The evolutionary history was inferred by using the Maximum Likelihood method based on 
the JTT matrix-based model (Jones et al., 1992). RHS genes with mobile element insertions are marked 
with + for (t r unca ted  ingi), * (RIME A), )  for (RIME B), and (/) for DIRE. The phylogenetic tree 
was obtained automatically by applying Neighbour-Join and BioNJ algorithms to a matrix of pairwise 
distances estimated using a JTT model, and then selecting the topology with superior log likelihood. 
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Due to the complexity involved in analysing all RHS genes and the relative abundance 
of subfamilies of RHS3 and RHS4 in TREU 927, only members of the RHS3 and 4 
families were analysed in this here (highlighted by the dashed bracket in Figure 5--4). 
Before the investigation into RHS/pseudogenes, it is worth considering the different 
arrangements of retroelements that were found inserted in the RHS pseudogenes in 
the T.brucei genome. Inspection of the obtained sequences of RHS genes with 
insertions showed a number of overall possible conformations of insertion: 
Retroelements (ingi or RIMEs) could be inserted in different combinations: full ingi, 
truncated ingi, full RIME or truncated RIME (which may correspond to RIME A or RIME 
B) (See Figure 5-5). 
 
 
 
A 
 
 
B 
 
 
 
C 
 
 
 
. 
D 
E 
F 
Figure 5-5. Schematic diagram of the RHS pseudogenes inserted with retroelements. (A) Indicates a 
full ingi insertion with the green and the red colours indicating the truncated ends of the ingi by RIME A 
and RIME B respectively. (B) shows the truncated ingi insertion where RIME B is missing, (C) 
illustrates the truncated ingi insertion where RIME A is missing, (D) shows the full RIME insertion 
without any component of ingi, (E) half RIME (RIME A) insertion, and (F) half RIME  (RIME B) 
insertion. Black arrows represent the 12 bp repeat generated by the reteroelement insertion. 
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Most retroelements share several properties including (i) variability in copy   number; 
 
(ii) insertion site polymorphism; and (iii) the duplication of a few base pairs of host DNA 
at each end of every new element insertion site (the hallmark of retroelement insertion) 
(Margaret et al., 2001). ingi and RIME have been proven to generate repeat flanking 
in their insertion that varies from 8bp to 12bp (Bringaud et al., 2004). This is important 
to highlight since some of the RHS/ pseudogenes do not possess a retroelement, but 
leave behind the flanking repeat when they are excised. These traces of the 
retroelement could help the investigate the evolutionary process of the RHS 
pseudogenes by indicating where an element has historically been situated. For 
example, the following sequence of events, RHS to RHS + Insertion (=pseudogene) 
to RHS + traces of insertion (=pseudogene), follows a temporal sequence that could 
be used to infer a timing sequence of evolutionary events for a given gene. In an 
epidemiological context, this could be used to track the evolution and transmission 
of field strains with time. 
 
5.4.2.1 RHS 3 and RHS4 mutational change analysis 
 
Mutations are the cause of the most genetic variation and cover changes in a single 
replicating genome, whether they are caused by DNA replication errors such as base 
pair substitutions, insertions and deletions or by the activity of transposons and 
insertion sequence elements that can move around (and replicate) in the genome. 
 
5.4.2.1.1 Gene duplication 
 
Gene duplication is an event in which one gene gives rise to two genes that cannot be 
operationally distinguished from each other (Roy and Deo, 2014). Gene duplication 
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can be classified into three categories; (i) one copy may simply become 
silenced by degenerative mutations (non-functional); (ii) one copy may acquire 
a novel, beneficial function and become preserved by natural selection with 
the other copy retaining the original function (neo-functionalisation); or (iii) 
both copies may become partially compromised by mutation accumulation to 
the point at which their total capacity is reduced to the level of the single-
copy ancestral gene (sub-functionalisation) (Lynch and Conery, 2000). One 
duplication of particular interest in the phylogenetic tree is in chromosome 4 
of the TREU927 genome where a series of duplications took place (see 
Figure 5-6) 
 
 
  
 
 
Figure 5-6. Diagrammatical representation of the consequences of duplicated genes and the 
role of duplication in the evolution of RHS genes using the RHS gene in chromosome 4 of 
TREU 927 genome. An example of sub-functionalisation is highlighted in blue where the 
amino acid sequence shown (GSFLL) represents  the retrotransposon insertion site. 
 
The above figure is an exemplary illustration of gene conversion duplication 
of RHS genes in the TREU927 genome; gene conversion is known as a 
transfer of sequence from one paralogue to the other. The full nucleotide 
alignment is listed in Appendix 3. In Figure 5-6 only 3 duplicate RHS genes 
were illustrated, however there are two more other duplicated genes 
Tb927.4.260 and Tb927.4.300. According to the nucleotide sequence 
alignments the duplicated genes have adopted mutations at the N-terminal, 
Ancestor 
Tb927.2.1180 GSF LL 
 Tb927.4.280 GSF LL    Tb927.4.290  GSF  LL   
Tb927.4.270 GSF LL 
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which formed a chimeric gene that contains a 5’ extremity of RHS1 
pseudogene and RHS 3 at the c-terminal (3’ extremity). Once gene duplicates 
have diverged sufficiently so that they differ in their functionality (or non-
functionality), gene conversion events can become deleterious - for example, 
by introducing disrupting mutations from a pseudogene into its functional 
duplicate. A substantial proportion of disease alleles in Gaucher disease result 
from the introduction of mutations into the glucocerebrosidase gene from a 
tandemly repeated pseudogene (Tayebi et al., 2003). The duplicated genes 
evidently exhibited the retrotransposon insertion site, however due to the 
amino acids’ base changes the duplicated genes have lost the ATP/GTP 
motif. The selection on this family of genes was estimated (comparing the 
parent gene and the duplicated genes) by estimating the ratio of non-
synonymous to synonymous substitution rates using the formula ω = (dN, 
amino acid changing)/(dS, amino acid retaining). With ω <0, ω =1 and ω>1 
indicating purifying, neutral and adaptive evolution (Yanget al., 2000). 
Nonsynonymous and synonymous substitution rates (denoted as Ka and Ks, 
respectively) were estimated using the KaKs Calculator (1.2) (Zhang et al., 
2006), with the method of model averaging YN. This produced a result which 
showed neutral evolution (ω =1), suggesting that early in their history many 
gene duplicates experience a phase of relaxed selection or even accelerated 
evolution at replacement sites (Lynch and Conery, 2000). 
 
 
 
5.4.2.1.2 Role of Mobile elements insertion in RHS genes evolution 
 
According to McClintock (1978) mobile elements have the ability to induce mutational 
changes in the genome through transposition, and  McClintock reported a genome 
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restructuring process mediated by TE activity as an essential component of the hosts’ 
response to stress. 
 
5.4.2.1.2.1 Chromosomal translocation 
 
Mobile elements insertion (transposition) can cause of number of chromosomal 
structural changes, such as translocation and inversion. As Lim (1988) has reported, 
such changes in Drosophila melanogaster are shown to be mediated by hobo 
transposable elements. Gray (2000) has suggested two possible mechanisms by 
which mobile element-associated chromosomal rearrangements can occur: (1) 
indirectly by homologous recombination or (2) directly by an alternative transposition 
process. As shown in Figure 5-7, the first scenario could be applied to 
Tb927.6.5170RHS pseudogenes. 
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The first mechanism is more related to this type of duplication, whereby the indirect 
action of MGEs triggers chromosomal rearrangements by presenting the genome with 
multiple similar sequences between which strand transfers can occur. Moreover, multi- 
gene families possess a risk of homologous or ectopic recombination in which genetic 
exchange takes place, either intra-chromosomally or inter-chromosomally, between 
two members of the family located in different chromosomal regions (Kidwell, 2000). 
Such events can cause duplications or deficiencies. 
On the other hand, Tb927.6.5160 is a pseudogene formed through the duplication of 
a functional gene (the parent gene being Tb927.2.1180) and a subsequent 
translocation from chromosome 1 to chromosome 6. Comparison of the DNA 
sequence of these two genes can be used to infer how recently this event has taken
Tb9276.5170 
Chr 6 
Duplication 
 
Chr1 Tb927.2.1180 
Figure 5-7. Schematic representation of putative RHS pseudogene duplication and chromosomal 
translocation of Tb927.2.1180, a functional RHS gene (Parent gene) in T. brucei. The duplicated 
pseudogene (Tb927.6.5160) is seen on chromosome 6 and the mobile element associated 
chromosomal translocation is shown in Tb927.6.5170 where the orange circle indicates a truncated 
ingi (RIME B is missing) insertion. 
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place. For example, a recent duplication and translocation event would result in a 
very high sequence identity between both sequences whilst a less recent event 
would be shown by a greater divergence in DNA sequences. An alignment of both 
sequences is shown Figure 5-8. In this case sequence identity was determined as 
being at 88%. As Pei et al. (2012) have indicated, the higher the homology, the 
more recent the evolutionary event will have occurred. 
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Tb927.2.1180 ATGAATCAACAGGTTCCTATTGAAGGAAGGGGTGACATTGAGGGAAGGAGACGAGAAAAT 
Tb927.6.5160 ATGAATCAACAGGTTCCTATTGAAGGAAGGGGTGACATTGAGGGAAGGAGACGAGAGCGT 
******************************************************** * 
 
Tb927.2.1180 GAGGAGGCTGCGCGTAACGATGCGGAACCTCCAGTAGTGCAGCAACGAGTGGAGAATAAC 
Tb927.6.5160 GAGGAGGCTGCGCGTAACGATGCGGAACCTCCAGCAGTGCAGCAACGAGTGGAGAATAAC 
********************************** ************************* 
 
Tb927.2.1180 AACCAACCACAATGGGGTCTTTTCAGCTGCGTTGACGCAGTTTTGCTGAATGGTCTGCCA 
Tb927.6.5160 AAACAACCACAATGGACAATTTTGAGCAGCGTTGAAGCAGTTTTGCTGAATGGTCTGCCG 
** ************ **** *** ******* *********************** 
 
Tb927.2.1180 CATCCTAGAAATATGATGTTGAATGATTTTTTGAGGCGTAATTTTGGCAGAAGATAT-AA 
Tb927.6.5160 CATCCTGGAAATATGAGTGTAAATGATTTTTTGAGGTTTAATTT-ACTCGAAGATATCGA 
****** ********* * *************** ****** ******** * 
 
Tb927.2.1180 TGTGAATGAAGAAAAT---AATGTATCAATGTCTGCGTTCGTACTGGAACCTGAAGAGTA 
Tb927.6.5160 TTTGGATCAGCGTCTCCTGAGAGCATCAATGTTTGCCTTTGTACAACGATGTGAAGAGTA 
* ** ** * *  * ******** *** ** **** * ********* 
 
Tb927.2.1180 TATTAATGACGTTAATGCGCTCAATCGAATATTCGCGACAACAGAGTATAAAGTGTACAA 
Tb927.6.5160 TATTAATGACGTTAATACACTCAATCGAATATTCGCGGCAGTAGCGTATAAAGTGTACAA 
**************** * ****************** **  ** *************** 
 
Tb927.2.1180 ACGTTTTGTCAGCGTCTATGGTTTCTTTGAGGATGAGGGAATATTGAATCTTCAGCGCTG 
Tb927.6.5160 ACGTTTTGTCAGCATCTATGGTTTCTATGAGGATGAGGGAATATTGAATCTCAGGCGCTG 
************* ************ ************************ ****** 
 
Tb927.2.1180 GCAACAAGCAGATGAGGAAGCAAAGGTCAGGTTACAGGCGGATATTCGTGGACTGAGAGA 
Tb927.6.5160 GCAACAAGCAAATGAGGAAGTAAAGGCCAGGTTACACGTGAATATTCGTGGACTGAGAAA 
********** ********* ***** ********* * * ***************** * 
 
Tb927.2.1180 TGGAGAGCGCCTTTGGATTGTTGTCACTAACATGTTGAATGATGCACTCAATGAAGCAAG 
Tb927.6.5160 TGGAGATCAAACTTGGATTATTGTCACTAACATGTTGAATGATGCACTCAAAGAAGCATT 
****** * ******* ******************************* ****** 
 
Tb927.2.1180 GGAACGAGCTGCTCAAACAGCTTGTAGTGCTGTCGAACTGAAAGGATTGTATGAATCCAT 
Tb927.6.5160 GGGAGAAGCTGCCCAAACAGCTGGTGGTGCTGTCGAACTCTCAGGTTTGTATGATTCCAT 
** *  ****** ********* ** ************* *** ******** ***** 
 
Tb927.2.1180 ATATAATGCGAAATGGAGTTATGTGATGTCGGGTTATCATACAGAGCCACTTGGCATGAA 
Tb927.6.5160 TTATAATGCGAAATGGAGTTACGTGATGTCGGGTTATGATGCAGGGCCATTTGGAATGTA 
******************** *************** ** *** **** **** *** * 
 
Tb927.2.1180 AGTGTTCGATGGAAGGCCGCAGCGCATGTGGACCGAAGAAGATGTGGATATAACTCCTCT 
Tb927.6.5160 TGTATTCAATGGAAGACCACAGCGCATATGGACCGAAGCGGAGGTGGATATAACTCCTGA 
** *** ******* ** ******** **********  ** *************** 
 
Tb927.2.1180 TCCTGCGAATGTTGATGCAGAGATTGAGGAGAGACCCGATGGTTTGGAGATTTTTGTTCT 
Tb927.6.5160 TCCTGCGAATGTTGATGCAGAGATTGAGGAGAGACCTTATGGTTTGGAGATTTTCGTTCT 
************************************  **************** ***** 
 
Tb927.2.1180 CACTTCGGAGAAAGGTTGGCCATACAACAGGTTTGCATTGGATTACACTACGGGGCGCAA 
Tb927.6.5160 CACGTCTGAGGAAGGTTGGCCATACAACAGGTTTGAAATGGATTACACTACGGGGCGCAA 
*** ** *** ************************ * ********************** 
 
Tb927.2.1180 AGTAGTATTTCAGCACGTATACATCCGTCGTGAAATTGTGCGCGTGTGGTATAAAGTCGA 
Tb927.6.5160 AGCAGCATTTCAGCATGTATACATCCGTCGTGAAATTATGCGCGTGTGGTATATAATTCA 
** ** ********* ********************* *************** * * * 
 
Tb927.2.1180 AAAAGATCTGAAAACATGGTGGGTGGAAAAGACAGCTCACAGACCACCGATACATATTGT 
Tb927.6.5160 ACGAGGATTGCAAACATGGTGGGTGGAAAAGACGGCTCACAGACCACCGATACATATTGT 
* ** ** ********************** ************************** 
 
Tb927.2.1180 TATTGGTACACCTGGTATTGGTAAATCATATGGCCTTGGATCATTTTTGCTTCATTCGTT 
Tb927.6.5160 TATTGGTACAGCTGGTATTGGTAAATCATGTGGTGTTGGATCATTTTTGCTTCATTCCCT 
********** ****************** ***  ********************** * 
 
Tb927.2.1180 GCTTCACTTCCATGAAGGAATGCTTGATGTTGTTGCATATTTCACAGACACGATCGCCTA 
Tb927.6.5160 GCTTCACTTCCATGAAGGAATGCTTGATGTTGTTGCGTATTTCACAGACACGATCGCCTT 
************************************ ********************** 
 
Tb927.2.1180 CTTAATATATAACAGAAAGGGTGATGAAAGAGGGAGGGTTGTGCGGTACGAATATTTGAG 
Tb927.6.5160 CCTCATATACAACAGAAAGGGTGATGAAAGAGGGAGGGTTGAGCGGTACGAAGGTTCGAG 
* * ***** ******************************* ********** ** *** 
Tb927.2.1180 AGCTGCGGTCAACGCCATAAATAAAATGAAATTTGAAAACAGAGGACACATTATTATGGA 
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Tb927.6.5160 AGCTGCGGTCAACGCCATGAATAAAATGAAATTTGAAAACGGAGGTCACATCATTATGGA 
****************** ********************* **** ***** ******** 
 
Tb927.2.1180 CATAAGGTATGCAATGCAGCAGCTTTACACTCAACTTCCCTCTGATGTTTGGAGTGTAAC 
Tb927.6.5160 CACAAGGTACGCAACGCAGCAGCTGTATACTCATCTTCCCTCTTATACTTGGGGTGTAAC 
** ****** **** ********* ** ***** ********* **  **** ******* 
 
Tb927.2.1180 TATTTTCACTTCCCCGAATAGTTCCCACTTTGGTAACTGGACTACAATTACGGGAGGCCG 
Tb927.6.5160 TTTCCTCACTTTTCCGAATAGTGCCCGTTTTGATGACTGGACTACAAATAGGGGAGGCCG 
* *  ******  ********* ***  **** * ************ ** ********* 
 
Tb927.2.1180 CCAAATTATTATAAACTGTGATGATGTGCGTGACATGAAGGCATTTGTGGCATGGAAAAA 
Tb927.6.5160 CCAAATTATTATAAACTGTGATGATGTGCGTGACATGAAGGCATTTGTGGCATGGAAAAA 
************************************************************ 
 
Tb927.2.1180 ACTGTCAATACATACAAGGGAAAAGGTATCCAACAGAAGAAGACACGAATTGAGGAAGGA 
Tb927.6.5160 GCTGTCAATACATGCAAGGAAAAAGGTATCCAACAGAAGAAGACACGAATTGAGGAAGGA 
************ ***** **************************************** 
 
Tb927.2.1180 AATGGAAGATGAGTGGAGAATAGTGGAGGGACGTATTAATTCAATTGGGCTTTTGCCTCG 
Tb927.6.5160 AATGGAAGATGAATGAAAAATAGTGGAGGGACGTATTAATTCAATTGGGCCTCTGCATCC 
************ ** * ******************************** * *** ** 
 
Tb927.2.1180 TTATATATTTGTTTTAAGCTGTTATGAATGGCGTCTGAAAAGAGTTCATGATGCGTTGGA 
Tb927.6.5160 TTATATATCTGGTTTAAGATGTTATGAGTGGCGTCTGAAAAGAGTGCATGATGCGTTGGA 
******** ** ****** ******** ***************** ************** 
 
Tb927.2.1180 AACTATGAAGAAGTCGGATGAATATTCCTATAATGATATTATTGAGCATACCGCTGCCTG 
Tb927.6.5160 AACTATGAAGAAATCGGGTGAATATTCCTATAATAATATTATTGAGCATACGGCTGCCAG 
************ **** **************** **************** ****** * 
 
Tb927.2.1180 GAAGAACAATGAAGTTACGGAAAAGTTGGTAAAGGTTGTAAGAGTAAAGGGAAATGTTGG 
Tb927.6.5160 AGAGAACAATGAAGTTATGAACAAGTTGGAGAAGATTGTAAGAGTAAAGGCAAATGTTGG 
*************** * * *******  *** *************** ********* 
 
Tb927.2.1180 ATTTATCGAATCATTTAAATTTCAAGCTCTATCACTGATGATTCGAAATATGATGATGAG 
Tb927.6.5160 AGGAATCGAATCATACAAATGTCAAGCTCTATCACCGATGATCCGACATATGATGATGAG 
* **********  **** ************** ****** *** ************* 
 
Tb927.2.1180 TTAA 
Tb927.6.5160 CTAA 
*** 
   Figure 5-8. DNA sequence alignment between the parent gene (Tb927.2.1180) and duplicated 
pseudogene (Tb927.6.5160). The alignment was carried out using EBI clustalW2 with default settings. 
The identity is calculated at ~88%. Base pair identities are shown by *. 
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5.4.3 Evolutionary time dimensions of RHS genes 
 
The transposition (insertion) of non-LTR retrotransposons, including ingis or RIMEs, 
produces a duplication of the target sequence to form a direct repeat of a few bases (11-
14bp) flanking the inserted retroelement. In terms of T. brucei, Bringaud et al. (2002) 
have reported that the formation of 12-bp sequences are possibly the result of multiple 
ingi/RIME insertions at the same site with the consequence being multiple duplications 
of the target site, each flanked by retroelements. Based on these facts we hypothesised 
that we could categorise the evolution of RHS/pseudogenes according to where the 
mobile element was inserted and excised and when a fingerprint was left with the 12bp 
flanking sequences as evidence for their past-existence (Figure 5--9). 
 
 
Figure 5-9. Schematic diagram illustrating a possible evolutionary scenario for the RHS pseudogenes. (A) is 
an RHS gene, (B) is a RHS pseudogene that possess a mobile element insertion highlighted by the red oval 
(this could be either ingi or RIME), and (C) a RHS pseudogene that possess the flanking direct repeat 
highlighted by two opposite arrows and fingerprints of the mobile element traces highlighted by red 
(explosion marks). Dashed lines indicate the sequence similarities 
 
According the above figure which shows possible categorisation based on an 
evolutionary time dimension, RHS genes/pseudogenes can be classified into three 
classes: (1) original state (A in Figure 5-9), (2) intermediate state, the transposition of the 
A 
B 
C 
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retroelement has occurred (B in Figure 5-9) and (3) recent state whereby the MGEs have 
been excised and left fingerprint traces or did not leave any traces in the RHS 
pseudogene (C in Figure 5-9). Therefore, MGEs’ insertion in RHS3 and RHS4 were 
screened for the duplicated repeat sequences flanking the inserted MGEs (Table 5-1) 
 
Gene Name 5' Insertion target MGE type Duplicated 
Sequence 
Tb927.4.220 AGTTGGTGTTGGCTCGT TCCTGCTCCAA RIME TCCTGCTCCAA 
Tb927.5.280 TGAGAGCATGGTGGGTA  Truncated ingi ingi 
Tb927.6.5170 TCATTTTTGCTTCATTC  Truncated ingi  
Tb927.6.5180 Truncated ingi TTTTGCTTCATT RIME TTTTGCTTCATT 
Table 5-1. The duplicated repeat sequence flanking the MGE insertions in RHS pseudogenes in the TREU927 
genome. 
As can be seen from Table 5 - 1, the duplicated sequences are flanking the MGEs 
insertion, and Bringaud et al. (2004) have suggested that this 12bp repeat is the result 
of a multiple ingi/RIME insertion, which is related to Tb927.5.5180 where multiple 
insertions have occurred, whereas Tb927.5.280 and Tb927.6.5170 do not possess a 
duplicated flanking repeat, which is in accordance with the work of Bringaud et al. 
(2004) wherein the authors reported that not all the MGEs are inserted between two 
flanking repeats. 
The hypothesis was thus investigated using three methods: first by aligning each RHS 
pseudogene in Table 5-1 with its sequence related RHS gene in accordance with the 
phylogenetic tree (Figure 5-4); secondly a further alignment was carried out between 
each of the RHS pseudogenes in Table 1 and its related sub-family, for example 
Tb927.6.5180 was aligned with all the RHS4 genes in the TREU927 genome; thirdly 
and finally a BLAST search with the insertion target nucleotide sequences of RHS3 
and RHS4 was carried out. 
The result of the final experiment did support the original hypothesis, as the recent 
state of the evolutionary RHS was found in RHS4 subfamilies where the two sets   of 
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the flanking direct repeat were present showing that the MGE had been excised, as it 
has shown that the Tb927.1.70 (RHS Gene), that possesses the duplicated insertion 
target (12bp direct repeat) at both the 5' and 3' end, which suggest that the excision 
of RIME has occurred, through possible homologous recombination (Bringaud et al., 
2004). 
An alignment between Tb927.6.5180 and Tb927.2.1210 (first method) showed that 
Tb927.2.1210 possesses a MGEs insertion target, and it was shown that 
Tb927.2.1210 has the first set of the 12bp flanking sequences. However, the presence 
of the same sequence of the insertion target (12bp repeat) in the Tb927.2.1210, could 
be considered as evidence for a past insertion and excision (Figure 10). In order to 
discern whether the traces of MGEs were present in Tb927.2.1210, further alignment 
between Tb927.2.1210 and the MGEs (ingi and RIME) was carried out. The results 
did not confirm the presence of traces. 
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Figure 5-10. Schematic diagram of the duplicated 12bp repeat similarities between 
Tb927.2.5180, Tb927.2.1210 and Tb927.1.70. The straight line represents the absolute 
alignment and the dashed line indicates high identity between the three sequences. and i 
represents the truncated ingi. Crosses indicate the excision of RIME, and the blue 
scribble indicates the sequence which is not related to any of the MGEs. The duplicated 
repeats (5' and 3' ends) that flank the MGE (insertion target) are in green boxes. The 
RHS/pseudo genes nucleotide sequences are indicted in blue boxes. 
 
In summary, the amino acid sequence alignment of the RHS pseudo genes (Appendix 
 
2) illustrated that the majority of the RHS genes have a retroelement insertion 
target site. However, the presence of one set of the duplicated repeat has 
resulted from the insertion of MGEs and can be considered as evidence of 
MGE excision, and it can be concluded that Tb927.1.70 is in the “recent state” 
in terms of the evolutionary time dimension of the RHS/pseudogenes in the 
RHS3 and RHS 4 subfamilies 
. 
5.4.4 Mobile genetic element markers in the  differentiation of 
trypanosome strains 
Mobile genetic elements have been proven to be reliable genetic markers. 
Thus, a possible MGE marker that can differentiate between T.b.brucei and 
T.b.gambiense was investigated based on the method of retro-insertion 
analysis. Retro-insertion is defined as a comparative investigation of the 
presence or absence of retroelements at multiple loci in the genomes 
Tb927.6.5180  TTTTGCTTCATT  TTTTGCTTCATT 
CCCTGCTTCACTTCCA 
Tb927.2.1210 ATACGGTGTTGGATCAT TTTTGCTTCATT 
Tb927.1.70 
ATACGGTGTTGGATCAT 
TTTTGCTTCATT 
 
TTTTGCTTCATT 
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(Shedlock et al., 2004). According to Jackson et al. (2010) intraspecific 
genome divergence between T.b.brucei and T.b.gambiense is estimated to 
be 1% where the indels or insertions are generally caused by mobile 
elements. 
Once such insertion sites have been identified, sequences flanking the MGEs at a 
specific locus can be used as primers to amplify genomic DNA isolated from a parasite. 
When the PCR products are visualised an agarose gel, individuals with insertions at 
both alleles will show a single high molecular mass band while individuals with no 
insertions at either allele will give a single low molecular mass band (Tu and Li, 
2000). Alu elements have been shown to be extremely powerful genetic markers using 
this locus- specific PCR method (Stoneking et al., 1997). In this section retro-
insertion will be studied in T. b. brucei and T. b. gambiense, using BLAST searches 
on the NCBI database. A comparison will be made between all the RHS 
pseudogenes that are inserted with a MGE present in the T. b. brucei TREU927 strain 
(see Table 2) and the correspondent RHS pseudogenes in the T.b.gambiense 
genome (DAL 972). The sequences of the flanking region of the RHS 
pseudogenes will be examined for sections that are identical or which show high 
similarity between the subspecies. Candidate genes for further analysis will be 
selected from those where the MGEs are missing in the DAL 972 gene compared to 
the corresponding TREU927 gene. This can help to find a potential marker which 
could be used in differentiating between T.b.brucei and T.b.gambiense. 
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RHS Gene Location RIME ingi 
Tb927.2.1150 Chromosome 2 RIME A  
Tb927.2.1160 Chromosome 2 RIME B  
Tb927.4.100 Chromosome 4 RIMEA  
Tb927.4.110 Chromosome 4 RIMEB  
Tb927.4.210 Chromosome 4 RIMEA  
Tb927.4.220 Chromosome 4 RIME B  
Tb927.5.280 Chromosome 5  Truncated ingi 
Tb927.6.5170 Chromosome 6  Truncated ingi 
Tb927.6.5180 Chromosome 6 RIME Truncated ingi 
Tb927.10.110 Chromosome 10 RIME  
Tb927.11.4770 Chromosome 11  Truncated ingi 
Table 5-2. The RHS genes that have an MGE insertion. 
Out of the 59 RHS genes only 11 have the ingi/RIME insertion Tb927.11.4770 has 
the truncated ingi insertion and another mobile element known as DIRE small 
degenerate retroposons (0.55 kb) that have been found in genomes of L.major and 
named LmSIDERs. The results of the BLAST searches revealed, that out of the eleven 
RHS pseudogenes, 4 RHS pseudogenes from TREU 927 (Tb927.5.280, 
Tb927.5.5170, Tb927.6.5180, and Tb927.11.4770) could be considered as potential 
markers, since their corresponding RHS pseudogenes in DAL 972 (T.b.gambiense) 
lacked a MGE insertion. However, due to the relatively small size of the RIME, the 
presence of the hallmark of retroelements in the inserted RIME, and the presence of 
the duplicated 12bp repeats in Tb927.6.5180, this gene is the most suitable RHS 
pseudogene as a potential marker. There was a high homology shown by the RHS 
pseudogenes flanking sequences of Tb927.6.5180 and Tbg972.6. 4970 (see Figure 5-
11). 
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Figure 5-11. Schematic diagram of the nucleotide comparison between RHS pseudogenes of the TREU927 (upper line) and DAL972 (lower line) genomes. The MGE 
insertions are indicated by (A), (B), blue triangle, and yellow pentagon, representing RIME A, RIME B, truncated ingi and DIRE respectively. The straight lines 
indicate the high homology alignments. Where the A or the B is present on their own, this indicates half of a RIME insertion. 
 
T.b.brucei 
T.b.gambiense 
 
The purpose of this comparison was to identify sequences that could be used to 
generate PCR primers from the RIME and its flanking DNA sequences to distinguish 
between the two subspecies. In greater detail, the aim was to identify a forward 
primer from the Tb927.6.5180 flanking sequences and a reverse primer from the 
homologous flanking regions of Tb927.6.5180 and Tbg972.6.4970. The size of the 
amplicons would be different due to the insertion of the RIME element in the T. b. 
brucei sequence. Figure 5-12 shows a CLUSTALW alignment of the two sequences 
to demonstrate the regions of homology and difference. 
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Tb927.6.5180 CAACGCGGCGACTG--CGAAGAAACGTCGCTGCACTTGATGAGCTGTCCCGGTTTGAAGG 
Tbg972.6.4970 ------GATTATTATTCGGAGAG-------TGAAATGAATCAACAGGTCCCTATTGAAGG 
* * * ** *** ** * *  ** * * *  **  ******* Tb927.6.5180 
AGTTACGTGTCAGATTTGCGGTAGAAGGTGAGTGTGTGCAGGATGTATGCTTCTCCAAAA Tbg972.6.4970      
A---AGGGGTGACAATGAGGGAAGGAGACGAGAGCGTG-AGGAGG----CTGCGCGTAAC 
* * * ** * * * ** ** ** *** * *** **** * ** * * ** 
Tb927.6.5180 GGCTGGCGCAGTTTCT--CATTGCGGT--TGAACGGAGC--------CGGCCGCAGGTGA 
Tbg972.6.4970 GAT--GCGGAACCTCCAACAGTGCAGCAACGAGTGGAGAATAACAAGCAACCACAATGGA 
*  *** *  **  ** *** *   **  ****   *  ** **  ** Tb927.6.5180 
-AGTCCTCACCTAAGGTAA--CAGTCATACAACCCACTCTCCC---TTCTGCAACTTCCC Tbg972.6.4970      
CAATTTTGAGCAGCGTTGAAGCAGTTTTGCTGAATGGTCTGCCGCATCCTGGAAATATGA 
* * * * * * * * **** * * *** ** * *** ** * 
 
Tb927.6.5180 CCCTTATTG-----CCGAGTGTGGAGCAAGCAGGAAAAGCACCGGACGCAGGAATAGTCC 
Tbg972.6.4970 GTGTAAATGATTTTTTGAG-GTTTAATTTACTCGAAGA-TATCGATT-------TGGATC 
* * ** *** ** * * *** * * ** * * * 
 
Tb927.6.5180 AGACACCCTCAGAGACAGAGGAGGTATGCAGTCA-ACAAGCAACAGAAACAGAAAGAGGG 
Tbg972.6.4970 AG-CGTCTCCTGAGAGCATCAATGTTTGCCTTTGTACAA-CGATGTGAAGAGTATATTAA 
** * * * **** * ** *** * **** * * ** ** * 
 
Tb927.6.5180 GGA-GAGAATAA---TAAACGAATA---ACAAAAATCAAAACAAAAGGATTGCTAA---- 
Tbg972.6.4970 TGACGTTAATACGCTCAATCGAATATTCGCGACAAT-AGCGTATAAAGTGTACAAACGTT 
** * **** ** ****** * * *** * * ** * * * ** 
 
Tb927.6.5180 TTGACATCTTTGGGAGAGTCCGGGGTGAGGGGGGCTTCTCG--CCCCATCTGCTGTATTC 
Tbg972.6.4970 TTGTCAGCATCTATGGTTTCTATGAGGATGAGGGAATATTGAATCTCAGGCGCTG-GCAA 
*** ** * * * ** * ** * *** * * * * ** **** 
 
Tb927.6.5180 CGTTCAACTGCGGAGCTACAACAAAAATTATAGAGGGTGTGTTAGGATGAATAAAAAAGG 
Tbg972.6.4970 CAAGCAAATGAGGAAGTAAAGACCAGGTTACAC-GTGAATATTCGTG-GACTGAGAAATG 
* *** ** *** ** * * *** * * * * ** * ** * * *** * 
 
Tb927.6.5180 GAGACTCTGCCACAGTCGCCAGACCGATAGCATCTCAGGGCTCTACGGTGATG-GCTGAT 
Tbg972.6.4970 GAGATCAAACTTGGATTATT--GTCACTAACATGTTGAA---------TGATGCACTCAA 
**** * * * ** *** * ***** ** * 
 
Tb927.6.5180 GGCCGCGCCAGTTGGGAGAAACTCTCACGAAGGCACGAAGAAAATTCAAAAAAAAAAATT 
Tbg972.6.4970 AGAAGCA----TTGGGAGAAGCTGCC-CAAACAGCTGGTGGTGCTGTCGAACTCTCAGGT 
* ** ********* ** * * ** * * * ** * * 
 
Tb927.6.5180 TTGCTTCATTCCCCTGGCGATGCCGACCACCTCAACGTGGTGCCAGGGTCCAGTACCCCG 
Tbg972.6.4970 TTGTATGATTCCATTTATAATGCGAAATGGAGTTACGTGATGTCGGGTTATGATGCA--G 
*** * ***** * **** * ***** ** * ** * * * * 
 
Tb927.6.5180 TATCATCGGGG------GAAGCCAA---GAGCCAGCAGCGTTCCTTTCATGGGGAACACT 
Tbg972.6.4970 AGCCATTTGGAATGTATGTATTCAATGGAAGACCACAGCG-------CATATGGACCGAA 
*** ** * * *** ** * ***** *** *** * 
 
Tb927.6.5180 GCTGTGCTCCGGCTACGGCATC--ATACAGCACAGG--GATCAGCAGCGTCTTGCTGGGA 
Tbg972.6.4970 GCGGAGGT--GGATATAACTCCTGATCCTGCGAATGTTGAT--GCAGAGA-TTGAGGAGA 
** * * * ** ** * * ** * ** * * *** **** * *** * ** 
 
Tb927.6.5180 CACCGTTTTTCATTTGTCGGTCCCTGGGCACGTGCCAGCGTGCCATCAGCAGTATCATCC 
Tbg972.6.4970 GACC--TTATGGTTTGGAGATTTTCGTTCTCACTTCGGAGAAGGGTTGGCCATA-CAACA 
*** ** * **** * * * * * * * * * ** ** ** * 
 
Tb927.6.5180 GCACTAAGATG--CTGCTGTCCGGTGATGTGGACCTCCAAAAAAGGATTGCCAATTGGCA 
Tbg972.6.4970 GGTTTGAAATGGATTACACTACGG-GATG--------CAAAGCAGCATT-----TCAGCA 
* * * *** * * * *** **** **** ** *** * *** 
 
Tb927.6.5180 TCTTTTGGAGAGTCCAGGGTGGGAGGCTTCTCGCCCCATCTGCTGTATTCCGTTCATATG 
Tbg972.6.4970 TGTAT----ACATCC--GTCGTGAAATTATGCG---CGTGTGGTATAT------------ 
* * * *** * * ** * ** * * ** * *** 
 
Tb927.6.5180 CGGAAATACAACAAAAATTATAGAGGGTGTGTTAGGATGAATGAAAAAGGGAGACTCTGC 
Tbg972.6.4970 ----AATTCAACGAGGGTTGCAAA--------CATGGTGGGTGGAAAAGACAG-CTC--- 
*** **** * ** * * * * ** ** ***** ** *** 
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Tb927.6.5180 CACAGTCGCCAGACCGATAGCATCTCAGGGCTCTACGGTGATGGCTGATGGCCGCGCCAG 
Tbg972.6.4970 -ACAG--ACC--ACCGATA-CAT-----------------ATTGTTATTGGTACAGCTGG 
**** ** ******* *** ** * * *** ** * 
 
Tb927.6.5180 TGGGGGGAAACTCTCACGAAGGCACGAAGAAAATTCTAAAAAAAAAAATTTTGCTTCATT 
Tbg972.6.4970 TATTGGTAAA---TCATGTGGTGTTGGA------TC----------ATTTTTGCTTCATT 
* ** *** *** * * * * ** * ************ 
 
Tb927.6.5180 CCCTGCTTCACTTCCATGAAGGAATGCTTGATGTTGTTGCGTATTTCACGGGCGGGATAG 
Tbg972.6.4970 CCCTGCTTCACTTCCATGAAGGAATGCTTGATGTTGTTGCGTATTTCACAGGCGGGATAG 
************************************************* ********** 
 
Tb927.6.5180 CCTACTTAATATATAACGATAAACCCGGTGAAGAGGGGAGAGTTGAGCAGTATAAAGGCG 
Tbg972.6.4970 CCTACTTAATATATAATGATAAACCCGGTGAAGTGGGGAGGGTTGAGCAGTATAAAGGCG 
**************** **************** ****** ******************* 
 
Tb927.6.5180 TGACAGCTTCTGTGAGGGGAATAAATGCAGTAAAGTACGAAAAGACAGGTCACATCATTA 
Tbg972.6.4970 TGACAGCTTCTGTGAGGGCAGTAAATGCAGTAAAGTACGAAAAGACAGGTCACATCATTA 
****************** * *************************************** 
 
Tb927.6.5180 TGGACACAAGGTACGCAACGCAGCAGCTGTATACTCATCTTCCCTCTTATACTTGGGGTG 
Tbg972.6.4970 TGGACACAAGGTACGCAACGCAGCAGCTGTATACTCATCTTCCCTCTTATACTTGGGGTG 
************************************************************ 
 
Tb927.6.5180 TAACTTTCCTCACTTTTCCGAATAGTGCCCGTTTTGATGACTGGACTACAAATAGGGGAG 
Tbg972.6.4970 TAACTTTCCTCACTTTTCCGAATAGTGCCCGTTTTGATGACTGGACTACAAATAGGGGAG 
************************************************************ 
 
Tb927.6.5180 GCCGCCAAATTATTATAAACTGTGATGATGTGCGTGACATGAAGGCATTTGTGGTATGGA 
Tbg972.6.4970 GCCGCCAAATTATTATAAACTGTGATGATGTGCGTGACATGAAGGCATTTGTGGCATGGA 
****************************************************** ***** 
 
Tb927.6.5180 AAAAGCTGTCTGTAGCATCATGCTATGCGATACTTGATAAAGAGTCACAGGTGAGGATTG 
Tbg972.6.4970 AAAAGCTGTCTGTAGCATCATGCTATGCGATACTTGATAAAGAGTCACAGGTGAGGATTG 
************************************************************ 
 
Tb927.6.5180 TAGAAGAAATCAAAAATGAGTGGAAAACAATAGAGGGCCGTGTTGATGTAGTTGGGCCAG 
Tbg972.6.4970 TAGAAGAAATCAAAAATGAGTGGAAAACAATAGAGGGCCGTGTTGATGTAGTTGGGCCAG 
************************************************************ 
 
Tb927.6.5180 TGCCTCGTTGCGTTTACGACAGCATGGAGTACACAAAACGTGTGTCTCAGGCAAAAAAGA 
Tbg972.6.4970 TGCCTCGTTGCGTTTACGACAGCATGGAGTACACAAAACGTGTGTCTCAGGCAAAAAAGA 
************************************************************ 
 
Tb927.6.5180 CGATAACGGCCATCAATGATGATAACAAAAGACACTACGAGGACATAATGATGAAAATTG 
Tbg972.6.4970 CGATAACGGCCATCAATGATGATAACAAAAGACACTACGAGGACATAACGATGAAAATTG 
************************************************ *********** 
 
Tb927.6.5180 CCGGTTGGCAAAATGATAAGGTAACGCACAGGTTAGTGAGAATCGTTCGTGTGCGAGATG 
Tbg972.6.4970 CCGGTTGGCAAAATGATAAGGTAACGCACAGGTTAGTGAGAATCGTTCGTGTGCGAGATG 
************************************************************ 
 
Tb927.6.5180 CCGGAGAGAGCATCGATGGATACCGCTGCAGGCCACTTTCGGCTTGCATTGGGAA-TGCT 
Tbg972.6.4970 CCGGAAAAAGCATCGATGGATACCGCTGCAGGCCACTTCCGGCTTGCATTGGGAAATGCT 
***** * ****************************** **************** **** 
 
Tb927.6.5180 ATATTTTTAAAACTGCTTTCCATTATTGTGCAGAAAATGGCTATCCGTCAAGTTATGATT 
Tbg972.6.4970 ACATTTTTAAAACTGCTTTCCATTATTGTGCAGAAAACGGCTATCCGTCAAGTTACGATT 
* *********************************** ***************** **** 
 
Tb927.6.5180 TCAGACGAGAGTGCTGCGGCCAACGTTTTCAAATCGGGGGCGTTGTTTGCATTTCTTTTT 
Tbg972.6.4970 TCAGACGAGAGTGCTGCGGCCAACGTTTTCAAATCAGGGGCGTTGTTTGCATTTCTTTTT 
*********************************** ************************ 
 
Tb927.6.5180 CCTCGAGTTTTTAAAGTTATCAGAGACAACATAAAATACCTGCGGCGGCCGGGTGGACCG 
Tbg972.6.4970 CCTCGAGTTTT------------------------------------------------- 
*********** 
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Tb927.6.5180 GAAGAGAAACGATGCATACTGAAAGACATGACTCCTCAGCAGTTGAGACTCACTGGGCAG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AAGTTTTTACCAGATGCCAGACAGCAGCCAATGGAGAAGTGTGAATACATGGTTCTCTAC 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CGCCCTGCCACAGTCAATGAACCCGTGGTGGATGGCTTTTTTTTCGTTGAGGGGCGGCTC 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AGGAAAACTCCTAAGGGCAGGGCGGCACTGACCACTCCAAATATAGCTGTGCTTTTACAA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 GTAACCAAGTTGGCATGTCACCCCACCACTGCGTCAAAGGTGCAGAAGTTCCGAGAAAAC 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 ATGGCAAGATATTTTTCTGATTGGGGTGCGTTTTCCAGCAACATGGTTTGGGAGATGATA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TACATCAATGGAGCTAGTGGTGGTGTGATTACAAGATGGCAGCTTTGTGATGGCGACGAC 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CCCGCCGAAGCGGCTGATATGTGGAGAAACATGACTCAATACCAAGTAACGTTAAGAGAA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 GAAATGCAGGGGCAGCTAATGCGAGCATATGCAGAAGAAGGTTGGTATCGGGATGCTCCA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CTTCTGGCCATGGAGCCTGCGCCGCAGCCACGCAACGAGCAAGCGGGAGCGCAAGGAGGG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TGAGGCGATTTCACAGCATTGAGTGAGGTAGAAGCTGAGTAAAAATATCCGGCCTGGTAT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 GTTATGGTGGACGCGAGCAGTCAACAGTGTACGGTGCTAATGTGGGGCGAGGCGGCGTTT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TTTCCATTCAAAGTCAAATTGAGTTATCGTATCATTGGGAGGCCAGCAGTCCTAACTGCC 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AAAACAGGGTAAATGGCTTTGTCTTAATGCTTGACATGACAGGATGCGCTGCAAGGGAGT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AATATTCAGCAAATAGCGGCTATAGTAATCATCTTATTCTTTTCAACAAGCAGTCAAATG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CGGCGGTTAGTGCAGGAAAGGGACGTGATAATTCGCTTGAGTGTCGGGAGGGATGGGAGG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 GAAGTGGAAATGAAGACGACTAAGGAATAGTAAAAGTAGTATTTTATCGGCTAACGCGTA 
Tbg972.6.4970 ------------------------------------------------------------ 
176  
Tb927.6.5180 ACTGGAGTTAAGCCACATCGTAATCTTAAGGGGCACAGAGAAAGACAGAAATAATGTTAT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CGACGGACGTAAGAAAACATTGTAACGTTTTGTTTTCATTTTTGCTATTACCAACTCAAG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AATTGGATTATACTAGACTAACTCTTCACATCTTCCTTTCATTTATACAATCTAAATTTT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CCATCCGTGTAGAGATAGGAATCTATAGTCCAATGATAAAAGGAACAAAAATGTAATAGT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 ACTTTTCGCTTCTTCGCCATCCGTGGTGGAGAGAGAGTATTGGAAACATGCCTCAACTCT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 AACTCTGCTGAATCCTATTTCCAGTAGGTGTAATGGGAGAGGGATTGTGACGGAGTGAAA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TATGCAAACATTAGAAGCAGTTACTGGATGTGCTGTTTCATATACGAGCTGTTATAATTA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TATTATACATGTTAGTTATGGTTGCAGTTATGGAGCAGCTCTTGATGGTGTTCTTCGCAG 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 ACGCGCAGCTGGTGACGTGATTGTGTCCATTTTCCTCTCTCACTCTCTTTCTTTCTTCAA 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TTATTTGTCGGTGTGCAAACATACTATGATATGTTGTCTTCTCTTTACTTATAATCACTT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 CTGTTATCCTGGTTGAGGGTTGGCAGTTGGGCCTCTCTCCACACGTGGCAACCTTAAACT 
Tbg972.6.4970 ------------------------------------------------------------ 
 
 
Tb927.6.5180 TATGTTGCTGGTTGCCTCCAGCAGCAAATCCCATATCATCATCAACATTGATACGA 
Tbg972.6.4970 -------------------------------------------------------- 
 
Figure 5-12. DNA sequence alignment between Tb927.6.5180 and Tbg972.6.4970. The start and the end 
of the truncated ingi and full RIME insertions are coloured with red and highlighted in yellow 
respectively. The duplicated 12bp repeats are underlined with dashed lines and the potential PCR primers are 
in white colours in black background.  
 
One set of the 12bp duplicated repeats is present in Tbg972.6.4790, which could be 
considered as molecular signature for MGE excision, and this could be useful in 
studying the phylogenetic inference of different T.b.gambiense isolates. The hypothesis 
is that when the PCR amplification is carried out using the proposed primers on T.b. 
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gambiense, the resultant amplicons would be easily recognisable bands resolved by 
agarose gel electrophoresis as the T.b.brucei amplicon will have a larger molecular 
weight due to the insertion of the RIME. 
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5.4 Discussion 
 
To develop improved molecular epidemiological tools for the identification of T. brucei 
strains and the study of the epidemiology of sleeping sickness, a detailed, deeper, 
bioinformatics study into trypanosomal MGEs was required. Trypanosomatid 
sequencing projects have aided the investigation of MGEs and their functions. The 
dynamic nature of MGEs can cause a swift evolutionary divergence and this constitutes 
a potentially powerful tool for species identification and phylogenetic inference. 
Furthermore, MGEs can be used as passive markers for studying the processes of 
mutation and selection (Wickstead et al., 2003). 
 
 
Since the RHS genes and their pseudogenes contain hot spots for retroelement 
insertions, they were targeted in this study as being a suitable location in the genome 
to search for the insertions of elements, such as RIME and ingi, in the Tb927/4 strain 
genome. Initially 59 RHS genes were found in the database of which only 11 have 
ingi/RIME insertions. These are defined as pseudogenes. One of these RHS 
pseudogenes (Tb927.6.5180) has a double insertion. This study’s findings were in 
contrast to those of Bringaud et al. (2002) where the authors reported on 55 RHS genes 
with 16 of them having an ingi/RIME insertion. Bringaud et al. (2002) reported only 1 full 
member of RHS6, and this did correlate accordingly with the findings in this study. 
The increase in the number of identified RHS/pseudogenes could be due to the number 
of unclassified RHS genes founded in chromosome 7, or it may be due to gene 
duplication over the evolutionary process. As Emes and Yang (2008) have reported, the 
genes identified in T.brucei are frequently duplicated, suggesting interaction with the 
external host environment. In addition, the lower number of MGEs insertions and the 
truncated  ingi's  insertions  could  possibly  be  due  to  a  higher  rate  of homologous 
recombination between repetitive DNA as Melville et al. (1999) have argued. Moreover, 
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according to the phylogenetic tree constructed from the amino acid sequence 
alignments of the RHS genes (Figure 4), there are three clades. These are RHS1 / 
RHS2, RHS3 / RHS4 and RHS5 / RHS6. These correlate with the families described by 
Bringaud et al. (2002); the authors have reported that RHS3 is related to RHS4 by 43% 
whereas RHS5 is similar to RHS6 by 50%. 
 
Due to the abundance of RHS3 and RHS 4 subfamilies in TREU927 genome, they were 
chosen for detailed analysis in this study. This aims of this study were to investigate the 
mutational changes which have occurred in the RHS3 and RHS4 subfamilies, to 
categorise the RHS genes according to their evolutionary state, and finally to find a 
suitable marker to distinguish between T.b.brucei and T.b.gambiense, using the retro- 
analysis method. Initially two examples of mutational changes were investigated: firstly 
gene duplication, and the outcome of this was that the duplicated genes were chimeric 
genes, as a result of homologous recombination between two copies from different 
subfamilies, the crossing over taking place in the N-terminal region upstream of the 
retroelement insertion site (Bringaud et al., 2002). These types of homologous 
recombination events are probably the tip of the iceberg, since several undetectable 
events probably occur between the abundant homologous sequences clustered in large 
sections of multiple chromosomes (Bringaud et al., 2002). The founding of the fate 
selected gene duplications was sub-functionalization, since the duplicated genes 
exhibited the C-terminus of RHS3 including the Retrotransposon insertion site from the 
parent gene. Hurle (2004) has suggested that duplicated genes act as a source of 
protein sub-functionalisation, via evolution of key positions in the protein, and that this 
adaptation  is  reflective  of  organism-specific  selective  pressures.  Also,  the natural 
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selection estimation was calculated as ω=1, suggesting that early in their history, many 
gene duplicates experience a phase of comfortable selection or even accelerated 
evolution (Emes and Yang, 2008), which could be related to the parasite survival. Gene 
duplication has been shown to be critical to the survival of P. falciparum in the human 
host by aiding the development of drug resistance (Price et al., 2004), and the antigenic 
diversity necessary for immune evasion (Freitas-Junior et al., 2000). As Bringaud et al. 
(2002) have reported the diversity observed in the RHS multigene family is probably 
generated by the high rate of recombination in subtelomeric regions, and this may be 
advantageous for the parasite. A mutational example was studied in which the effect of 
the MGEs transposition in RHS 3 and RHS4 evolution was examined. Tb927.6.5170, 
which has a truncated ingi insertion, was studied, and chromosomal translocation was 
found to have occurred indirectly via homologous recombination intra-chromosomally. 
 
 
The evolutionary time dimension of RHS3 and RHS4 in TREU927 genome was studied 
based on the presence of the duplicated 12bp repeat which has formed due to MGEs 
insertion. Since the original state and intermediate state were known, the recent state 
was investigated. We found the recent state was present in chromosome 1 
(Tb927.1.70). The importance of this study can be interpreted as being to have fitted 
the three classes of the RHS evolutionary time dimensions into sleeping sickness 
epidemiological studies, since pseudogenes possess good properties as markers for 
epidemiological studies as they are large non-protein coding regions. As such they are 
subject to mutations that are free of selective pressure and are well suited for 
differentiating closely related isolates (Sacramento et al., 1992). Based on the above 
classification of the time dimensions of evolutionary events of the RHS pseudogenes, a 
framework for differentiating between T.brucei isolates collected from different foci and 
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geographical locations could be developed. The principle behind this characterisation is 
that the state of the evolutionary timing of isolates (original, intermediate or recent) can 
be determined using this set of markers. So, for example, in a given collection of 
isolates, those that have evolved more recently can be distinguished from those that 
have evolved earlier. As Edwards and Gibbs (1992) have reported, even when a rare 
deletion of an element occurs, it leaves behind a molecular signature in the flanking 
sequences of a locus. This is could be useful for trypanosomiasis epidemiological 
studies, as it could allow us to differentiate between isolates from different foci and 
geographical locations according to temporal dimensions. Edwards and Gibbs (1992) 
have successfully used this approach whereby they reported on a comparison between 
a tightly linked marker within the human genome and studies of baboon DNA samples. 
This revealed that the original insertion was a relatively early event in primate evolution, 
but the Alu sequence loss leading to the dimorphism occurred much more recently. Loss 
of Alu insertions are therefore a mechanism for the generation of human Alu 
dimorphisms. 
Finally, ingi/RIME (T.brucei), L1Tc/NARTc (T.Cruzi) and L. major DIREs share the first 
78–79 nucleotides even though they are unrelated to each other (Bringaud et al., 2006). 
It is thus hard to differentiate between the trypanosomatids using retroposons as 
markers. However, according to Jackson et al. (2010) intra-specific genome divergence 
between T.b.brucei and T.b.gambiense is estimated to be 1% where the indels or 
insertions are generally caused by mobile genetic elements. These authors have 
reported the deletion or insertion differences between T.b.brucei and T.b.gambiense 
being typically caused by transposable elements and internal VSG ‘islands’. On 
chromosome 9, a 7 kb insertion occurs in T. b. brucei due to an ingi element (at 1.24 
Mb) not present in T. b. gambiense. 
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In this study we hypothesised that a RIME element could be inserted into one of the 
RHS genes of the TREU 927 genome but not in the correspondent RHS pseudogene 
in the DAL 972 (T.b.gambiense). We could thereby consider this as potential marker for 
differentiating between T. brucei and T.b.gambiense. Each RHS-psuedo gene that 
contains RIME insertion was compared to the DAL972 genome (BLAST search). It was 
found that RHS pseudogenes (Tb927.6.1150) have a high similarity (95%) with 
Tbg972.6.4970 RHS genes in term of the flanking region, but the RIME insertion was 
missing in the Tbg972.6.4970. Also, the fact that Tb927.6.1150 did not have similarities 
to the other T.brucei sub-species was an encouraging sign for the production of a 
reliable marker. However, due to the time limitations we were not able to test this 
provisional hypothesis, but past experiments including those of Stoneking et al. (1997), 
Witherspoon et al. (2006) and Mondenet al. (2014) have indicated support for this 
hypothesis; the advantages of using MGEs as genetic markers is that they can show 
more accurate relationships than many other genetic markers such as single nucleotide 
polymorphisms (SNP), microsatellites, and restriction fragment length polymorphisms 
(RFLP). 
MGEs including RIME play a very important role in phylogenetic studies of parasites, as 
well as in the epidemiology of sleeping sickness. Based on the findings of this chapter, 
a marker that could be used to differentiate between T.b.brucei and T.b.gambiense can 
be potentially developed. 
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6.1 General discussion 
 
In this thesis ways to improve the field molecular diagnosis of African 
trypanosomiasis were studied. This study has centred around 36 blood samples of 
human patients, which were positively tested for trypanosomiasis by CATT, which were 
collected on FTA cards from Angola. Cox et al. (2005) have developed a nested ITS- 
PCR, which is more sensitive than the single round PCR reaction. This development 
allowed major simplification of the entire sample processing protocol whilst at the same 
time allowing the same diagnostic sensitivity to be applied in the detection of all 
important African trypanosome species. However, targeting a single punch from the 
FTA card matrices increase the chances of false negative PCR results since the 
targeted punch may lack parasite DNA (uneven distribution of the parasite DNA). A 
previous study that was carried out by Cox et al. (2010) has investigated the use of FTA 
cards in the diagnosis of trypanosomiasis. The authors have reported that a single 
punch from the FTA card may lead to false PCR negative results, and hence the 
wrong prevalence. This was found to be due to the uneven distribution of a sample on 
the card. Subsequently, this will have an impact on the sensitivity of this PCR technique. 
This is especially true when the parasite density is low, which means the chances of a 
single punch containing trypanosome DNA is low. 
Therefore, initially in this study we have experimentally tackled this problem for 
diagnosis from the Angolan human samples. To achieve this, more than one punch (5 
punches) from the patient samples that were collected from Angola, were selected for 
Chelex DNA elution prior to the ITS-PCR amplification. However, prior to the Chelex 
DNA elution, the validity of the Chelex elution was investigated using mammalian tubulin 
PCR. According to the mammalian tubulin PCR results the Chelex elution approach 
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could be considered as convenient and a reliable approach to be used in field 
diagnostic laboratories for trypanosomiasis. Also, the choice of the DNA extraction kit 
should be based on economic and time factors particularly in field laboratories located 
in Africa; considering the estimated cost of less than 0.16 US$ per sample for Chelex 
elution (Strøm et al., 2014). It can be concluded from this study Chelex elution has been 
shown to be reliable and economically suitable for trypanosomiasis molecular 
diagnosis. The advantages of Chelex elution includes low cost, less time and effort 
consuming, and other several advantages are mentioned in (chapter 3) 
Moreover, the nested ITS-PCR technique efficiency in diagnosing HAT was tested. To 
begin with the hypothesis of the testing a single punch directly by nested ITS-PCR 
was studied. when single punch was taken from FTA spotted with trypanosome DNA, 
which have produced a  0% detection. However, as described in Chapter 3 (Figure 3-5) 
the advantage of the nested ITS-PCR over a single round ITS-PCR in terms of sensitivity 
was noticed. As the positive control (liquid trypanosome DNA) of the PCR reaction 
failed to produce any bands in the first reaction, but after the second reaction a clear 
band was recorded. That was produced by introducing to the two inner primers (ITS3 
and ITS4), which makes the technique very much more sensitive, and in this application 
a two round amplification strategy has a second desirable effect. In the second round 
of the PCR the amount of the target is increased, whilst the amount of potentially 
inhibitory factors are greatly diluted (Cox, 2007). However, the nested Chelex/ITS-PCR 
has shown lower sensitivity when it was carried out on DNA eluted from FTA cards 
spotted with blood (Angolan Samples) than DNA eluted from FTA card spotted with 
liquid trypanosome DNA (T. b. rhodesiense stock from Uganda); 46.5% and 67% 
respectively. This could be attributed to different factors whether limitations related to 
the FTA card or to the assay itself. Technical problems that are related to the FTA card 
include; the age of the FTA cards, since the samples 
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were collected in the 2001 it is hard to remove all the PCR inhibitors, as Becker et al. 
(2004) have reported in assays, that  long-term storage (>9 months) has been shown to 
prevent the complete removal of blood from discs by washing. Also, Matovu et al. 
(2010) attributed their low sensitivity of SRA-PCR, to a decrease in DNA quality during 
storage, as up to 1 year elapsed between sampling and execution of the tests. 
In addition, the presence of the host DNA and blood inhibitors such as Haem, 
Lactoferrin, IgG and non-target DNA post the sample processing could contribute  to the 
low sensitivity of the nested ITS-PCR in this particular study. As there are a variety of 
studies have proven that porphyrin compounds that are present in the haem component 
of the red blood cells are one of the major PCR inhibitory components of blood. These 
compounds have been shown to inhibit the activity of the thermo-stable DNA 
polymerases used in the PCR reaction (Loparev et al., 1991; Wooden et al., 1993; Akane 
et al., 1994; Cox, 2007). Although, the use of Chelex in DNA elution from blood samples 
helps in removing such inhibitors, by binding to the Chelex®100 bead matrix itself (Walsh 
et al., 1991). However, Becker et al. (2004)  have found that the presence of PCR 
inhibitors cannot be completely ruled out after Chelex®100 extraction. A further evidence 
that PCR inhibitors could play role in lowering the sensitivity of the PCR amplification, 
Adams et al. (2006, 2008) reported a lower trypanosome detection using PCR (43.1%). 
The authors explained this low detection rate because the presence of inhibitors such 
as proteases or haem moieties from the midgut of the fly. However, the sensitivity was 
increased to 78% after storage of the midgut samples in 100% ethanol and 
purification of DNA using ammonium acetate precipitation. 
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Moreover, further technical issues in using FTA cards that may be related to the low 
sensitivity. Ahmed et al. (2013) have suggested that the low sensitivity of nested ITS- 
PCR may could be due to that the fact that the ITS reaction was optimized to work on 
washed discs rather than eluted DNA. As an explanation for the low sensitivity for Cox 
et al. (2005) ITS-PCR in comparison to TBR-PCR. However, Nijru et al. (2005) have 
reported the opposite, as the authors have extracted DNA from blood samples with 
Qiagen extraction kits that costs £3.02 per sample [Qiagen website, 2015] and 2 μl of 
the extract was used as a template in the PCR reaction. Extraction of DNA directly from 
blood samples increased the sensitivity for the ITS reaction while elution of DNA from 
the FTA cards inhibits the ITS PCR (Ahmed et al., 2013). 
On the other hand, the low sensitivity of the nested ITS-PCR could be attributed to the 
fact that internal transcribed genes present in low numbers ~hundreds, in comparison 
to 177 bp DNA satellite repeat sequence that present in large number ~10,000 in the 
T.brucei genome. As Thumbi et al. (2008) and Ahmed et al. (2013) explained their low 
sensitivity of nested ITS-PCR in comparison to TBR-PCR. 
In summary, FTA card field application have many advantages which ease the collection, 
mobilization, and storage of the samples, and in this study have shown promising 
potential should further evaluation be considered. For instance by either lysing the 
blood before applying it on the FTA card that  (Ahmed, 2009), MDA (Chapter 3) which 
costs nearly £13 per sample, or multiple washing before Chelex elution to ensure the 
removal of as much as possible of PCR inhibitors. Moreover, although nested ITS-PCR 
has offered great deal of help to the field diagnosis of trypanosomiasis in the past by 
reducing the consumed time and costs, and have shown a promising potentials in this 
study. Further evaluation of the technique   is   recommended.   Particularly   detailed   
investigation   into   the internal 
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transcribed genes in the pathogen T.brucei i.e. T.b.gambiense genome, in order to 
design more specific primers, which will enhance the sensitivity of the assay. Moreover, 
many publications including; Matovu et al. (2010) where the authors compared 
molecular trypanosome detection methods (nested SRA-PCR and SRA-LAMP 
[chapter1]). The authors have reported a higher sensitivity with less time consumed 
using SRA-LAMP than nested SRA-PCR, from a single punch from FTA card spotted 
with blood infected with tryapanosomiasis. Also, Ngotho et al. (2015) have tested the 
blood, cerebrospinal fluid (CSF), saliva, and urine, of six vervet monkeys were 
experimentally infected with T. b. gambiense. Using parasitological methods, TgsGP 
PCR and LAMP. The detection by LAMP was significantly higher than that of 
parasitological methods and PCR in all the samples. Therefore, in interest of comparing 
the sensitivity of ITS-PCR versus LAMP. Chelex/ITS LAMP should be taking into 
consideration, first by using the ITS primers from Cox et al. (2005), then with more 
specific primers should new primers been designed. Also, it would be interesting to find 
the outcome of Chelex/nested ITS-PCR, should it be carried on CSF samples rather 
than blood. To investigate its usefulness in staging the disease, and compare the its 
sensitivity between blood and CSF. Finally, nested Chelex/ITS-PCR and FTA cards 
promises the possibility of carrying out large-epidemiological studies on African 
trypanosomiasis in a simple and cost-effective way, which would contribute to the 
elimination of sleeping sickness road map. 
 
 
Further objectives of this thesis were to investigate the sensitivity of the MGE-PCR 
compared to nested ITS-PCR on FTA cards and to evaluate the use of MGE-PCR 
directly from FTA cards. Previous studies have proven MGE-PCR is a powerful 
molecular tool in studying diseases caused by pathogenic parasites, such as 
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Toxoplasma gondii (Terry et al., 2001) and T.brucei (Tilley et al., 2003). According to 
our knowledge MGE-PCR was not tested on FTA cards. In this study MGE-PCR was 
carried out on eluted DNA from FTA cards of patients who have been tested positively 
for trypanosomiasis by CATT (Angolan samples). In this study MGE-PCR has 
recorded higher sensitivity than nested ITS-PCR in detecting trypanosomes. However, 
the specificity of REV B could not be determined through DNA sequencing, this could 
be due to nonspecific primer binding since the single primer protocol is used to 
amplify unknown region of DNA or REV B is not specific to detect trypanosome as it was 
proven in the successful amplification of tryp-negative blood. Also, the resultant 
data of the DNA sequencing was not readable i.e. mixed peaks and short nucleotides 
sequence. This could be due to the fact single primer amplification is a linear reaction, 
where the amount of the produced DNA post amplification as single primer will produce 
half the number of copies produced by two set of primers. This can be overcome by 
cloning as Matsui et al (1993) have reported; where the DNA will be cloned with either 
with either oligo (dT) priming or random hexamers, in the case of T.brucei mobile 
elements where the 3' end is occupied by poly (A) tail oligo (dT) is more suitable. The 
produced population of cDNA will be then amplified by single primer amplification. 
Subsequent the amplification the amplified products will be inserted into suitable 
bacteriophage (DNA cloning).  
In order to improve the sequencing of the amplified products by REV B, the produced 
amplicons were cut by restriction enzyme (AlwNI) to ease the priming process for the 
primer. However, the DNA sequencing of the post-amplification product did not record 
any sign of improvement. Which may due to the presence of contaminants that cannot 
be separated from the template DNA that led to inefficient amplification by REV B. 
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Which could also have affected the sequencing of RIME A and RIME B amplified 
products. 
Although MGE-PCR recorded a higher sensitivity than nested ITS-PCR. However, the 
sequencing data of the amplicons resulting from REVB was not readable. Even 
though different approaches were followed (chapter 4) to improve the sequencing data, 
yet with no sign of improvement. Thus, in terms of future work another approach could be 
followed to improve the sequencing data, subsequently determining the specificity of 
REV B. Which is generating double-stranded DNA from the linear reaction caused 
by single primer amplification. By oligo (dT) priming, once the double stranded DNA is 
generated, it will be cloned into a suitable bacteriophage. After growing sufficient amount 
DNA, sequencing the product may give a clearer picture about the specificity of the 
REV B as Matsui et al. (1993) have reported. 
 
Based on the findings in (chapter 4), a more specific protocol based on MGEs is 
required. To achieve this, a bioinformatics analysis of mobile elements inserted in 
RHS/pseudogenes in the T.brucei genome was carried out. The aims of this were to 
locate variable regions of these genes that could be used as detailed markers for 
trypanosome strain identification to improve the specificity of MGE-PCR. Sequences of 
the RHS genes were retrieved from the T.brucei brucei and T. brucei gambiense 
genomes to investigate positional diversity of MGEs within this family of genes. 
Differences were found in t h e  presence/absence of RIME elements in one RHS 
gene between the two subspecies. More detailed investigation of all RHS gene 
classes in T.b.brucei showed six classes of RHS gene types and within each 
class, individual sequences showed evidence of insertion by MGEs.   
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In some specific   instances, evidence of pre-insertion, insertion and subsequent 
removal of MGEs was seen. This enabled a temporal evolutionary sequence of 
events to be interpreted. 
We were able to class the RHS pseudogenes into three categories including; the original 
state, intermediate state and the recent state. Based on the presence and the excision 
of the mobile element. This will aid the study of sleeping sickness epidemiology, by 
tracking the migration of T.brucei populations, according to if the elements are present 
in some species and not others, they can be used to determine the evolutionary history 
of those species. As Batzer and Deininger, 2002 reported an Alu subfamily known as 
young Alu subfamilies (have inserted into the human genome most recently) are 
polymorphic with respect to the presence or absence of insertion in different human 
genomes. Those relatively few elements that are present in the genomes of some 
individuals and absent from others are referred to as Alu-insertion polymorphisms. This 
polymorphism has been used to study human genomic diversity (Roy-Engel et al., 
2001). 
A potential marker that would differentiate between the T.b.brucei and 
T.b.gambiense was found. The potential of this marker is high as it would differentiate 
between the two sub-species via the produced amplicons. Where an insertion of RIME 
was found in the TREU927 genome and was absent in the Tbg972 genome, this 
represents a potential mobile element marker for studies of the epidemiology and 
control of sleeping sickness. Where two PCR primers from the flanking region of the 
RIME (chapter 5), rather than single primer (REV B). That will amplify the RIME 
present in the parasite genome, in case of T.b.gambiense the produced gel band will 
be smaller than T.b.brucei, due to the absence of the RIME insertion in the 
T.b.gambiense. Hypothetically based on the bioinformatics experiments, this is 
considered as powerful tool that will ease studying large-scale samples, and 
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economically friendly. As the differentiation could be visualised by the amplicon sizes 
on the gel image. Most studies of population genetics in T.brucei species are 
facilitated by mitochondrial DNA, microsatellites, AFLP, or RFLP. However, 
retrotransposon insertions represent a valuable tool because of their unique 
combination of genetic properties and the observation that they are one of the least 
expensive molecular markers to assay. Ideally, all one needs to assay a population is a 
thermal cycler and gel electrophoresis equipment. This approach will allow for 
different T.brucei isolates to be typed in large- scale studies. These genes offer the 
opportunity to develop specific molecular epidemiological tools for investigating the 
evolution of MGEs in field samples and the possibility of a method for temporally 
informed epidemiological tracking of isolates. 
 
 
One of the limitations of this study is the number of the studied RHS genes families 
(RHS3 and RHS4 only), in order to make this study more specific and accurate is to 
study the rest of the RHS gene families’ i.e. RHS1, RHS2, RHS5, and RHS6. Also, in 
this study only three genomes of the T.brucei subspecies have been studied which are 
TREU 927, Tb427 and Tbg972, which belong to T.brucei, T.brucei (lister strain) and 
T.b.gambiense subspecies respectively. To take this approach forward in the future it 
would be useful to conduct a similar investigation to the 1092 human genome project 
where scientists have planned to sequence the genomes of at least one thousand 
anonymous human participants from a number of different ethnic groups within three 
years (McVean et al., 2012). Such a project in trypanosomes could open a large number 
of possibilities for the development of new tools for the detection and tracking of 
trypanosomes. It, of course, would not be achievable before the 2020 proposed 
deadline for elimination. 
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In summary, these studies should also shed new light on the biology of these interesting 
mobile elements and provide a comparative assessment of their role in shaping the 
genetic relationship between T.brucei species. 
 
 
Moreover, the meaning of elimination is “reduction to zero of the incidence of infection 
caused by a specific pathogen in a defined geographical area, as a result of deliberate 
efforts; continued actions to prevent re-establishment may be required.” (WHO, 2013). 
According to the past, HAT elimination was proven to be a hard task and requires 
huge amount of effort, time, and resources (Franco et al., 2014b). Therefore, there 
are questions to be asked as we are five years away from the deadline that was set by 
WHO in 2013. First are we in position to meet this target? Second should we meet 
the deadline, is it going to be sustainable elimination? WHO (2013) have designed this 
road map into 2 phases; the initial goal is 2020 where the predicted reported cases to be 
one new case per 10 000 inhabitants in 90% of foci. The final goal in the future should 
be the sustainable elimination of the disease, defined as the interruption of the 
transmission of gambiense HAT, which has been targeted for 2030 (WHO, 2013). 
WHO (2013) are optimistic and believe this road map is feasible, should several 
measures be followed; one of the steps is developing new tools for case detection, that 
will extend the possibilities for diagnosis and surveillance in the health system. This 
present study concentrates on improving the current molecular diagnostic tools and 
developing a new marker that has the potential to contribute towards meeting the target 
by 2020. Chelex/nested ITS-PCR is considered a reliable tool for detecting 
trypanosomes in the field. However, the outcome of this study suggests that various 
improvements are required. For instance the usefulness of FTA cards as a source 
for storing and mobilizing the samples. Previous studies and this study have shown    
that the age of the stored sample on FTA card has a negative impact on the detection 
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rate by molecular tools, in this case the nested ITS-PCR. Also, the form of the samples, 
as in this study whole blood was shown that have a negative impact on the detection rate 
by nested ITS-PCR. Due to the PCR inhibitory factors present in the blood. Even though 
for the samples who have been positively tested for DNA elution using mammalian 
tubulin PCR, have failed to amplify after the second round nested ITS-PCR. This raise 
a questions related to the validity of FTA cards in field diagnosis of trypanosomiasis. 
Further concern that should be taking into consideration is to test CSF rather than blood, 
as especially in the Gambian form of HAT, the parasite density will be present in higher 
concentration in CSF than in the blood, particularly at the later stages of the Gambian 
HAT. Kyambadde et al. (2008) have reported a higher sensitivity when the PCR was used 
to detect trypanosome in the CSF (61.7%) than in the blood (57.1%). Also, in this study 
patients were recorded as second-stage of the Gambian HAT, were missed by the 
nested ITS-PCR amplification. This highlights the shortage of the assay in 
determining the stage of the disease. The outcome of this study have agreed with the 
weakness of the molecular diagnostic tools (nested ITS-PCR) against the 
parasitological tools (CATT) in diagnosing Gambian sleeping sickness. Also, Njiru et al. 
(2004) have reported a comparison between three methods including CATT, PCR and 
MHCT, in detecting T.evansi in 549 camels from Kenya. The authors have reported that 
CATT is more sensitive in determining the prevalence of trypanosomes (45.5%) using 
CATT, in comparison to (5.3%) and (26.6%) for MHCT and PCR respectively. However, 
in previous studies (Penchenier et al., 2000; Solano et al. 2002) have reported that 
molecular tools are more sensitive using TBR PCR Moser et al. (1989), than CATT. 
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On the other hand, Solano et al. (2002) have reported 100% sensitivity and 92% 
specificity, when Chelex was used to elute DNA from blood samples, prior TBR PCR. 
This support the suggestions of Ahmed et al. (2013), that nested ITS-PCR developed 
by Cox et al. (2005) was only designed to work on a single punch from the FTA cards. 
Beside, according to the outcome of (chapter 4) where Chelex/MGE-PCR have shown 
higher sensitivity than Chelex/ITS-PCR from the same samples. Yet the MGE-PCR 
lacks the specificity based on the post-amplification analysis, to investigate the 
produced amplicons was unsuccessful. However, it was the first time (to our knowledge) 
that MGE-PCR was applied directly on FTA cards spotted with blood of infected patients 
by trypanosomiasis. Yet it has shown promising potentials, should more efforts be 
carried to increase the specificity of the MGE-PCR. Which have led us to investigate the 
mobile elements in T.brucei genome in more depth bioinformatically. In order to develop 
a  new molecular marker based on the MGEs present in T.brucei genome and 
strengthen the prospect of MGE-PCR. 
 
 
The elimination of gambiense HAT is largely relying on the sustained political stability in 
Africa. Welburn and Maudlin (2012) have expressed their views on the role of the public-
private funding in eliminating gambian sleeping sickness. The authors have suggested 
that public–private funding mechanisms should not be excluded. It is timely to take up 
the tools available and invest in new tools – including novel financial instruments – to 
eliminate this disease from Africa. Also, despite the epidemiology of gambiense HAT 
being generally well understood, some scientific questions remain unanswered. 
Particularly in areas related to the presence and distribution of the disease, as well as 
the role of animals as reservoirs of T. b. gambiense (WHO, 2013). 
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As Njiokou et al., (2010) h a v e  r e p o r t e d  t h a t  a  PCR results have detected T. 
b. gambiense group 1 DNA in 27 (3.08 %) domestic animals of 875 animals from 
Cameron. If T. b. gambiense is able to be transmitted from animals to humans and from 
humans to animals, it will have an impact on the transmission rate, as it will increase the 
transmissibility index. Subsequently the expected number of reported cases will be 
increased as well. 
The outcome of this study (chapter 5) a potential marker to be used in strain typing 
of T.brucei has been developed. We believe that trypanosomiasis epidemiological 
studies will undoubtedly benefit from this development. The principle of this marker is 
that isolates of T.brucei from different geographical locations and periods can be 
differentiated, according to the insertion or the absence of the MGEs (RIME) in the 
genome. This molecular marker will answer epidemiological related question, 
particularly in cases that are falling outside tsetse-infested areas, cases originating from 
areas with no reported history of HAT. Moreover, since HAT is described as focal 
disease. Therefore, Geo-referenced data are crucial in controlling programmes of HAT. 
As we learnt from the “Dracunculiasis Eradication Program”, where the number of 
cases has dropped from 3.5 million in the mid-1980s in 20 countries worldwide, to 126 
in 2014 (Weekly epidemiological record, 2010; Global Health Observatory, [WHO 
website]), where the Geo-referenced has played an important role. This potential 
marker can benefit from Geographical Information Systems (GIS) -based 
methodology for risk estimation was developed and tested in six Central African 
countries (Cecchi et al., 2009). Since an ideal GIS would contains detailed information 
on each known case of the disease, including: geographic coordinates of the patient's 
household, sex and age of the patient, exact date of disease detection or reporting, 
duration of illness, mortality/recovery rates. Also, information on the location of the 
patient's working place would be needed, as well as the patterns of people mobility in 
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the area (Cecchi et al., 2009). Such information will be very useful for predicting the 
evolution of the disease and the efficiency of the control measures. Also, GIS will enable 
us to identify, localize and characterize biotopes and zones of high transmission risk 
where vector control can be implemented. Consequently, vector control costs will be 
reduced (Simo et al., 2014). Thus, a combination of work between the mapping 
methods and the new potentially developed marker would have a huge positive 
impact towards the road map of HAT elimination. 
 
 
In summary, the road map to eliminate HAT by 2020, and the decline in the number of 
cases, reflects the increase awareness of the disease and the huge amount of efforts 
and work done over the years, in developing new tools to control sleeping sickness. In 
this study we present ways to improve molecular diagnosis of sleeping sickness, and it 
can be concluded that further investigations are required to compete with the complexity of 
the disease and the pathogens. Also, this study produced a new potentially promising 
genetic marker to be used in epidemiological studies of trypanosomiasis in the future. 
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6.1 Future work 
 
The outcome of this research is promising and worthy of further development. Firstly, an 
in-depth investigation into the internal transcribed spacer genes within the T.b.gambiense 
genome is warranted in order to design enhanced species specific primers that could be 
tested on the Angolan patient samples. Secondly, the Chelex eluted DNA from the 
Angolan patient FTA cards could be tested using the TBR-PCR approach. This should 
give a clearer picture regarding the presence, or the absence, of trypanosome DNA since 
TBR-PCR has been shown to have a higher sensitivity than ITS-PCR in detecting 
trypanosomes. Finally, an alternative molecular tool, LAMP (see Chapter 1) could be 
applied on the eluted DNA from the FTA cards that were collected from Angola, in order 
to compare the sensitivity between ITS-PCR and LAMP techniques. Furthermore, it would 
be useful to collect additional blood samples from healthy participants from Angola.  
These could be analysed by the nested ITS-PCR approach in order to have greater 
confidence in the specificity of the technique when applied to the detection of 
trypanosomes.  Finally, based on the bioinformatics results presented in Chapter 5, the 
designed primers should be experimentally applied on the Angolan samples 
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6.2 Conclusion 
 
Successful molecular diagnosis of sleeping sickness in Africa is largely based on the 
availability of the field laboratories that require a genomic material of an appropriate 
quality and concentration to be present within the sample under examination. Thus, 
according to the work presented in this thesis, different blood preparations should be 
considered before spotting onto FTA cards. Also, a  further consideration should be 
taking into account, is the age of the FTA card. From this study based on economical and 
time consuming considerations Chelex elution is highly recommended to extract genomic 
materials from the FTA card. Moreover, Chelex/ITS-PCR is arguably economically 
acceptable and less time consuming, however, further investigations are required to 
improve its sensitivity. Furthermore, despite the successful history of MGE-PCR in 
epidemiological studies of sleeping sickness, based on conclusion of chapter 4 REV B 
specificity is still under question. Finally, from the bioinformatical experiments chapter 
5, where the use of mobile elements in the diagnosis of trypanosomiasis was investigated. 
It can be concluded from the retro-analysis study, mobile elements as markers can possess 
a great potential for studying the epidemiology of sleeping sickness, which will enhance 
the prospects of MGE-PCR in term of specificity. 
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Appendix 1 
 
Figures below illustrate the full information obtained from the source of the collection 
 
 
 
Figure (1). The collected samples from patients on FTA card from Angola. Illustrates the Age, Gender, 
previous and the sample collection locations 
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Figure (2). The medical history of the participant patients in this study 
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Figure (3). The occupation of the participant patients in this study. 
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Figure (4). The treatment information of the patients and the initial diagnosis at the arrival at the hospital. 
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Figure (5). The symptoms and the duration of the symptoms of the participant patients. 
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Appendix 2 
 
The multiple alignment of the amino acid sequences of the RHS/pseudogenes present 
in TREU927 genome. Illustrating two features of the RHS genes subfamilies 
RHS1 KGVEYVFKSDVYIRREALRVWYKVENVLNRWLMDEVIVDDASNVLIGTPGIGKSFSVGSL 
Tb927.1.180 KGVEYVFKSDVYIRREALRVWYKVENVLNRWLMDEVIVDDASNVLIGTPGIGKSFSVGSL 
Tb927.1.220 KGVEYVFKSDVYIRREALRVWYKVENVLNRWLMDEVIVDDASNVLIGTPGIGKSFSVGSL 
Tb927.2.100 KGVGYVFNSDVYIRRETLRVWHKVKERLNQWLMGEVAINPMFHVVIGTPGIGKSFSVGSL 
Tb927.4.110#* KGVGYVFNSDVYIRRETLRVWHKVEERLNQWLMGEVAINPMFHVVIGTPGIGKSFSVGSL 
Tb927.2.370 KGVEYVFKSDVYIRREALRVWYKVENVLNRWLMDEVIVDDASNVLIGTPGIGKSFSVGSL 
Tb927.4.200 KGVEYVFKSDVYIRRETLRVWHKVEERLNKWLMGEVTVNPMFHVLIGTPGIGKSFSTAPF 
Tb927.6.160 KGVEYVFNDDVYIRRETLRVWHKVEERLNKWLMGEVIVNPMAHVLIGTPGIGKSFSTAPF 
Tb927.4.100#   ----------------------------------------------------------  I 
 
RHS2 RVWYLVKHRLDLWLGPGVNKKQIPCVLVGTPGIGKSFGVGSFLLQRLLHYDSELLRNIAY 
Tb927.2.1160#*      ------------------------------------------------------------ 
Tb927.4.220#* -----------------------------------------------------MNQQVPI 
Tb927.2.400 RVWYLVKHRLDLWLGPGVNKKQIPCVLVGTPGIGKSFGVGSFLLQRLLHYDSELLRNIAY 
Tb927.2.280 RVWYLVKHRLDLWLGPGVNKKQIPCVLVGTPGIGKSFGVGSFLLQRLLHYDSELLRNIAY 
Tb927.4.210#* -----------------------------------------NPAPRVAALRFGAVADYRL 
Tb927.10.110#* ------------------------MAAAVGGNSHEGTKKKKILLQRLLHYDSELLRIIAC 
Tb927.2.380 RVWYLVKQRLDLWLGPELVEEPFPCVLVGTPGIGKSFGVGSFLLQRLLHYDSERLRNIAY 
Tb927.2.1180 RNDAEPPVVQQRVENNNQPQWGLFSCVDAVLLNGLPHPRNMMLNDFLRRNFGRRYNVNEE 
Tb927.6.5160 RNDAEPPAVQQRVENNKQPQWTILSSVEAVLLNGLPHPGNMSVNDFLRFNLLEDIDLDQR 
Tb927.4.280 PPPAQPPQMPQRYKRFS--DWKMNSTVRDFLLEEYATLPKMNLHDFLNQCFSNTYNT--- 
Tb927.4.290 PPPAQPPQMPQRYKRFS--DWKMNSTVRDFLLEEYATLPKMNLHDFLNQCFSNTYNT--- 
Tb927.4.270 PPPAQPPQMPQRYKRFS--DWKMNSTVRDFLLERYATLPKMNLHDFLNQCFSNTYNT--- 
Tb927.4.260 PPPAQPPQMPQRYKRFS--DCKMNSTVRDFLLEEYATLPKMNLHDFLNQCFSNTYNT--- 
Tb927.4.300 PPPAQPPQMPQRYKRFS--DWKMNSTVRDFLLEEYATLPKMNLHDFLNQCFSNTYNT--- 
Tb927.5.280^*       --------------------WVLGSNVKDVLLEEYAGLKDMKLHEFLNQHIGETLGTP-- 
Tb927.6.150 --------------------------------NETALFESVFLKHVQLGECSSGCVCNPG 
Tb927.2.1150#*      -----------------FCSKGCCITIRSCCGISLILRARHIFSSGRQTIIREGLYSMKR 
 
RHS3 REIVRVWYKVEKDLKTWWVEKTAHRPPIHIVIGTPGIGKSYGLGSFLLHSLLHFHEGMLD 
Tb927.2.340 REIMRVWYIIQRGLQTWWLNDTAHRPPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGMLD 
Tb927.2.470 REIMRVWYIIQRGLQTWWVEKTARRTPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGMLD 
Tb927.2.450 REIMRVWYIIQRGLQAWWVEKTAQRTPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGMLD 
Tb927.1.120 REIMRVWYIIQRGLQGRWVEK-AEITPRHIVIGTPGIGKSYGVGSFLLHSLLHFNDGMLD 
Tb927.2.1210 REIMRVWYIIQRGLQGRWVEKADITP-RHIVIGTPGIGKSYGVGSFLLHSLLHFHEGMFD 
Tb927.2.560 REIMRVWYIIQRGLQGRWVEKAEITP-RHIVIGTPGIGKSYGVGSFLLHSLLHFNDGMLD 
Tb927.1.70 REIMRVWYKVEKGLRACWVEKAE-DSPIHIVIGTPGIGKSCGLGSFLLHSLLHFHEGMLD 
Tb927.4.240 REIMRVWYIIQRGLQGRWVEKAQ-RPPIHIVIGTPGIGKTCGLGSFLLHSLLHFNEGMLD 
Tb927.2.510        REIMRVWYIIQRGLQTWWVERTARITPRHIVIGTPGIGKSYGVGSFLLYSLLHFHDGMFN 
 
 
RHS4 IRREIMRVWYIIQRGLQTWWLNDTAHRPPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.2.340 IRREIMRVWYIIQRGLQTWWLNDTAHRPPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.6.5170^* IRREIMRVWYIIQKDLKAWWVEKTAHRPPIHIVIGTPGIGKSCGVGSFLLH--------- 
Tb927.2.450 IRREIMRVWYIIQRGLQAWWVEKTAQRTPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.2.470 IRREIMRVWYIIQRGLQTWWVEKTARRTPIHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.1.120 IRREIMRVWYIIQRGLQGRWVEKAEITP-RHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.2.560 IRREIMRVWYIIQRGLQGRWVEKAEITP-RHIVIGTPGIGKSYGVGSFLLHSLLHFNDGM 
Tb927.2.1210 IRREIMRVWYIIQRGLQGRWVEKADITP-RHIVIGTPGIGKSYGVGSFLLHSLLHFHEGM 
Tb927.6.5180^#*# -----------------------------------------------MLHSLLHFHEGMM 
Tb927.1.70 IRREIMRVWYKVEKGLRACWVEKAE-DSPIHIVIGTPGIGKSCGLGSFLLHSLLHFHEGM 
Tb927.4.240 IRREIMRVWYIIQRGLQGRWVEKAQ-RPPIHIVIGTPGIGKTCGLGSFLLHSLLHFNEGM 
Tb927.2.510        IRREIMRVWYIIQRGLQTWWVERTARITPRHIVIGTPGIGKSYGVGSFLLYSLLHFHDGM 
 
RHS5 WNVVRNGIELWRTQRVIPGCLYLPRSYVAIGNPGIGKSQNLGSFILYKLLHYDAEELPV 
Tb927.1.420 WNVVRNGIELWRTQRVIPGCLYLPRSYVAIGNPGIGKSQNLGSFILYKLLHYDAEELPV 
Tb927.2.1170 WNFVRSGIELWRAQRVIPGCPYLPRSYVAIGNPGIGKSQNLGSFILYKLLHYDAEELPV 
Tb927.4.250 WNVVRSGIELWRTQRVIPGCLYLPRSYVAIGNPGIGKSQNLGSFILYKLLHYDAEELPV 
Tb927.6.140 WNVVRNGIELWRTQRVIPGCPYLPRSYVAIGNPEIGKSQNSGSFILYKLLHYDAEDLPI 
Tb927.2.240 WNVVRNGIELWRTQRVMPRCLYFPRSYLAIGNPGIGKSQNLGSFILYKLLHYDAEELPI 
Tb927.2.1080       WNVVRSGIELWRTQRVMPRCLYFPRSYLAIGNPGIGKSQNFGSFILYKLLHYDAEELPV 
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RHS6 RTQRALPGCLHFPRAYLAIGNPGIGKSQNLGSFILYNLLHYDAEELPVVAYFRGVAAYIF 
Tb927.11.4770*^ RTQRALPGCLYFPRSYVAIGNPGIGKSQNLGSFILYNLLHYDAEELPVVAYFRGVAAYIF 
 
Figure (6). The multiple alignment of amino acid sequences of RHS genes present in TREU927 and 
RHS genes families (1-6). The alignments was carried according to the each RHS gene family. The 
GTP motif is highlighted in red. The RHS genes that possess a mobile elements are marked with (^) for 
ingi insertion, (#) RIME B and (*) RIME A. The alignment was carried in EBI clustalw. 
 
 
Tb927.2.280 TPGIGKSFGVGSFLLQRLLHYDSELLRNIAYFVKGRAYIFFRATNDHPGKVVFYEKEKDG 360 
Tb927.2.400 TPGIGKSFGVGSFLLQRLLHYDSELLRNIAYFVKGRAYIFFRATNDHPGKVVFYEKEKDG 360 
Tb927.2.380 TPGIGKSFGVGSFLLQRLLHYDSERLRNIAYFVKGEAYIFFRATNDHPRKVVFYEKEVDG 360 
Tb927.10.110#* GGNSHEGTKKKKILLQRLLHYDSELLRIIACFVKGGAYIFFRATNGHPGRVVFYE-ENDG 64 
Tb927.4.210#* ------------NPAPRVAALRFGAVADYRLFCEGGIYFLHGDKRSSGKGCILKRKWSGC 48 
Tb927.1.180 TPGIGKSFSVGSLLLYKLLHYEASQLQIIIYVVRGKAYVFHKPIGGRAGYVTFYNDYGNA 398 
Tb927.1.220 TPGIGKSFSVGSLLLYKLLHYEASQLQIIIYVVRGKAYVFHKPIGGRAGYVTFYNDYGNA 398 
Tb927.2.370 TPGIGKSFSVGSLLLYKLLHYEASQLQIIIYVVRGKAYVFHKPIGGRAGYVTFYNDYGNA 399 
Tb927.2.100 TPGIGKSFSVGSLLLYKLLHYEASQLQIIIYVVRGKAYVFHKPIGGRAGYVTFYSNYENA 394 
Tb927.4.100# ------------ILLYKLLHYEASQLQIIIYVVEGEAYVFRKPKGDRAGYVTFYSNYKSA 48 
Tb927.4.200 TPGIGKSFSTAPFLLYKLLHYESSQLQIIIYVVRGKAYVFHKPKGGRAGYVTFYSNYEQA 243 
Tb927.6.160 TPGIGKSFSTAPFLLYKLLHYEASQLQIIIYVVRGKAYVFHKPIGGRAGYVTFYSNYEHA 243 
Tb927.4.110#* TPGIGKSFSVGSLLLYT------------------------------------------- 359 
Tb927.1.70 TPGIGKSCGLGSFLLHSLLHFHEGMLDVVAYFVGKIAYLIYNKKPGEEGRVEEDRSTDSA 235 
Tb927.4.240 TPGIGKTCGLGSFLLHSLLHFNEGMLDVVAYFVGKIAYLIHNKKPGEEGRVEEDRSTDSA 359 
Tb927.2.510 TPGIGKSYGVGSFLLYSLLHFHDGMFNVIAYFVGKIAYLIYNKKPGEEGRVERYKVPEDA 393 
Tb927.2.1210 TPGIGKSYGVGSFLLHSLLHFHEGMFDVVAYFTDGIAYLIYNKKPGEEGRVEEYEDVKAA 384 
Tb927.6.5180^#*# -------------MLHSLLHFHEGMLDVVAYFTGGIAYLIYNDKPGEEGRVEQYKGVTAS 47 
Tb927.2.560 TPGIGKSYGVGSFLLHSLLHFNDGMLDVVAYFVGKIAYLIYNKKPGEGGKVEQYEDVKAA 388 
Tb927.6.5160 TAGIGKSCGVGSFLLHSLLHFHEGMLDVVAYFTDTIAFLIYNRKGDERGRVERYEGSRAA 382 
Tb927.6.5170^* TPGIGKSCGVGSFLLH-------------------------------------------- 337 
Tb927.2.1180 TPGIGKSYGLGSFLLHSLLHFHEGMLDVVAYFTDTIAYLIYNRKGDERGRVVRYEYLRAA 381 
Tb927.4.220#* TAGIGKSVGVGSFLLQ-------------------------------------------- 343 
Tb927.2.340 TPGIGKSYGVGSFLLHSLLHFNDGMLDVVAYFTDGNAFLIYNKKPGEEERVVQYEHVKAA 381 
Tb927.2.470 TPGIGKSYGVGSFLLHSLLHFNDGMLDVVAYFVGKIAYLIYNKKPGEEGRVERYKVPEDA 382 
Tb927.2.450 TPGIGKSYGVGSFLLHSLLHFNDGMLDVVAYFVGEIAFLIYNKKPGEEGRVEKYVVSKNA 381 
Tb927.1.120 TPGIGKSYGVGSFLLHSLLHFNDGMLDVVAYFTDGIAYLIYNKKPGEEGRVERYKFPEDA 381 
Tb927.4.280 TSGIGKTCGLGSFLFYSLLHFNEGMLDVVAYFLEDAAFLIYNREGEGRGTVDEYKRWESA 359 
Tb927.4.290 TSGIGKTCGLGSFLFYSLLHFNEGMLDVVAYFLEDAAFLIYNREGEGRGTVDEYKRWESA 359 
Tb927.4.270 TSGIGKTCGLGSFLFYSLLHFNEGMLDVVAYFLEDAAFLIYNREGEGRGTVDEYKRWESA 359 
Tb927.4.260 TSGIGKTCGLGSFLFYSLLHFNEGMLDVVAYFLEDSAFLIYNREGEERGTVDEYERWESA 359 
Tb927.4.300 TSGIGKTCGLGSFLFYSLLHFNEGMLDVVAYFLEDAAFLIYNREGEERGTVDEYERWESA 374 
Tb927.5.280^* TPGIGKYGLGLFFTSF-------------------------------------------- 276 
Tb927.2.1170 NPGIGKSQNLGSFILYKLLHYDAEELPVVAYFRGVAAYIFEKSGGGGVGRVREYS--KEA 233 
Tb927.4.250 NPGIGKSQNLGSFILYKLLHYDAEELPVVAYFRGVAAYIFEKSDNGGVGRVREYS--KEA 233 
Tb927.1.420 NPGIGKSQNLGSFILYKLLHYDAEELPVVAYFRGVAAYIFEKSSGGGVGRVKKYS--KGA 233 
Tb927.6.140 NPEIGKSQNSGSFILYKLLHYDAEDLPIAAYFCGEVAYIFEKLGEGGVGIIRQYG--KGA 170 
Tb927.2.240 NPGIGKSQNLGSFILYKLLHYDAEELPIVAYFCGVAAYIFEKSGGGGVGRVREYS--KEA 233 
Tb927.2.1080 NPGIGKSQNFGSFILYKLLHYDAEELPVVAYFRGVAAYIFEKSGGGGVGRVREYS--KEA 233 
Tb927.11.4770*^ NPGIGKSQNLGSFILYNLLHYDAEELPVVAYFRGVAAYIFEKSGGGGVGRVREYS--KEA 182 
Tb927.2.1160#* SAGIGKSVGAGY------------------------------------------------ 327 
Tb927.6.150 SGGFTDTYCYWYTWYWIMWPWIIFASFIASLPRNACCCVFHR-------RDSLLNIQKEK 271 
Tb927.2.1150#* IESVGGHSMYARQLPSEGFSWER------------------RAGQIKCGHICLHDGKCCA 267 
Figure (7). The amino acid sequences multiple alignment of RHS genes present in TREU927. The 
insertion site sequence for mobile element is underlined, the RHS genes that possess a mobile 
elements are marked with (^) for ingi insertion, (#) RIME B and (*) RIME A. 
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Tb927.4.290 ------------------------------------------------------------ 
Tb927.4.280 ------------------------------------------------------------ 
Tb927.4.270 ------------------------------------------------------------ 
Tb927.4.260 ------------------------------------------------------------ 
Tb927.4.300 ATGTCAAGAGCCAATAGCCCCGCAGCTCCACAAGGAAATAACGCAAACCCACAAGTGCCA 60 
Tb927.2.1180 ------------------------------------------ATGAATCAACAGGTTCCT 18 
 
 
Tb927.4.290 ------------------AT------GAGGAGGCCACGGGATGAACATGTAGCACCTCCT 36 
Tb927.4.280 ------------------AT------GAGGAGGCCACGGGATGAACATGTAGCACCTCCT 36 
Tb927.4.270 ------------------AT------GAGGAGGCCACGGGATGAACATGTAGCACCTCCT 36 
Tb927.4.260 ------------------AT------GAGGAGGCCACGGGATGAACATGTAGCACCTCCT 36 
Tb927.4.300 AATAACATTGAAGGGCCCAT------GAGGAGGCCACGGGATGAAAATGTAGCACCTCCT 114 
Tb927.2.1180 ATTGAAGGAAGGGGTGACATTGAGGGAAGGAGACGAGAAAATGAGGAGGCTGCGCGTAAC 78 
** ***** * * ****  * *  ** * * 
 
Tb927.4.290 CCTGCTCAGCCTCCACAGATGCCGCAGAGA-TATAAAAGATTTTCTGATTGGAAAATGAA 95 
Tb927.4.280 CCTGCTCAGCCTCCACAGATGCCGCAGAGA-TATAAAAGATTTTCTGATTGGAAAATGAA 95 
Tb927.4.270 CCTGCTCAGCCTCCACAGATGCCGCAGAGA-TATAAAAGATTTTCTGATTGGAAAATGAA 95 
Tb927.4.260 CCTGCTCAGCCTCCACAGATGCCGCAGAGA-TATAAAAGATTTTCTGATTGTAAAATGAA 95 
Tb927.4.300 CCTGCTCAGCCTCCACAGATGCCGCAGAGA-TATAAAAGATTTTCTGATTGGAAAATGAA 173 
Tb927.2.1180 GATGCGGAACCTCCAGTAGTGCAGCAACGAGTGGAGAATAACAACCAACC--ACAATGGG 136 
***  * ****** *** ***  ** *  * ** * * * * **** 
 
Tb927.4.290 -------CAG-TACAGTGAGGGATTTTTTGCTGGAAGAATATGCGACATTGCCCAAA-AT 146 
Tb927.4.280 -------CAG-TACAGTGAGGGATTTTTTGCTGGAAGAATATGCGACATTGCCCAAA-AT 146 
Tb927.4.270 -------CAG-TACAGTGAGGGATTTTTTGCTGGAAAGATATGCGACATTGCCCAAA-AT 146 
Tb927.4.260 -------CAG-TACAGTGAGGGATTTTTTGCTGGAAGAATATGCGACATTGCCCAAA-AT 146 
Tb927.4.300 -------CAG-TACAGTGAGGGATTTTTTGCTGGAAGAATATGCGACATTGCCCAAA-AT 224 
Tb927.2.1180 GTCTTTTCAGCTGCGTTGACGCAGTTTT-GCTG-AATGGTCTGCCACATCCTAGAAATAT 194 
 *** * *  *** * * **** **** ** * *** **** *** **  
Tb927.4.290 GAATCTGCATGACTTTTTGAATCAATGCTTCT--CAAACACGTATAACAC-AGTGAA--- 200 
Tb927.4.280 GAATCTGCATGACTTTTTGAATCAATGCTTCT--CAAACACGTATAACAC-AGTGAA--- 200 
Tb927.4.270 GAATCTGCATGACTTTTTGAATCAATGCTTCT--CAAACACGTATAACAC-AGTGAA--- 200 
Tb927.4.260 GAATCTGCATGACTTTTTGAATCAATGCTTCT--CAAACACGTATAACAC-AGTGAA--- 200 
Tb927.4.300 GAATCTGCATGACTTTTTGAATCAATGCTTCT--CAAACACGTATAACAC-AGTGAA--- 278 
Tb927.2.1180 GATGTTGAATGATTTTTTGAGGCG-TAATTTTGGCAGA-AGATATAATGTGAATGAAGAA 252 
 ** ** **** *******  *  *  ** *  ** * *  ***** * ****  
Tb927.4.290 -----TGTGTCAATGGAAACGTTTGTTAAGAATCCTGAAGATTATATTAAGGATGCCGAG 255 
Tb927.4.280 -----TGTGTCAATGGAAACGTTTGTTAAGAATCCTGAAGATTATATTAAGGATGCCGAG 255 
Tb927.4.270 -----TGTGTCAATGGAAACGTTTGTTAAGAATCCTGAAGATTATATTAAGGATGCCGAG 255 
Tb927.4.260 -----TGTGTCAATGGAAACGTTTGTTAAGAATCCTGAAGATTATATTAAGGATGCCGAG 255 
Tb927.4.300 -----TGTGTCAATGGAAACGTTTGTTAAGAATCCTGAAGATTATATTAAGGATGCCGAG 333 
Tb927.2.1180 AATAATGTATCAATGTCTGCGTTCGTACTGGAACCTGAAGAGTATATTAATGACGTTAAT 312 
 *** ****** **** ** * * ******** ******** ** * *  
Tb927.4.290 ATTCTTGA--GGATATACAGGGGCTTTATGAGTTCAGGGAGTACAAAAGGATTGTTGAGA 313 
Tb927.4.280 ATTCTTGA--GGATATACAGGGGCTTTATGAGTTCAGGGAGTACAAAAGGATTGTTGAGA 313 
Tb927.4.270 ATTCTTGA--GGATATACAGGGGCTTTATGAGTTCAGGGAGTACAAAAGGATTGTTGAGA 313 
Tb927.4.260 ATTCTTGA--GGATATACAGGGGCTTTATGAGTTCAGGGAGTACAAAAGGATTGTTGAGA 313 
Tb927.4.300 ATTCTTGA--GGATATACAGGATACGGATGAGTTT--------CAA-----TTACTGAGG 378 
Tb927.2.1180 GCGCTCAATCGAATATTC-GCGACAACA-GAGTATAAAGTGTACAAACGTTTTGTCAG-- 368 
 **  *  * **** * * * **** *** **  
Tb927.4.290 AACTGCCTGAAACAGAAATGTGGATAAACTACCTTAAAGAGGAAAAAAT-TTTTACCATC 372 
Tb927.4.280 AACTGCCTGAAACAGAAATGTGGATAAACTACCTTAAAGAGGAAAAAAT-TTTTACCATC 372 
Tb927.4.270 AACTGCCTGAAACAGAAATGTGGATAAACTACCTAAAAGAGGAAAAAAT-TTTTACCATC 372 
Tb927.4.260 AACTGCCTGAAACAGAAATGTGGATAAACTACCTTAAAGAGGAAAAAAT-TTATACCATC 372 
Tb927.4.300 G-----------CAGATATTT-----ATCTCTCT----GAGGAAAAAAT-TTTTACCATC 417 
Tb927.2.1180 ------------CGTCTATG-------GTTTCTTTGAGGATGAGGGAATATTGAATCTTC 409 
 * ** * * ** ** *** **  * * **  
Tb927.4.290 AGCGATTGGGTGAACGGTGCAACTCCAGAGGTGAA----AAACTCCAT-----TAGCCCC 423 
Tb927.4.280 AGCGATTGGGTGAACGGTGCAACTCCAGAGGTGAA----AAACTCCAT-----TAGCCCC 423 
Tb927.4.270 AGCGATTGGGTGAACGGTGCAACTCCAGAGGTGAA----AAACTCCAT-----TAGCCCC 423 
Tb927.4.260 AGCGATTGGGTGAACGGTGCAACTCCAGAGGTGAA----AAACTCCAT-----TAGCCCT 423 
Tb927.4.300 AGCGATTGGGTGAACGGTGCAACTCCAGAAGTGAA----AAACTCCAT-----TAGCCCC 468 
Tb927.2.1180 AGCGCT--GGC-AACAA-GCAGATGAGGAAGCAAAGGTCAGGTTACAGGCGGATATTCGT 465 
 **** *  ** *** *** * ** * ** * * ** ** *  
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 Tb927.4.290 GTAGCAAGGG--GAAGG------TTGAAT-GCAGT-AC-AACATGCTG----------TC 462 
Tb927.4.280 GTAGCAAGGG--GAAGG------TTGAAT-GCAGT-AC-AACATGCTG----------TC 462 
Tb927.4.270 GTAGCAAGGG--GAAGG------TTGAAT-GCAGT-AC-AACATGCTG----------TC 462 
Tb927.4.260 GTAGCAAGGG--GAAGG------TTGAAT-GCAGT-AC-AATATGCTG----------TC 462 
Tb927.4.300 GTAGCAAGGG--GAAGG------TTGAAT-GCAGT-AC-AACATGCTG----------TC 507 
Tb927.2.1180 GGACTGAGAGATGGAGAGCGCCTTTGGATTGTTGTCACTAACATGTTGAATGATGCACTC 525 
 * * ** *  * ** *** ** *  ** ** ** *** ** **  
Tb927.4.290 ACGGAATCAGAAGTATG-GTTTCT---GCCGCGTGT--TTCTGTCAAAAGTTGTCGAGAT 516 
Tb927.4.280 ACGGAATCAGAAGTATG-GTTTCT---GCCGCGTGT--TTCTGTCAAAAGTTGTCGAGAT 516 
Tb927.4.270 ACGGAATCAGAAGTATG-GTTTCT---GCCGCGTGT--TTCTGTCAAAAGTTGTCGAGAT 516 
Tb927.4.260 ACGGAATCAGAAGTATG-GTTTCT---GCCGCGTGT--TTCTGTCAAAAGTTGTCGAGAT 516 
Tb927.4.300 ACGGAATCAGAAGTATG-GTTTCT---GCCGCGTGT--TTCTGTCAAAAGTTGTCGAGAT 561 
Tb927.2.1180 AATGAAGCAAGGGAACGAGCTGCTCAAACAGCTTGTAGTGCTGTCGAA--CTGAAAGGAT 583 
 *  *** ** * * * * * ** * ** ***  * ***** ** ** ***  
Tb927.4.290 GTTTACGATTCTTTTTACAATGCGAAATGGAGTTATGTGATGTCGGGTTATGATGCGGAG 576 
Tb927.4.280 GTTTACGATTCTTTTTACAATGCGAAATGGAGTTATGTGATGTCGGGTTATGATGCGGAG 576 
Tb927.4.270 GTTTACGATTCTTTTTACAATGCGAAATGGAGTTATGTGATGTCGGGTTATGATGCGGAG 576 
Tb927.4.260 GTTTACGATTCTTTTTACAATGCGAAATGGAGTTATGTGATGTCGGGTTATGATGCGGAG 576 
Tb927.4.300 GTTTACGATTCTTTTTACAATGCGAAATGGAGTTATGTGATGTCGGGTTATGATGCGGAG 621 
Tb927.2.1180 -TGTATGAATCCATATATAATGCGAAATGGAGTTATGTGATGTCGGGTTATCATACAGAG 642 
 * ** ** **  * ** ********************************* ** * ***  
 
Tb927.4.290 CCACTTGGAATGAAGGTATTCGATGGAAGGCCGCAGCGCATATGGACGGAGGCAGAATTG 636 
Tb927.4.280 CCACTTGGAATGAAGGTATTCGATGGAAGGCCGCAGCGCATATGGACGGAGGCAGAATTG 636 
Tb927.4.270 CCACTTGGAATGAAGGTATTCGATGGAAGGCCGCAGCGCATATGGACGGAGGCAGAATTG 636 
Tb927.4.260 CCACTTGGAATGAAGGTATTCGATGGAAGGCCGCAGCGCATATGGACGGAGGCAGAATTG 636 
Tb927.4.300 CCACTTGGAATGAAGGTATTCGATGGAAGGCCGCAGCGCATATGGACGGAGGCAGAATTG 681 
Tb927.2.1180 CCACTTGGCATGAAAGTGTTCGATGGAAGGCCGCAGCGCATGTGGACCGAAGAAGATGTG 
******** ***** ** *********************** ***** ** * *** ** 
702 
Tb927.4.290 AATATAACTCCTAAAACTGCCGATGTTGATGCAAGAGTAAAGGAAGGATCCAATGGTTTG 696 
Tb927.4.280 AATATAACTCCTAAAACTGCCGATTTTGATGCAAGAGTAAAGGAAGGATCCAATGGTTTG 696 
Tb927.4.270 AATATAACTCCTAAAACTGCCGATGTTGATGCAAGAGTAAAGGAAGGATCCAATGGTTTG 696 
Tb927.4.260 AATATAACTCCTAAAACTGCCGATGTTGATGCAAGAGTAAAGGAAGGATCCAATGGTTTG 696 
Tb927.4.300 AATATAACTCCTAAAACTGCCGATTTTGATGCAAGAGTAAAGGAAGGATCCAATGGTTTG 741 
Tb927.2.1180 GATATAACTCCTCTTCCTGCGAATGTTGATGCAGAGATTGAGGAGAGACCCGATGGTTTG 
*********** ****  ** ******** *  ****  ** ** ******** 
762 
Tb927.4.290 GAGATTTTTGTTCTTACGTCGGAGAAGGGTTGGCCATACAACAGGTTTGTATTGGGTTAC 756 
Tb927.4.280 GAGATTTTTGTTCTTACGTCGGAGAAGGGTTGGCCATACAACAGGTTTGTATTGGGTTAC 756 
Tb927.4.270 GAGATTTTTGTTCTTACGTCGGAGAAGGGTTGGCCATACAACAGGTTTGTATTGGGTTAC 756 
Tb927.4.260 GAGATTTTTGTTCTTACGTCGGAGAAGGGTTGGCCATACAACAGGTTTGTATTGGGTTAC 756 
Tb927.4.300 GAGATTTTTGTTCTTACGTCGGAGAAGGGTTGGCCATACAACAGGTTTGTATTGGGTTAC 801 
Tb927.2.1180 GAGATTTTTGTTCTCACTTCGGAGAAAGGTTGGCCATACAACAGGTTTGCATTGGATTAC 
************** ** ******** ********************** ***** **** 
822 
Tb927.4.290 ACTGAGAGATGCAAGACAATTTGCAAGCATGTATATATCCGTCGTGAAATTATGCGCGTG 816 
Tb927.4.280 ACTGAGAGATGCAAGACAATTTGCAAGCATGTATATATCCGTCGTGAAATTATGCGCGTG 816 
Tb927.4.270 ACTGAGAGATGCAAGACAATTTGCAAGCATGTATATATCCGTCGTGAAATTATGCGCGTG 816 
Tb927.4.260 ACTGAGAGATGCAAGACAATTTGCAAGCATGTATATATCCGTCGTGAAATTATGCGCGTG 816 
Tb927.4.300 ACTGAGAGATGCAAGACAATTTGCAAGCATGTATATATCCGTCGTGAAATTATGCGCGTG 861 
Tb927.2.1180 ACTACGGGGCGCAAAGTAGTATTTCAGCACGTATACATCCGTCGTGAAATTGTGCGCGTG 
***  * * **** * * * **** ***** *************** ******** 
882 
Tb927.4.290 TGGTATATAATCCAACGAGGTCTGAAAGCATGGTGGATGGAAGCAACAGCTGAGGGTCCA 876 
Tb927.4.280 TGGTATATAATCCAACGAGGTCTGAAAGCATGGTGGATGGAAGCAACAGCTGAGGGTCCA 876 
Tb927.4.270 TGGTATATAATCCAACGAGGTCTGAAAGCATGGTGGATGGAAGCAACAGCTGAGGGTCCA 876 
Tb927.4.260 TGGTATATAATCCAACGAGGTCTGAAAGCATGGTGGATGGAAGCAACAGCTGAGGGTCCA 876 
Tb927.4.300 TGGTATATAATCCAACGAGGTCTGAAAGCATGGTGGATGGAAGCAACAGCTGAGGGTCCA 921 
Tb927.2.1180 TGGTATAAAGTCGAAAAAGATCTGAAAACATGGTGGGTGGAAAAGACAGCTCACAGACCA 
******* * ** **  ** ******* ******** ***** ****** *  * *** 
942 
Tb927.4.290 CCAATACATATTATTATTGGCACGTCTGGAATTGGTAAAACATGTGGCCTTGGATCATTT 936 
Tb927.4.280 CCAATACATATTATTATTGGCACGTCTGGAATTGGTAAAACATGTGGCCTTGGATCATTT 936 
Tb927.4.270 CCAATACATATTATTATTGGCACGTCTGGAATTGGTAAAACATGTGGCCTTGGATCATTT 936 
Tb927.4.260 CCAATACATATTATTATTGGCACGTCTGGAATTGGTAAAACATGTGGCCTTGGATCATTT 936 
Tb927.4.300 CCAATACATATTATTATTGGCACGTCTGGAATTGGTAAAACATGTGGCCTTGGATCATTT 981 
Tb927.2.1180 CCGATACATATTGTTATTGGTACACCTGGTATTGGTAAATCATATGGCCTTGGATCATTT 
** ********* ******* **  **** ********* *** **************** 
1002 
Tb927.4.290 TTATTTTATTCACTGCTTCACTTCAATGAAGGAATGCTTGATGTTGTTGCATATTTCTTG 996 
Tb927.4.280 TTATTTTATTCACTGCTTCACTTCAATGAAGGAATGCTTGATGTTGTTGCATATTTCTTG 996 
Tb927.4.270 TTATTTTATTCACTGCTTCACTTCAATGAAGGAATGCTTGATGTTGTTGCATATTTCTTG 996 
Tb927.4.260 TTATTTTATTCACTGCTTCACTTCAATGAAGGAATGCTTGATGTTGTTGCATATTTCTTG 996 
236  
 Tb927.4.300 TTATTTTATTCACTGCTTCACTTCAATGAAGGAATGCTTGATGTTGTTGCATATTTCTTG 1041 
Tb927.2.1180 TTGCTTCATTCGTTGCTTCACTTCCATGAAGGAATGCTTGATGTTGTTGCATATTTCACA 
**  ** ****  *********** ******************************** 
1062 
Tb927.4.290 GAGGATGCTGCCTTCCTGATATACAACCGAGAGGGTGAGGGAAGAGGGACTGTTGATGAA 1056 
Tb927.4.280 GAGGATGCTGCCTTCCTGATATACAACCGAGAGGGTGAGGGAAGAGGGACTGTTGATGAA 1056 
Tb927.4.270 GAGGATGCTGCCTTCCTGATATACAACCGAGAGGGTGAGGGAAGAGGGACTGTTGATGAA 1056 
Tb927.4.260 GAGGATTCTGCCTTCCTGATATACAACCGAGAGGGTGAGGAAAGAGGGACTGTTGATGAA 1056 
Tb927.4.300 GAGGATGCTGCCTTCCTGATATACAACCGAGAGGGTGAGGAAAGAGGGACTGTTGATGAA 1101 
Tb927.2.1180 GACACGATCGCCTACTTAATATATAACAGAAAGGGTGATGAAAGAGGGAGGGTTGTGCGG 
** **** * * ***** *** ** ******* * ********  **** 
1122 
Tb927.4.290 TACAAACGCTGGGAGTCTGCCGTTGCTGCCATAAATAAAATGAAATCTGAAAGCAAAGGG 1116 
Tb927.4.280 TACAAACGCTGGGAGTCTGCCGTTGCTGCCATAAATAAAATGAAATCTGAAAGCAAAGGG 1116 
Tb927.4.270 TACAAACGCTGGGAGTCTGCCGTTTCTGCCATAAATAAAATGAAATCTGAAAGCAAAGGG 1116 
Tb927.4.260 TACGAACGCTGGGAGTCTGCCGTTGCTGCCATAAATAAAATGAAATCTGAAAGCAAAGGG 1116 
Tb927.4.300 TACGAACGCTGGGAGTCTGCCGTTGCTGCCATAAATAAAATGAAATTTGAAAACAGAGGA 1161 
Tb927.2.1180 TACGAATATTTGAGAGCTGCGGTCAACGCCATAAATAAAATGAAATTTGAAAACAGAGGA 
*** ** * * **** ** ******************* ***** ** *** 
1182 
Tb927.4.290 CACATTGTTATGGACACAAGGTATGCAATGGAGGAACTATACACTCAACTTCCCTCTGAT 1176 
Tb927.4.280 CACATTGTTATGGACACAAGGTATGCAATGGAGGAACTATACACTCAACTTCCCTCTGAT 1176 
Tb927.4.270 CACATTGTTATGGACACAAGGTATGCAATGGAGGAACTATACACTCAACTTCCCTCTGAT 1176 
Tb927.4.260 CACATTGTTATGGACACAAGGTATGCAATGGAGCAACTATACACTCAACTTCCCTCTGAT 1176 
Tb927.4.300 CACATTATTATGGACACAAGGTATGCAATGGAGAAACTATACACTCAACTTCCCTCTGAT 1221 
Tb927.2.1180 CACATTATTATGGACATAAGGTATGCAATGCAGCAGCTTTACACTCAACTTCCCTCTGAT 
****** ********* ************* ** * ** ********************* 
1242 
Tb927.4.290 GTTTGGAGTGTAACTTTCCTCACTTTCCCTAAAAGTGCCCATTTTGATGAGTGGAGTGCA 1236 
Tb927.4.280 GTTTGGAGTGTAACTTTCCTCACTTTCCCTAAAAGTGCCCATTTTGATGAGTGGAGTGCA 1236 
Tb927.4.270 GTTTGGAGTGTAACTTTCCTCACTTTCCCTAAAAGTGCCCATTTTGATGAGTGGAGTGCA 1236 
Tb927.4.260 GTTTGGAGTGTAACTTTCCTCACTTTCCCTAAAAGTGACCATTTTGATGAGTGGAGTGCA 1236 
Tb927.4.300 GTTTGGAGTGTAACTTTCCTCACTTTCCCTAAAAGTGCCCATTTTGATGAGTGGAGTGCA 1281 
Tb927.2.1180 GTTTGGAGTGTAACTATTTTCACTTCCCCGAATAGTTCCCACTTTGGTAACTGGACTACA 
*************** *  ****** *** ** ***  *** **** * * **** * ** 
1302 
Tb927.4.290 AATAAGGGAGGCCACCATATTATTATAAACTGCGATGATGTGCGTGACATGAAGGCATTT 1296 
Tb927.4.280 AATAAGGGAGGCCACCATATTATTATAAACTGCGATGATGTGCGTGACATGAAGGCATTT 1296 
Tb927.4.270 AATAAGGGAGGCCACCATATTATTATAAACTGCGATGATGTGCGTGACATGAAGGCATTT 1296 
Tb927.4.260 AATAAGGGAGGCCACCAAATTATTATGAACTGCGATGATGTGCGTGACATGAAGGCATTT 1296 
Tb927.4.300 AATAAGGGAGGCCACCAAATTATTATGAACTGCGATGATGTGCGTGACATGAAGGCATTT 1341 
Tb927.2.1180 ATTACGGGAGGCCGCCAAATTATTATAAACTGTGATGATGTGCGTGACATGAAGGCATTT 
* ** ******** *** ******** ***** *************************** 
1362 
Tb927.4.290 ATGGCATGGAAAAAGCTGTCAATACATACAGGAGAAAAGGTGTCCAACAGAAGAAGATAC 1356 
Tb927.4.280 ATGGCATGGAAAAAGCTGTCAATACATACAGGAGAAAAGGTGTCCAACAGAAGAAGATAC 1356 
Tb927.4.270 ATGGCATGGAAAAAGCTGTCAATACATACAGGAGAAAAGGTGTCCAACAGAAGAAGATAC 1356 
Tb927.4.260 ATGGCATGGAAAAAGCTGTCAATACATACAGGAGAAAAGGTGTCCAACAGAAGAAGATAC 1356 
Tb927.4.300 ATGGCATGGAAAAAGCTGTCAATACATACAGGAGAAAAGGTGTCCAACAGAAGAAGATAC 1401 
Tb927.2.1180 GTGGCATGGAAAAAACTGTCAATACATACAAGGGAAAAGGTATCCAACAGAAGAAGACAC 
************* *************** * ******** *************** ** 
1422 
Tb927.4.290 GAATTGAAGAGAGAAATTGAAGATGAGTGGAAAATAGTGGAGGGACGCATTAATTTAATT 1416 
Tb927.4.280 GAATTGAAGAGAGAAATTGAAGATGAGTGGAAAATAGTGGAGGGACGCATTAATTTAATT 1416 
Tb927.4.270 GAATTGAAGAGAGAAATTGAAGATGAGTGGAAAATAGTGGAGGGACGCATTAATTTAATT 1416 
Tb927.4.260 GAATTGAAGAGAGAAATTGAAGATGAGTGGAAAATAGTGGAGGAACGCATTAATTTAATT 1416 
Tb927.4.300 GAATTGAAGAGAGAAATTGAAGATGAGTGGAAAATAGTGGAGGGACGCATTAATTTAATT 1461 
Tb927.2.1180 GAATTGAGGAAGGAAATGGAAGATGAGTGGAGAATAGTGGAGGGACGTATTAATTCAATT 
******* **  ***** ************* *********** *** ******* **** 
1482 
Tb927.4.290 GGACCGCTGCCTCGTTATATATTTGGTTTAGGTTGTTATGAGTGGCATCTGAAAAGTGTG 1476 
Tb927.4.280 GGACCGCTGCCTCGTTATATATTTGGTTTAGGTTGTTATGAGTGGCATCTGAAAAGTGTG 1476 
Tb927.4.270 GGACCGCTGCCTCGTTATATATTTGGTTTAGGTTGTTATGAGTGGCATCTGAAAAGTGTG 1476 
Tb927.4.260 GGACCGCTGCCTCGTTATATATTTGGTTTAGGTTGTTATGAGTGGCATCTGAAAAGTGTG 1476 
Tb927.4.300 GGACCGCTGCCTCGTTATATATTTGGTTTAGGTTGTTATGAGTGGCATCTGAAAAGAGTG 1521 
Tb927.2.1180 GGGCTTTTGCCTCGTTATATATTTGTTTTAAGCTGTTATGAATGGCGTCTGAAAAGAGTT 
** * ****************** **** * ******** **** ********* ** 
1542 
Tb927.4.290 TATGATGCGTTGAGAGCTATGAAGAAATCTGATAAATATTGCTATAATGATATTATTGAA 1536 
Tb927.4.280 TATGATGCGTTGAGAGCTATGAAGAAATCTGATAAATATTGCTATAATGATATTATTGAA 1536 
Tb927.4.270 TATGATGCGTTGAGAGCTATGAAGAAATCTGATAAATATTGCTATAATGATATTATTGAA 1536 
Tb927.4.260 TATGATGCGTTGAGAGCTATGAAGAAATCTGATAAATATTGCTATAATGATATTATTGAA 1536 
Tb927.4.300 TATGATGCGTTGAGAGCTATGAAGAAATCTGATAAATATTGCTATAATGATATTATTGAA 1581 
Tb927.2.1180 CATGATGCGTTGGAAACTATGAAGAAGTCGGATGAATATTCCTATAATGATATTATTGAG 
***********  * ********** ** *** ****** ****************** 
1602 
237  
 Tb927.4.290 CACACGGCTGACTGGCGGAACGATGAAGTTATGAACAAGTTGGTGAAGATTGTAAGAGTA 1596 
Tb927.4.280 CACACGGCTGACTGGCGGAACGATGAAGTTATGAACAAGTTGGTGAAGATTGTAAGAGTA 1596 
Tb927.4.270 CACACGGCTGACTGGCGGAACGATGAAGTTATGAACAAGTTGGTGAAGATTGTAAGAGTA 1596 
Tb927.4.260 CACACGGCTGACTGGCGGAACGATGAAGTTATGAACAAGTTGGTGAAGATTGTAAGAGTA 1596 
Tb927.4.300 CACACGGCTGACTGGCGGAACGATGAAGTTATGAACAAGTTGGTGAAGATTGTAAGAGTA 1641 
Tb927.2.1180 CATACCGCTGCCTGGAAGAACAATGAAGTTACGGAAAAGTTGGTAAAGGTTGTAAGAGTA 
** ** **** ****  **** ********* * * ******** *** *********** 
1662 
Tb927.4.290 AAAGGAAATGTTGGAGGAGTCGAATCATACAAATGTCAAGCCCTATCACTGATGATCAGA 1656 
Tb927.4.280 AAAGGAAATGTTGGAGGAGTCGAATCATACAAATGTCAAGCCCTATCGCTTATGATCAGA 1656 
Tb927.4.270 AAAGGAAATGTTGGAGGAGTCGAATCATACAAATGTCAAGCCCTATCGCTGATGATCAGA 1656 
Tb927.4.260 AAAGGAAATGTTGGAGGAGTCGAATCATACAAATGTCAAGCCCTATCGCTGATGATCAGA 1656 
Tb927.4.300 AAAGGAAATGTTGGAGGAGTCGAATCATACAAATGTCAAGCCCTATCGCTGATGATCAGA 1701 
Tb927.2.1180 AAGGGAAATGTTGGATTTATCGAATCATTTAAATTTCAAGCTCTATCACTGATGATTCGA 
** ************ *********  **** ****** ***** ** ***** ** 
1722 
Tb927.4.290 
Tb927.4.280 
Tb927.4.270 
Tb927.4.260 
Tb927.4.300 
Tb927.2.1180 
AATATGATGATGAATTAA 1674 
AATATGATGATGAATTAA 1674 
AATATGATGATGAATTAA 1674 
AATATGATGATGAATTAA 1674 
AATATGATGATGAATTAA 1719 
AATATGATGATGAGTTAA 1740 
************* **** 
 
Figure (8). Nucleotide sequence alignments the duplicated genes, of RHS/pseudogenes present in 
TREU927 genome. The adopted mutations at the N-terminal, is underlined. 
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